oxonic acid has been researched along with Lymph Node Metastasis in 404 studies
Oxonic Acid: Antagonist of urate oxidase.
Excerpt | Relevance | Reference |
---|---|---|
"This study evaluated long-term outcomes for patients who received adjuvant gemcitabine plus S-1 chemotherapy after resection for pancreatic carcinoma." | 9.16 | Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma. ( Hashimoto, Y; Kondo, N; Murakami, Y; Nakagawa, N; Nakashima, A; Sudo, T; Sueda, T; Uemura, K, 2012) |
"This is the first phase II study of S-1 monotherapy for patients with metastatic colorectal cancer after failure of both irinotecan- and oxaliplatin-containing regimens." | 9.12 | A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens. ( Ahn, JB; Cho, BC; Chung, HC; Jeung, HC; Rha, SY; Roh, JK; Roh, WJ; Yoo, NC, 2006) |
"The aim of this study was to investigate the prognostic significance of HuR in cholangiocarcinoma patients who received adjuvant gemcitabine-based chemotherapy (AGC) after surgical resection." | 7.88 | Cytoplasmic Hu-Antigen R (HuR) Expression is Associated with Poor Survival in Patients with Surgically Resected Cholangiocarcinoma Treated with Adjuvant Gemcitabine-Based Chemotherapy. ( Kondo, N; Murakami, Y; Nakagawa, N; Sueda, T; Takahashi, S; Toyota, K; Uemura, K, 2018) |
"We report the case of a patient in which S-1 plus anastrozole was administered as first-line chemotherapy for Stage IV breast cancer with skin invasion, multiple lymph node metastasis, and lymphangitis carcinomatosis." | 7.85 | [A Case of Stage IV Breast Cancer with Extensive Metastasis Successfully Treated with S-1 plus Anastrozole Therapy]. ( Akami, T; Hatakeyama, T; Matsumura, A; Mugitani, T; Ogino, S; Okano, S; Sakai, T, 2017) |
"We report curative resection of an advanced intrahepatic cholangiocarcinoma that responded well to combined S-1 and gemcitabine chemotherapy(GS therapy)." | 7.83 | [Resection of Advanced Intrahepatic Cholangiocarcinoma after an Effective Response to S-1 and Gemcitabine Combination Therapy]. ( Fukuda, S; Kuga, Y; Moriya, T; Nishida, T, 2016) |
"A 70-year-old woman with pulmonary carcinomatous lymphangitis and paraaortic lymph node metastases due to gastric cancer, was treated by combination chemotherapy of S-1 and irinotecan (CPT-11)." | 7.74 | [A case of advanced gastric cancer with pulmonary carcinomatous lymphangitis and paraaortic lymph node metastases responding to combination chemotherapy of S-1 and irinotecan(CPT-11)]. ( Adachi, K; Arimoto, Y; Nishio, K; Ohba, H; Ohtani, H; Shintani, M; Yui, S, 2008) |
"Peritoneal metastasis of gastric cancer has extremely poor clinical outcomes." | 5.40 | Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites. ( Emoto, S; Ishigami, H; Kaisaki, S; Kitayama, J; Watanabe, T; Yamaguchi, H; Yamashita, H, 2014) |
"We report a case of advanced gastric cancer successfully treated with preoperative S-1/Lentinan (LTN)chemotherapy followed by curative gastrectomy." | 5.39 | [A case of advanced gastric cancer with para-aortic lymph node metastasis successfully treated with preoperative S-1/Lentinan chemotherapy followed by curative gastrectomy]. ( Aono, T; Deguchi, K; Deguchi, T; Endo, S; Fujitani, K; Fukui, A; Fushimi, H; Higashi, S; Iwase, K; Kawada, J; Matsuda, C; Nishikawa, K; Noguchi, Y; Nomura, M; Okumura, Y; Takagi, M; Tamagawa, H; Tanaka, Y; Yoshida, H, 2013) |
"A 70-year-old male presented with gastric cancer with para-aortic lymph node metastasis." | 5.36 | [A case of gastric cancer with para-aortic lymph node metastasis successfully treated with S-1/paclitaxel/lentinan combination therapy]. ( Matsunaga, N; Nakagawa, Y; Noda, S; Yanagawa, K, 2010) |
"This study evaluated long-term outcomes for patients who received adjuvant gemcitabine plus S-1 chemotherapy after resection for pancreatic carcinoma." | 5.16 | Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma. ( Hashimoto, Y; Kondo, N; Murakami, Y; Nakagawa, N; Nakashima, A; Sudo, T; Sueda, T; Uemura, K, 2012) |
"This is the first phase II study of S-1 monotherapy for patients with metastatic colorectal cancer after failure of both irinotecan- and oxaliplatin-containing regimens." | 5.12 | A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens. ( Ahn, JB; Cho, BC; Chung, HC; Jeung, HC; Rha, SY; Roh, JK; Roh, WJ; Yoo, NC, 2006) |
"The aim of this study was to investigate the prognostic significance of HuR in cholangiocarcinoma patients who received adjuvant gemcitabine-based chemotherapy (AGC) after surgical resection." | 3.88 | Cytoplasmic Hu-Antigen R (HuR) Expression is Associated with Poor Survival in Patients with Surgically Resected Cholangiocarcinoma Treated with Adjuvant Gemcitabine-Based Chemotherapy. ( Kondo, N; Murakami, Y; Nakagawa, N; Sueda, T; Takahashi, S; Toyota, K; Uemura, K, 2018) |
"We report the case of a patient in which S-1 plus anastrozole was administered as first-line chemotherapy for Stage IV breast cancer with skin invasion, multiple lymph node metastasis, and lymphangitis carcinomatosis." | 3.85 | [A Case of Stage IV Breast Cancer with Extensive Metastasis Successfully Treated with S-1 plus Anastrozole Therapy]. ( Akami, T; Hatakeyama, T; Matsumura, A; Mugitani, T; Ogino, S; Okano, S; Sakai, T, 2017) |
"We report curative resection of an advanced intrahepatic cholangiocarcinoma that responded well to combined S-1 and gemcitabine chemotherapy(GS therapy)." | 3.83 | [Resection of Advanced Intrahepatic Cholangiocarcinoma after an Effective Response to S-1 and Gemcitabine Combination Therapy]. ( Fukuda, S; Kuga, Y; Moriya, T; Nishida, T, 2016) |
"This study enrolled 100 patients with Union for International Cancer Control (UICC) stages I-IV biliary tract cancer who underwent surgical resection, including 16 who received sequential adjuvant chemotherapy with gemcitabine or S-1." | 3.79 | Surgical treatment and adjuvant chemotherapy for patients with biliary tract cancer: single institution experience of 100 patients. ( Harada, N; Ikeda, T; Ikegami, T; Kawanaka, H; Maehara, Y; Matsuura, H; Morita, M; Okadome, K; Oki, E; Saeki, H; Shirabe, K; Soejima, Y; Uchiyama, H; Yamashita, Y; Yoshizumi, T, 2013) |
"A 70-year-old woman with pulmonary carcinomatous lymphangitis and paraaortic lymph node metastases due to gastric cancer, was treated by combination chemotherapy of S-1 and irinotecan (CPT-11)." | 3.74 | [A case of advanced gastric cancer with pulmonary carcinomatous lymphangitis and paraaortic lymph node metastases responding to combination chemotherapy of S-1 and irinotecan(CPT-11)]. ( Adachi, K; Arimoto, Y; Nishio, K; Ohba, H; Ohtani, H; Shintani, M; Yui, S, 2008) |
"High-dose toremifene therapy (120 mg/day) is useful for the recurrence of receptor-positive breast cancer." | 3.74 | [Evaluation of combination therapy of high-dose toremifene and oral chemotherapy]. ( Murakami, S; Yamamoto, Y, 2007) |
"We describe our experience with a patient who had undifferentiated gastric carcinoma with extensive lymph node metastasis, including para-aortic lymph-node metastasis, and had a complete response to induction therapy with methotrexate plus 5-fluorouracil (sequential therapy with MTX, 5-FU, and Leucovorin) and secondary treatment with oral TS-1." | 3.73 | [Stage IV gastric cancer patient who underwent palliative gastrectomy showing complete response to induction therapy with methotrexate plus 5-fluorouracil and secondary treatment with oral TS-1]. ( Hiramatsu, K; Mizukami, Y; Momiyama, M; Nagashima, T; Niimi, K; Suzuki, M, 2005) |
" Grade 3 or worse adverse events were less frequent in the elderly group receiving SOX than in the elderly group receiving CS except for the low incidence of sensory neuropathy (5." | 2.82 | Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer. ( Amagai, K; Bando, H; Chin, K; Fujii, H; Gotoh, M; Hamada, C; Hironaka, S; Hyodo, I; Imamura, H; Miwa, H; Nishikawa, K; Nishina, T; Niwa, Y; Shimada, K; Sugimoto, N; Tanabe, S; Tsuda, M; Tsuji, A; Yamada, Y; Yamaguchi, K; Yasui, H, 2016) |
"Patients with resected pancreatic cancer were randomly assigned (in a 1:1 ratio) to receive gemcitabine (1000 mg/m(2), intravenously administered on days 1, 8, and 15, every 4 weeks [one cycle], for up to six cycles) or S-1 (40 mg, 50 mg, or 60 mg according to body-surface area, orally administered twice a day for 28 days followed by a 14 day rest, every 6 weeks [one cycle], for up to four cycles) at the data centre by a modified minimisation method, balancing residual tumour status, nodal status, and institutions." | 2.82 | Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). ( Boku, N; Fukutomi, A; Hirano, S; Hishinuma, S; Imai, K; Kainuma, O; Kaneoka, Y; Konishi, M; Matsumoto, I; Morinaga, S; Nakamori, S; Ohashi, Y; Ojima, H; Okamura, Y; Sakamoto, H; Sata, N; Shimizu, Y; Sudo, T; Uesaka, K; Yamaguchi, R, 2016) |
"The purpose of this phase I study of the dose escalation of oxaliplatin in combination with oral S-1 and pelvic radiation preoperatively for poor-risk lower rectal cancer was to determine the dose-limiting toxicity (DLT) and recommended dose of oxaliplatin." | 2.80 | A phase I trial of preoperative S-1 in combination with oxaliplatin and pelvic radiation for lower rectal cancer with T4 and lateral pelvic lymph node metastasis. ( Fujita, S; Hamaguchi, T; Ito, Y; Kinugasa, Y; Moriya, Y; Noura, S; Ohue, M; Saito, N; Sakai, D; Shimada, Y, 2015) |
"In patients with highly advanced gastric cancer, the recurrence rate remains high and the prognosis disappointing." | 2.79 | Phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis: -KOGC04-. ( Fukada, J; Fukuda, K; Kawaguchi, O; Kawakubo, H; Kitagawa, Y; Matsuda, S; Saikawa, Y; Shigematsu, N; Takahashi, T; Takeuchi, H, 2014) |
"Locally advanced gastric cancer with extensive regional and/or para-aortic lymph node (PAN) metastases is typically unresectable and associated with poor outcomes." | 2.79 | Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. ( Fukushima, N; Mizusawa, J; Nashimoto, A; Sasako, M; Tanaka, Y; Tsuburaya, A, 2014) |
"Postoperative complications were identified in 18 patients and the overall morbidity rate was 26." | 2.79 | Low creatinine clearance is a risk factor for D2 gastrectomy after neoadjuvant chemotherapy. ( Aoyama, T; Cho, H; Hayashi, T; Ito, Y; Miyashita, Y; Morita, S; Nishikawa, K; Ogata, T; Sakamoto, J; Tanabe, K; Tsuburaya, A; Yoshikawa, T, 2014) |
" After six chemotherapy cycles, the short-term efficacy was evaluated according to the Response Evaluation Criteria in Solid Tumors guidelines and adverse reactions were recorded according to National Cancer Institute Common Toxicity Criteria 2." | 2.79 | Comparison of short-term efficacy and safety of TIROX and DCF regimens for advanced gastric cancer. ( Chang, ZW; Dong, L; Han, ZF; Li, J; Lou, XP; Lu, P; Miao, JH, 2014) |
"S-1 in patients with advanced gastric cancer (AGC)." | 2.78 | Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer. ( Lu, XY; Wang, ML; Wang, X; Yang, JF; Yu, HG; Zhou, LY, 2013) |
"Paclitaxel (160 mg/m²) was administered by infusion for 3 h on the first day." | 2.76 | A phase II multi-center study of triple therapy with paclitaxel, S-1 and cisplatin in patients with advanced gastric cancer. ( Goto, H; Haruta, J; Ina, K; Iwase, H; Kumada, T; Shimada, M; Shinoda, M; Sugihara, M; Tsuzuki, T, 2011) |
"CEA mRNA (+) patients with gastric cancer were treated postoperatively with S-1 monotherapy." | 2.75 | Phase II clinical trial of postoperative S-1 monotherapy for gastric cancer patients with free intraperitoneal cancer cells detected by real-time RT-PCR. ( Ito, S; Kodera, Y; Kojima, T; Mochizuki, Y; Nakanishi, H; Yamamura, Y, 2010) |
"Patients with advanced gastric cancer, naive to chemotherapy or not refractory to fluoropyrimidine, were enrolled." | 2.75 | Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer. ( Boku, N; Hironaka, S; Kojima, T; Machida, N; Muro, K; Shitara, K; Taku, K; Ueda, S; Yamazaki, K; Yokota, T, 2010) |
"Patients with histological proof of prostate cancer refractory to hormonal therapies were eligible." | 2.75 | Efficacy of S-1 in patients with castration-resistant prostate cancer: a phase II study. ( Akaza, H; Fujimoto, H; Ikemoto, I; Kobayashi, M; Naito, S; Namiki, M; Tsukamoto, T; Usami, M, 2010) |
" A pharmacokinetic study of PTX was also performed." | 2.74 | Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer. ( Hidemura, A; Ishigami, H; Kaisaki, S; Kamei, T; Kitayama, J; Miyato, H; Nagawa, H; Otani, K; Soma, D; Yamashita, H, 2009) |
"We report a patient with gallbladder cancer and multiple liver and lymph node metastases which completely responded to S-1, an oral fluoropyrimidine anticancer drug." | 2.73 | [Unresectable gallbladder cancer with lymph node and liver metastases completely responding to S-1 monotherapy - a case report]. ( Furuse, J; Ishii, H; Nakachi, K; Shimizu, S; Suzuki, E; Yoshino, M, 2007) |
"We treated 12 patients with advanced gastric cancer with 80 mg/m2 of S-1 for 21 days and 60 mg/m2 of cisplatin (CDDP) on day 8 every 5 weeks." | 2.71 | Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer. ( Baba, H; Endo, K; Ikeda, Y; Kohnoe, S; Okamura, T; Toh, Y; Yamamoto, M, 2003) |
"However, recurrence occurred and the patient achieved complete response following tegafur/gimeracil/oteracil-based chemotherapy." | 2.55 | Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature. ( Ikeyama, M; Ishizone, S; Nakayama, J; Yoshizawa, J, 2017) |
"We report a case of advanced gastric cancer that responded completely to S-1 neoadjuvant chemotherapy." | 2.53 | [A Case of Advanced Gastric Cancer with a Complete Response to S-1 Neoadjuvant Chemotherapy in an Elderly Patient]. ( Akashi, Y; Inagaki, Y; Inagawa, S; Kemmochi, A; Ohkohchi, N; Satomi, K, 2016) |
"An 80-year-old man with a local recurrence of gastric cancer was treated with S-1 monotherapy leading to a complete response(CR)." | 2.53 | [An Elderly Patient with Local Recurrence of Gastric Cancer Responding Completely to S-1 Monotherapy]. ( Hasegawa, M; Ichikawa, K; Kokado, Y; Koshiba, T; Kusama, T; Sone, N; Yamagami, K, 2016) |
"Without any sign of infection, leukocytosis developed around the 30th POD." | 2.46 | Aggressive recurrence of gastric cancer as a granulocyte-colony-stimulating factor-producing tumor. ( Asada, Y; Fujisawa, K; Iida, Y; Kawaguchi, M; Mitsui, T; Miura, S; Munemoto, Y; Sudo, Y; Takehara, A; Terada, T, 2010) |
"Moreover, pancreatic cancer in most patients is surgically unresectable at the time of diagnosis." | 2.43 | [Recent important insights into treatment of pancreatic cancer]. ( Abe, N; Atomi, Y; Sugiyama, M, 2005) |
"Although the prognosis of gastric cancer with a high level of lymph node metastasis is poor, TS-1 therapy may have a potent efficacy in gastric cancer patients with a high level of lymph node metastasis such as the current case." | 2.41 | [A complete response persisting for twelve months with the use of TS-1 in a patient with paraaortic lymph node metastasis of gastric cancer]. ( Hongo, S; Kusumoto, Y; Nakagawa, M; Sado, S; Tamaki, H; Watanabe, A; Yamada, T; Yoriki, R, 2001) |
"We report a case of gastric cancer in which pCR was obtained in the primary lesion, although stenosis appeared after the neoadjuvant chemotherapy." | 1.62 | [A Case of Gastric Cancer with Extensive Lymph Node Metastasis Causing Stenosis Symptoms in the Primary pCR after Preoperative Chemotherapy]. ( Hiramoto, H; Ishimoto, T; Kosuga, T; Masuyama, M; Matsui, T; Mochizuki, S; Nakamichi, N; Nakashima, S; Tsujiura, M, 2021) |
"Lymph node metastasis was an independent risk factor for both locoregional (P < 0." | 1.62 | Complete circumferential lymphadenectomy around the superior mesenteric artery with preservation of nerve plexus reduces locoregional recurrence after pancreatoduodenectomy for resectable pancreatic ductal adenocarcinoma. ( Hayami, S; Hirono, S; Kawai, M; Kitahata, Y; Kobayashi, R; Miyazawa, M; Okada, KI; Ueno, M; Yamaue, H, 2021) |
" Although weekly paclitaxel followed by reduced S-1 dosage was introduced after surgery, the recurrent mass was observed in the para-aortic region after 2 years." | 1.56 | [A Case of Long-Term Survival with Far Advanced Gastric Cancer after Multidisciplinary Treatments, including Conversion Surgery]. ( Akiyama, T; Fujiwara, Y; Higashida, M; Iwamoto, R; Kinoshita, S; Kitagawa, S; Kubota, H; Mineta, S; Okada, T; Okamoto, Y; Tsuruta, A; Ueno, M; Ueno, T; Watanabe, Y, 2020) |
"We report a case of advanced gastric cancer with right gastroepiploic vein tumor thrombus treated using preoperative S-1 plus cisplatin(CDDP)in which pathological complete response was achieved." | 1.51 | [A Case of Advanced Gastric Cancer with Right Gastroepiploic Vein Tumor Thrombus Treated by Preoperative S-1 plus CDDP That Resulted in Pathological Complete Response]. ( Arai, S; Goseki, N; Koike, M; Kuwabara, H; Nakamura, N; Sanada, T; Sato, T; Tomi, Y; Yoshida, T, 2019) |
"We diagnosed gastric cancer, UM, Less, Type 3, gastric neuroendocrine carcinoma, cT4aN3M0P0CY0, Stage ⅢC." | 1.51 | [Gastric Neuroendocrine Carcinoma(NEC)Treated with CDDP plus CPT-11 Chemotherapy]. ( Kawai, S; Nagase, M; Ono, K; Takehana, T; Yamamoto, K, 2019) |
"Lymph node metastasis was observed microscopically in the #6 lymph nodes." | 1.51 | [A Case of Gastric Small Cell Carcinoma with Rapid Regrowth after Surgery]. ( Aoyama, K; Hayashi, D; Kajiwara, Y; Mikane, Y; Miyake, T; Nishikawa, H; Nogami, T; Nonaka, Y; Shigemitsu, K; Shinoura, S; Syoji, R; Watanabe, M, 2019) |
"Fifty-four patients with resected pancreatic cancer were enrolled." | 1.51 | Body weight loss after surgery affects the continuity of adjuvant chemotherapy for pancreatic cancer. ( Furuhashi, S; Hiraide, T; Kikuchi, H; Kitajima, R; Kiuchi, R; Konno, H; Morita, Y; Sakaguchi, T; Shibasaki, Y; Takeda, M; Takeuchi, H, 2019) |
"His gastric cancer was judged to be resectable without retaining metastatic lymph nodes based on intraoperative findings and abdominal computed tomography." | 1.51 | [A Case of Long-Term Survival Following Two-Stage Surgery for Perforated Advanced Gastric Cancer Caused by Chemotherapy]. ( Fukuda, T; Hino, K; Kamiyama, K; Kato, N; Kojima, A; Ogura, G; Sawada, S; Uotani, H; Yamaguchi, T; Yamashita, I, 2019) |
"Although, gastric cancer is one of the most common cancers worldwide, alpha-fetoprotein (AFP) producing human epidermal growth factor receptor 2 (HER2) positive gastric cancers are rare." | 1.48 | Chemotherapy for alpha-fetoprotein producing gastric cancers expressing human epidermal growth factor receptor 2. ( Arakawa, Y; Hayashi, K; Nagasaki, E; Nakada, K; Tamura, M; Uwagawa, T; Yano, S, 2018) |
"This study suggests that platelets in gastric cancer stroma may create a favorable microenvironment for chemoresistance." | 1.46 | Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study. ( Fushida, S; Kinoshita, J; Miyashita, T; Ninomiya, I; Ohta, T; Oyama, K; Saito, H; Tajima, H; Tsukada, T; Yamaguchi, T, 2017) |
"On the other hand, the 2014 Japanese gastric cancer treatment guidelines(ver." | 1.46 | [A Case of Duodenal Invasive Advanced Gastric Cancer in Which the Primary Tumor Achieved pCR, but Viable Cancer Cells Remained in Lymph Node No.13 after Neoadjuvant Chemotherapy]. ( Choda, Y; Harano, M; Idani, H; Ishida, M; Kubota, T; Matsukawa, H; Miyake, S; Morito, T; Nakano, K; Ojima, Y; Okajima, M; Sato, D; Shiozaki, S; Sumitani, D, 2017) |
"Virchow's lymph node metastasis was confirmed 2 months after surgery." | 1.43 | [A Case of Virchow's Lymph Node Recurrence of Gastric Cancer Who Had Underwent Gastrectomy, and Treated with S-1 Monotherapy Leading to Complete Response (CR)]. ( Kabashima, A; Maekawa, S; Sanefuji, K; Tanaka, S, 2016) |
"He was diagnosed with gastric cancer with para-aortic lymph node metastases." | 1.43 | [Long-Term Complete Response by S-1 Chemotherapy for Gastric Cancer with Para-Aortic Lymph Node Metastases]. ( Akai, T; Higashi, Y; Kojima, T; Maruo, H; Nakamura, K; Nishiyama, R; Shoji, T; Taniguchi, M; Yamazaki, M, 2016) |
"We report a case of advanced gastric cancer with a pathological complete response after neoadjuvant chemotherapy." | 1.43 | [A Case of Advanced Gastric Cancer with a Pathological Complete Response after Neoadjuvant Chemotherapy(S-1/Oxaliplatin)]. ( Fukabori, M; Itoh, Y; Morita, A; Nakayama, M; Saito, H; Suematsu, Y; Takahashi, M; Wakabayashi, K; Yamagishi, S, 2016) |
"The standard of care for stage II/III gastric cancer in Japan is D2 dissection followed by adjuvant S-1 monotherapy." | 1.42 | A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for stage III/IV gastric cancer (CCOG 1106). ( Ishigure, K; Ishiyama, A; Ito, S; Kobayashi, D; Kodera, Y; Kurimoto, K; Matsui, T; Mochizuki, Y; Nakao, A; Nakayama, H; Sakamoto, J; Tanaka, N, 2015) |
"The indications for this were advanced gastric cancer with bulky N2 or N3 lymph nodes, or stage above T4a." | 1.42 | [A Study of Preoperative Chemotherapy with S-1 plus Cisplatin for Advanced Gastric Cancer]. ( Hiratsuka, M; Ishibashi, Y; Ito, Y; Mazaki, J; Omori, K; Suda, H; Suematsu, Y; Takahashi, M; Wakabayashi, K, 2015) |
"We report a rare case of recurrence with bone metastasis from early gastric cancer." | 1.42 | [A Case of Bone Metastasis from Early Gastric Cancer after a Five-Year Disease-Free Interval Following Gastrectomy]. ( Hamakawa, T; Hoshino, H; Ikeda, N; Kamigaki, S; Kawase, T; Kimura, Y; Makari, Y; Mikami, J; Munakata, S; Nakata, K; Ohzato, H; Tsujie, M; Yamamoto, T; Yamamura, J, 2015) |
"A 62-year-old man was diagnosed with gastric cancer and underwent distal gastrectomy, and D1+b lymph node dissection." | 1.42 | [Hepatic Resection of Multiple Liver Metastases from Gastric Cancer after Molecular Targeted Chemotherapy(S-1 plus Cisplatin plus Trastuzumab)]. ( Hosoda, Y; Kawada, J; Kim, Y; Nagai, K; Nishino, M; Okano, M; Okuyama, M; Tsujinaka, T; Yamasaki, M; Yasui, M, 2015) |
"The patient was diagnosed with gastric cancer with liver metastasis, Stage Ⅳ, and treated with chemotherapy (S-1 plus CDDP)." | 1.42 | [A Case Report--A Synchronous Liver Metastasis from Gastric Cancer Treated with Chemotherapy, Surgical Resection of the Gastric Cancer, and RFA of the Liver Metastasis]. ( Ishigami, E; Kawamoto, J; Miyazaki, M; Nakada, S; Shinoda, K; Teranaka, R; Yoichi, T, 2015) |
"He was diagnosed with advanced gastric cancer with multiple liver metastases." | 1.42 | [Multidisciplinary Therapy for Advanced Gastric Cancer with Liver and Brain Metastases]. ( Ako, E; Hirakawa, T; Kametani, N; Kanehara, I; Kato, Y; Komoto, M; Nakazawa, K; Nishimura, S; Taenaka, N; Tanaka, R; Yamada, N; Yamagata, S, 2015) |
"Abdominal computed tomography showed gastric cancer invasion to the left liver lobe." | 1.42 | [A Case of Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy]. ( Kawamoto, S; Maeno, H; Munechika, T; Nagao, S; Nomi, M; Okamoto, T; Sasaguri, T; Sueishi, K; Tanaka, K; Yonemitsu, K, 2015) |
"A 71-year-old man was diagnosed with gastric cancer (LM, Less, type 2, T4aN2M0, cStageⅢb)." | 1.42 | [A Case of Resected Advanced Gastric Cancer Exhibiting Pathological Complete Response after Neoadjuvant Che-motherapy(DTX/CDDP/S-1:DCS)]. ( Kunisaki, C; Masuda, M; Ohshima, T; Rino, Y; Suzuki, Y; Tsuburaya, A; Yukawa, N, 2015) |
"A diagnosis of advanced gastric cancer MLU, Circ, Type 3, 160 mm, tub2, cT4b (SI: panc), cN1, cM0, cH0, cP0, cCY0, cStage ⅢB was made." | 1.42 | [A Case of Advanced Gastric Cancer Responding to Neoadjuvant Docetaxel/CDDP/S-1 Therapy with Metallic Stent Placement, Leading to Curative Surgery]. ( Akiyama, H; Endo, I; Kimura, J; Kunisaki, C; Makino, H; Minami, Y; Suzuki, Y; Takagawa, R; Tsuburaya, A; Yazawa, K, 2015) |
"Patients with stage III gastric cancer who underwent D2 gastrectomy were enrolled." | 1.40 | Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer. ( Fuse, N; Goto, M; Hamaguchi, T; Ito, S; Katai, H; Konishi, M; Sano, T; Sasako, M; Shirao, K; Takahari, D; Tanigawa, N; Terashima, M; Yasui, H; Yoshimura, K, 2014) |
"Peritoneal metastasis of gastric cancer has extremely poor clinical outcomes." | 1.40 | Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites. ( Emoto, S; Ishigami, H; Kaisaki, S; Kitayama, J; Watanabe, T; Yamaguchi, H; Yamashita, H, 2014) |
" The goal of this study was to evaluate the efficacy and safety of combination therapy of cetuximab and S-1 combined with oxaliplatin (SOX) in Chinese patients with advanced gastric cancer." | 1.40 | Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer. ( Chen, XB; Hua, YW; Kong, Y; Liu, HX; Ma, EM; Yang, W; Zhang, B; Zhang, YL; Zhang, ZD, 2014) |
"The histologically diffuse type of gastric cancer accounted for 85% of cases." | 1.40 | Clinicopathological features and outcomes of gastric cancer patients with pulmonary lymphangitis carcinomatosa. ( Boku, N; Endo, M; Fukutomi, A; Funakoshi, T; Kenmotsu, H; Machida, N; Onozawa, Y; Todaka, A; Tsushima, T; Yamazaki, K; Yasui, H; Yokota, T, 2014) |
"We report a rare case in which primary squamous cell carcinoma of the nipple skin was successfully treated with S-1 alone." | 1.40 | [A case of squamous cell carcinoma of the nipple skin successfully treated with S-1 alone]. ( Ishikawa, M; Miyoshi, K; Murakami, S; Nakano, R; Ohuchi, K; Sozaki, M; Uchiyama, A; Umeda, S, 2014) |
"The study included 405 gastric cancer patients who underwent curative gastrectomy with D2 lymph node dissection and received adjuvant therapy between January 2008 and July 2009." | 1.40 | Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study. ( Bae, JM; Choi, MG; Kang, WK; Kim, S; Lee, J; Lee, JH; Lee, SJ; Lim, DH; Lim, HY; Park, JO; Park, SH; Park, YS; Sohn, TS, 2014) |
"The standard treatment for stage IV gastric cancer is chemotherapy, but outcomes remain poor." | 1.40 | Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients. ( Kiyozaki, H; Rikiyama, T; Saito, M; Suzuki, K; Takata, O, 2014) |
"We report a case of advanced gastric cancer that was successfully treated with second-line chemotherapy followed by curative conversion gastrectomy." | 1.40 | [A case of advanced gastric cancer successfully treated with second-line chemotherapy followed by curative conversion gastrectomy]. ( Asaoka, T; Endo, S; Fujitani, K; Fukuda, Y; Fukui, A; Fushimi, H; Harada, Y; Haraguchi, N; Hirao, M; Ikeda, M; Iwase, K; Kawada, J; Miyake, M; Miyamoto, A; Miyazaki, M; Nakamori, S; Nishikawa, K; Sekimoto, M; Takagi, M; Yamamoto, K, 2014) |
"A gastric cancer recurrence with paraaortic lymph node (PALN) metastasis was diagnosed fifteen months after the operation." | 1.40 | [A case of successful treatment of peritoneal dissemination from gastric cancer with S-1/DOC chemotherapy]. ( Ebisui, C; Fukuchi, N; Kinuta, M; Murata, K; Nushijima, Y; Okada, K; Okamura, S; Yanagisawa, T; Yokouchi, H, 2014) |
"Six months after surgery, recurrence was detected in the para-aortic lymph node." | 1.40 | [A case of gastric cancer showing response to first-line XP regimen after lymph node recurrence during the administration of S-1 as postoperative adjuvant chemotherapy]. ( Egawa, T; Ito, Y; Kemmochi, T; Mihara, K; Nagashima, A; Nishiya, S; Yamashiro, N, 2014) |
"Medical records of 133 patients with extrahepatic cholangiocarcinoma who underwent curative resection were reviewed retrospectively." | 1.39 | Perineural invasion in extrahepatic cholangiocarcinoma: prognostic impact and treatment strategies. ( Hashimoto, Y; Kondo, N; Murakami, Y; Muto, T; Nakagawa, N; Sasaki, H; Sudo, T; Sueda, T; Uemura, K; Urabe, K, 2013) |
"Here, we present a case of recurrent gastric cancer during S-1 adjuvant therapy that showed partial response to CDDP + capecitabine therapy." | 1.39 | [A case of mediastinal lymph node gastric cancer recurrence during S-1 adjuvant therapy successfully treated with cisplatin + capecitabine as second-line chemotherapy]. ( Ebata, T; Fukaya, M; Hirata, A; Igami, T; Itatsu, K; Nagino, M; Sugawara, G; Tsunoda, N; Uehara, K; Usui, H; Yokoyama, Y; Yoshioka, Y, 2013) |
"S-1/CDDP as a NAC regimen for advanced gastric cancer appears to be an effective treatment." | 1.39 | [A case of advanced gastric cancer with bulky lymph node metastases responding to S-1/CDDP neoadjuvant chemotherapy and leading to less invasive surgery and a pathologically complete response]. ( Eshita, Y; Ogawa, F, 2013) |
"A case of recurrent pancreatic cancer effectively responded to S-1 and irinotecan combined with third-line chemotherapy (IRIS) with PSK." | 1.39 | [A case of recurrent pancreatic cancer effectively responding to S-1 combined irinotecan third-line chemotherapy with PSK]. ( Asano, T; Ishii, M; Iwata, K; Kobayashi, H; Kobayashi, S; Koizumi, S; Okamura, R; Otsubo, T; Saji, O; Sumiyoshi, K, 2013) |
"We report a case of advanced gastric cancer successfully treated with preoperative S-1/Lentinan (LTN)chemotherapy followed by curative gastrectomy." | 1.39 | [A case of advanced gastric cancer with para-aortic lymph node metastasis successfully treated with preoperative S-1/Lentinan chemotherapy followed by curative gastrectomy]. ( Aono, T; Deguchi, K; Deguchi, T; Endo, S; Fujitani, K; Fukui, A; Fushimi, H; Higashi, S; Iwase, K; Kawada, J; Matsuda, C; Nishikawa, K; Noguchi, Y; Nomura, M; Okumura, Y; Takagi, M; Tamagawa, H; Tanaka, Y; Yoshida, H, 2013) |
"The postoperative diagnosis was gastric cancer fStage IA (T1a, N0, and M0)." | 1.39 | [A case of SPT therapy( S-1+CDDP+trastuzumab) was successful for HER2-positive gastric cancer accompanied by distant lymph node metastasis]. ( Aoki, T; Chono, A; Hyuga, N; Kobayashi, K; Matsumoto, T; Nishioka, K; Takachi, K; Takemoto, H; Uemura, Y; Watanabe, R; Yoshida, K, 2013) |
"The final diagnosis was stage II gastric cancer, designated T1N2M0 according to the Japanese classification of gastric carcinoma." | 1.38 | Intramucosal gastric cancer with fifteen metastatic lymph nodes: report of a case. ( Bando, E; Kawamura, T; Sasaki, K; Tanizawa, Y; Terashima, M; Tokunaga, M, 2012) |
" Two cycles of intraperitoneal chemotherapy with docetaxel combined with S-1, were administrated and gastrectomy with lymph node dissection was performed in cases without macroscopic PC at post-NIPS staging laparoscopy." | 1.38 | Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination. ( Doki, Y; Fujiwara, Y; Kurokawa, Y; Miyata, H; Mori, M; Nakajima, K; Takiguchi, S; Yamasaki, M, 2012) |
"The prognosis of gastric cancer with para-aortic lymph node (PAN) metastasis is poor." | 1.38 | Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes. ( Fujimura, T; Fujita, H; Fushida, S; Hayashi, H; Kinoshita, J; Kitagawa, H; Makino, I; Nakagawara, H; Nakamura, K; Ninomiya, I; Ohta, T; Oyama, K; Tajima, H; Takamura, H; Tani, T, 2012) |
"The patient was diagnosed with advanced gastric cancer accompanied by multiple bone metastases, with compression fractures in the thoracolumbar vertebrae as well as distant lymph node metastases." | 1.38 | [A case of advanced gastric cancer with multiple bone metastases and distant lymph node metastases successfully treated by S-1/CDDP combination chemotherapy]. ( Chiba, T; Fujiwara, H; Koeda, K; Mitomo, S; Sugai, T; Takahashi, M; Uesugi, N; Wakabayashi, G, 2012) |
" After recovery from the adverse event, another 4 courses at a 20% lower dosage for safety were administered." | 1.38 | [A case of S-1-resistant resected advanced gastric cancer with para-aortic lymph node recurrence responding to bi-weekly CPT-11 and CDDP]. ( Ikeda, T; Minamoto, K; Yuasa, I, 2012) |
"Patients who had Japanese Gastric Cancer Association (JGCA) cStage IIIB gastric cancer were enrolled onto this study and received oral S-1 (65 mg/m(2)/day) administration and 50-Gy radiotherapy followed by radical surgery." | 1.38 | Pilot feasibility study of neoadjuvant chemoradiotherapy with S-1 in patients with locally advanced gastric cancer featuring adjacent tissue invasion or JGCA bulky N2 lymph node metastases. ( Hagiike, M; Inoue, T; Kimura, T; Okano, K; Suzuki, Y; Usuki, H; Yachida, S, 2012) |
"We experienced two cases of Stage IV gastric cancer undergoing adjuvant surgery after down staging by chemotherapy." | 1.38 | [Two cases of stage IV gastric cancer undergoing adjuvant surgery after down staging by chemotherapy]. ( Azuma, T; Inoue, T; Mori, Y; Ohtani, H; Tamamori, Y, 2012) |
"He was diagnosed as advanced gastric cancer." | 1.38 | [A case of advanced gastric cancer with recurrence-free long survival showing disappearance of distant lymph node metastases by S-1/docetaxel therapy followed by curative resection]. ( Hirata, Y; Itagaki, T; Kameda, A; Miyahara, E; Okamura, K; Sasaki, T; Teramoto, S; Ukon, K, 2012) |
"We report a case of recurrent gastric cancer with paraaortic lymph nodes (No." | 1.38 | [A case of paraaortic lymph node metastasis of gastric cancer resistant to chemotherapy successfully treated with chemoradiation therapy]. ( Danno, K; Fujita, S; Imaoka, S; Kagawa, K; Kanoh, T; Kim, C; Kimura, Y; Monden, T; Ohnishi, T; Taniguchi, H; Tono, T; Yamada, Y; Yoshida, T, 2012) |
" The main adverse events were hematological toxicity, mucositis and dermatitis." | 1.37 | Efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck cancer. ( Murai, M; Ohashi, T; Ohnishi, M; Tanahashi, S, 2011) |
"In patients with stage II/III gastric cancer, tumors often recur even after curative D2 gastrectomy followed by adjuvant S-1 chemotherapy." | 1.37 | Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1. ( Aoyama, T; Cho, H; Hayashi, T; Ogata, T; Tsuburaya, A; Watanabe, T; Yoshikawa, T, 2011) |
" To the best of our knowledge, cases of EGC combined with metachronous osteosclerotic multiple bone and bone marrow metastases that respond to chemoradiotherapy are very rare." | 1.37 | Early gastric cancer combined with multiple metachronous osteosclerotic bone and bone marrow metastases that responded to chemoradiotherapy. ( Chiba, F; Kiyozaki, H; Konishi, F; Saito, M; Shuto, C; Takata, O; Yamada, S; Yoshida, T, 2011) |
"Gemcitabine was administered intravenously at a dose of 1000 mg/m(2) on days 1 and 15, and repeated every 4 weeks." | 1.37 | [Advanced gallbladder cancer that showed complete response to gemcitabine plus S-1 chemotherapy]. ( Handa, K; Hatogai, K; Hibi, T; Higuchi, H; Iwasaki, E; Izumiya, M; Kishino, R; Maeda, N; Mizuki, A; Mukai, K; Nakazawa, A; Seki, E; Shimoyama, Y; Takaishi, H; Takita, M; Tsukada, N, 2011) |
"No distant recurrence was noted during this time." | 1.37 | [A case of breast cancer with postoperative metastasis to the supraclavicular lymph nodes-recurrence-free survival achieved by surgical excision following chemotherapy]. ( Dan, N; Hori, T; Nishino, H; Tendo, M; Tezuka, K, 2011) |
"We report a case of anal cancer in a 58-year-old woman who complained of narrow, bloody stools and anal pain." | 1.37 | Clinical experience with chemoradiotherapy comprising S-1 plus low-dose cisplatin in a patient with stage IV anal cancer. ( Deguchi, T; Fujisaki, M; Kadomura, T; Kato, A; Kato, Y; Kitajima, M; Kojima, M; Kubota, K; Kuroda, J; Nitori, N; Okada, A; Origuchi, N, 2011) |
"The patient was diagnosed as having squamous cell carcinoma of the anal cana (l cStage III)." | 1.37 | [A case report of chemoradiotherapy combined with S-1 responding to squamous cell carcinoma of the anal canal]. ( Baba, H; Goseki, N; Kuwabara, H; Nakajima, K; Nakamura, H; Sanada, T; Wakabayashi, M, 2011) |
"Patients with T4 esophageal cancer generally have poor prognosis." | 1.37 | [A case of residual metastatic lymph node lesion following definitive chemoradiotherapy for T4 esophageal cancer, successfully treated by outpatient clinic-based sequential chemotherapy with docetaxel followed by S-1]. ( Fujiwara, H; Ichikawa, D; Ikoma, H; Kokuba, Y; Komatsu, S; Kuriu, Y; Murayama, Y; Nakanishi, M; Ochiai, T; Okamoto, K; Otsuji, E; Shiozaki, A; Yoneda, M, 2011) |
"Computed tomography showed nodal recurrence 6 months after surgery." | 1.37 | [A case of long-term survival of a patient with intrahepatic bile duct cancer and early nodal recurrence who responded to S-1 therapy]. ( Kametaka, H; Koyama, T; Makino, H; Seike, K, 2011) |
"We report two cases of advanced gastric cancer successfully treated with combination S-1 and docetaxel (DOC) therapy." | 1.36 | [Two cases of advanced gastric cancer with peritoneal dissemination, and Virchow's metastases successfully treated by combination therapy of S-1 and docetaxel]. ( Hasegawa, H; Kijima, T; Kitahara, M; Kubo, H; Miyahara, M; Tada, K, 2010) |
"The rectal cancer was in stage III, and the patient selected no adjuvant chemotherapy." | 1.36 | [A case of metachronous multiple lung metastases and intraabdominal lymph node metastases of rectal cancer responding to S-1]. ( Aiki, F; Hattori, A; Kakisaka, T; Kazui, K; Matsuhisa, T, 2010) |
" When chemotherapy with S-1 or UFT/LV started from the micrometastasis stage, not the advanced macroscopic metastasis stage, anti-LNM efficacy of S-1 was significantly higher than that of UFT/LV at the dosage in which antitumor activity of the two drugs against primary subcutaneous tumor was comparable." | 1.36 | Characterization of a novel lymph node metastasis model from human colonic cancer and its preclinical use for comparison of anti-metastatic efficacy between oral S-1 and UFT/ LV. ( Hirai, T; Ito, Y; Kato, T; Kodera, Y; Nakanishi, H; Nakao, A, 2010) |
"The human scirrhous gastric cancer cell line OCUM-2MLN and the human gastric fibroblasts NF-33 were used." | 1.36 | Combination effect of a TGF-beta receptor kinase inhibitor with 5-FU analog S1 on lymph node metastasis of scirrhous gastric cancer in mice. ( Hirakawa, K; Kawajiri, H; Miwa, A; Shimizu, K; Shimizu, T; Shinto, O; Yashiro, M, 2010) |
"We report a case of advanced gastric cancer, with cervical, axillary, and abdominal paraaortic lymph node metastases, that was successfully treated with chemotherapy and surgery." | 1.36 | Eight-year survival after advanced gastric cancer treated with S-1 followed by surgery. ( Chin, K; Hatake, K; Hijioka, S; Seto, Y; Yamamoto, N, 2010) |
"Due to advanced gastric cancer with abdominal para-aortic lymph node metastases, we performed a curative operation in three cases in which S-1/CDDP combination therapy proved effective." | 1.36 | [Three cases of gastric cancer with para-aortic lymph node metastases succesfully treated by S-1/CDDP combination therapy followed by curative resection]. ( Imai, T; Kanematsu, M; Kawai, M; Kunieda, K; Matsuhashi, N; Nagao, N; Nishina, T; Sakuratani, T; Sasaki, Y; Tajima, JY; Tanaka, C; Yamada, A, 2010) |
"A 70-year-old male presented with gastric cancer with para-aortic lymph node metastasis." | 1.36 | [A case of gastric cancer with para-aortic lymph node metastasis successfully treated with S-1/paclitaxel/lentinan combination therapy]. ( Matsunaga, N; Nakagawa, Y; Noda, S; Yanagawa, K, 2010) |
"Primary cutaneous squamous cell carcinoma (SCC) is a malignant tumor that arises from keratinizing cells of the epidermis or its appendages." | 1.36 | Metastatic cutaneous squamous cell carcinoma treated successfully with surgery, radiotherapy and S-1/cisplatin chemotherapy. ( Ibusuki, A; Kanekura, T; Kawai, K; Kubo, H; Matsushita, S; Mera, K; Tada, K; Yoshii, N, 2010) |
"In patients with advanced rectal cancer, preoperative chemoradiotherapy is superior to postoperative chemoradiotherapy because of causing less toxicity and achieving higher rates of sphincter preservation and curative resection." | 1.36 | A case of pathological complete response of advanced rectal cancer to preoperative chemoradiotherapy using S-1. ( Hama, T; Horiuchi, T; Ishida, K; Miyagawa, Y; Sakaguchi, S; Shono, Y; Tabuse, K; Tamagawa, K; Tanishima, H; Tsubakihara, H; Tsujimoto, T; Uemura, R, 2010) |
"In the case of pancreatic cancer that CRT is effective to the remission of primary lesion, CRT is potentially useful to perform for the control of metastatic lesion or palliative therapy." | 1.36 | [A 6-year survival case of locally advanced unresectable pancreatic tail cancer treated with chemo-radiation therapy]. ( Aoki, H; Choda, Y; Fujiwara, Y; Harano, M; Matsukawa, H; Ninomiya, M; Nishizaki, M; Ohno, S; Ojima, Y; Shiozaki, S; Takakura, N, 2010) |
"Lymph node metastasis was confirmed." | 1.36 | [A clinical case of lymph node recurrence after resection of gastric cancer successfully treated by combination chemotherapy with irinotecan and cisplatin]. ( Endo, W; Fujie, Y; Fukunaga, H; Hojou, S; Maeura, Y; Ota, H; Shimizu, K; Toyoda, Y; Yoshioka, A; Yoshioka, S, 2010) |
"A 42-year-old man with advanced rectal cancer underwent a low anterior resection with TME and pelvic lateral lymph-node and paraaortic lymph-node dissections." | 1.36 | [A long-term disease-free survival case of advanced rectal cancer with massive metastasis to the lateral pelvic and para-aortic lymph nodes]. ( Gotoh, K; Ishikawa, O; Kano, S; Kishi, K; Miyashiro, I; Motoori, M; Noura, S; Ohigashi, H; Ohue, M; Shingai, T; Takahashi, H; Yamada, T; Yano, M, 2010) |
"The patient was recurrence-free and her clinical course was satisfactory." | 1.35 | [Case of gastric cancer with recurrence of carcinomatous lymphangiosis of the lung 7.6 years after surgery and successfully treated with S-1/low-dose CDDP/Lentinan combination therapy]. ( Hirose, N; Kawano, T; Matsusaki, K; Minamisono, Y; Miura, O; Morita, M; Nagasaki, S; Okamoto, F; Okazaki, Y; Toda, T; Yamada, T, 2008) |
"Cholangiocarcinoma is a therapeutically challenging malignancy." | 1.35 | Long-term survival after multimodal therapy in a patient demonstrating intrahepatic cholangiocarcinoma with hilar invasion and intrahepatic metastases. ( Akaike, M; Morinaga, S; Shiozawa, M; Sugano, N; Sugimasa, Y; Wada, H; Yamamoto, Y, 2008) |
"Chemotherapy is rarely used in treating adenosquamous carcinoma, and it has been difficult to establish treatment guidelines due to the paucity of cases." | 1.35 | Adenosquamous carcinoma of maxillary sinus: case showing complete response to S-1. ( Hanata, K; Ishikawa, K; Nanjo, H; Suzuki, S, 2009) |
"A 82-year-old man with advanced gastric cancer underwent distal gastrectomy in January 2006." | 1.35 | [Complete response obtained with first-line therapy as S-1, followed by second-line 5'-DFUR plus paclitaxel therapy in a patient with multiple liver and lymph node metastases from gastric cancer]. ( Kitajima, Y; Miyazaki, K; Nakafusa, Y; Ohtsuka, T; Sato, S; Tanaka, M; Yakabe, T, 2009) |
"Approximately 50% of oral squamous cell carcinomas (OSCC) exhibit cervical lymph node metastasis." | 1.35 | S-1 mediates the inhibition of lymph node metastasis in oral cancer cells. ( Ando, Y; Hatori, M; Kurihara, Y; Sato, H; Shintani, S; Shirota, T; Tachikawa, T; Takayama, S, 2009) |
"The prognosis of gastric cancer patients with peritoneal dissemination is poor." | 1.35 | Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination. ( Hosogi, H; Obama, K; Okabe, H; Sakai, Y; Ueda, S, 2009) |
"A 45-year-old male patient with right colonic cancer, of which clinical finding was SIM1 (No." | 1.35 | [A case of advanced right colonic cancer successfully treated by surgery and post operative chemotherapy]. ( Inoue, S; Nasu, K; Noda, K; Umekita, N, 2009) |
" He was treated with single agent S-1 in 10 courses on a 4-week dosing regimen with a 2-week interval." | 1.35 | [A case of advanced gastric cancer with paraaortic lymph node recurrence reaching a long-term survival by S-1 chemotherapy]. ( Iwanaga, T; Iwasaki, Y; Matsumoto, H; Matsumura, H; Nakano, D; Ohashi, M; Takahashi, K; Yamaguchi, T, 2009) |
"Recently, chemotherapy against gastric cancer has been diversified with an appearance of new agents such as S-1, capecitabine, CPT-11, oxaliplatin, paclitaxel and docetaxel." | 1.35 | [A case of recurrence gastric cancer patient who was post operated and multi drug chemotherapy was effective for administration of S-1 and docetaxel combination therapy]. ( Ami, K; Andou, M; Arai, K; Fukuda, A; Ganno, H; Hataji, K; Kurokawa, T; Nagahama, T; Ohara, T; Tei, S, 2009) |
"The diagnosis was the esophageal cancer (type 2, 11 cm) with big lymph node metastasis on cardia (8 cm), and also pathologically poorly differentiated squamous cell carcinoma from two legions." | 1.35 | [A 14-month surviving patient on advanced esophageal cancer with big lymph node metastasis to cardia responding to S-1 plus cisplatin (CDDP) therapy at home]. ( Doi, T; Handa, R; Hoshi, M; Iijimal, S; Kato, T; Kikkawa, N; Kurokawa, E; Makari, Y; Miyake, Y; Ooshima, S, 2008) |
" As for the dosing method of combination chemotherapy,the patient was treated with a course of TS-1 80 mg daily divided into two doses over 21 days continuously, followed by a 14-day cessation of the drug,together with a dose of CDDP 70 mg on day 8." | 1.34 | [A case of advanced gastric cancer successfully treated with TS-1/CDDP combination chemotherapy, able to maintain CR for more than two years against multiple liver metastases]. ( Hayakawa, Y; Hioki, J; Irinoda, T; Kimura, T; Kobayashi, M; Matsumoto, Y; Meguro, E; Noda, Y; Takagane, A, 2007) |
"He was diagnosed as having esophageal cancer of stage IVa (T2N4M0) in October, 2002, and he received chemoradiotherapy (nedaplatin (CDGP)/5-fluorouracil (5-FU) total 6 course+60 Gy)." | 1.34 | [Recurrent esophageal cancer with complete response to TS-1 chemotherapy]. ( Chinen, T; Fujita, J; Hirata, T; Hokama, A; Kinjo, F; Kinjo, N; Nakachi, N; Nakamoto, M; Uchima, N; Watanabe, T, 2007) |
"A 37-year-old female with advanced gastric cancer and liver metastases was treated with S-1." | 1.34 | A case of suspected S-1 induced interstitial pneumonia. ( Koizumi, W; Munakata, M; Sakata, Y; Shitara, K, 2007) |
"A 62-year-old woman with Barrett's esophageal cancer was hospitalized." | 1.34 | Successful treatment of S-1 + CDDP followed by salvage EMR for a case with metastatic Barrett's esophageal cancer. ( Azuma, M; Higuchi, K; Katada, C; Koizumi, W; Nakatani, K; Nishimura, K; Saigenji, K; Sasaki, T; Shimoda, T; Tanabe, S, 2007) |
"We report a case with gastric cancer and lung metastasis,who responded remarkably to combination chemotherapy using S-1 and weekly CDDP." | 1.34 | [A case of advanced gastric cancer with lung metastasis effectively treated by combination chemotherapy using S-1 and CDDP]. ( Akamatsu, M; Karimata, H; Nagahama, M; Nishimaki, T; Takaesu, H; Teruya, J, 2007) |
"We report a case of recurrent gastric cancer with peritoneal dissemination and paraaortic lymph node metastases, successfully treated with weekly administration of paclitaxel." | 1.34 | [A case of S-1-resistant recurrent gastric cancer successfully treated with weekly administration of paclitaxel]. ( Hirata, K; Ito, T; Sato, T; Takashima, T, 2007) |
"She was diagnosed as primary gastric cancer with peritoneal dissemination and received systemic chemotherapy after distal gastrectomy for a primary lesion." | 1.34 | [A case of breast metastasis of gastric cancer]. ( Cho, H; Hasegawa, S; Kobayashi, O; Osaragi, T; Sairenji, M; Tsuburaya, A; Yoshida, T; Yoshikawa, T, 2007) |
"A 65-year-old man who had AFP producing gastric cancer with massive lymph-node metastasis was admitted to our institution." | 1.34 | [A case of curatively resected AFP producing gastric cancer with massive lymph node metastasis effectively treated by neoadjuvant-chemotherapy of S-1 and CDDP]. ( Amano, S; Aramaki, O; Kano, H; Kawasaki, A; Kuboi, Y; Mimatsu, K; Ogura, M; Oida, T, 2007) |
"Adjuvant chemotherapy for advanced gastric cancer has not yet been established." | 1.34 | [A case of advanced gastric cancer responding remarkably to neo-adjuvant combination chemotherapy using CPT-11 plus S-1]. ( Gotoh, M; Hashimoto, Y; Hoshino, Y; Kashimura, S; Kogure, M; Odashima, Y; Osuka, F; Otani, S; Saito, T; Saze, Z; Soeta, N; Terashima, M; Watanabe, K, 2007) |
"A 75-year-old male patient had advanced gastric cancer with severe lymph node metastasis." | 1.34 | [A case of gastric cancer with severe lymph node metastasis effectively treated with docetaxel / S-1 as neoadjuvant chemotherapy]. ( Itoh, J; Kawasaki, H; Kijima, H; Matsuya, H; Miyamoto, K; Sasaki, M; Shibata, S, 2007) |
"We report a recurrent case of gastric cancer with para-aortic lymph node metastasis that showed a marked response to systemic chemotherapy consisting of S-1 alone." | 1.34 | [Marked response to S-1 chemotherapy for para-aortic lymph node metastasis arising from gastric cancer]. ( Chikuba, A; Chikuba, H; Nakamoto, M; Nezu, M; Shimamura, H; Suzuki, T; Takiue, T; Teraishi, F, 2007) |
"We reported a case of unresectable gastric cancer presenting pylorus stenosis treated orally by S-1 therapy in a 72-year-old man who underwent gastrojejunostomy." | 1.34 | [A case of unresectable gastric cancer presenting pylorus stenosis treated orally with S-1 therapy after gastrojejunostomy]. ( Matsui, K; Morita, S; Shinbo, M; Tazawa, K; Tsukada, K; Yamada, A; Yamagishi, F; Yoshida, T, 2007) |
" The patient was treated with S-1 combined with CPT-11." | 1.34 | [An elderly patient with recurrent rectal cancer successfully responded to S-1 combined with CPT-11]. ( Doi, M; Egawa, T; Hayashi, S; Ito, Y; Kitano, M; Nagashima, A; Sekine, K; Shimizu, M; Yoshii, H, 2007) |
"Case 1: 66-year-old male with advanced gastric cancer invading the pancreas with metastasis to the liver and left neck lymph nodes." | 1.33 | [Three advanced gastric cancer patients successfully treated by combination therapy of docetaxel and TS-1]. ( Hamai, Y; Hihara, J; Ohta, K; Suzuki, T; Tanabe, K; Taomoto, J; Toge, T; Yoshida, K, 2005) |
"For this gastric cancer, clinical Stage IIIA (cT3N1HOPOMO), neoadjuvant chemotherapy with TS-1/CDDP was planned." | 1.33 | [A case of advanced gastric cancer responding to neoadjuvant TS-1/CDDP chemotherapy]. ( Inoue, S; Kawahara, Y; Kitamura, M; Kusano, T; Shioiri, T; Umekita, N; Warabi, M, 2005) |
" After that TS-1 was administered on a 4-week dosing regimen with a 2-week interval between sessions." | 1.33 | [A case of advanced gastric cancer with paraaortic lymph node metastasis reaching long-term survival by TS-1 treatment]. ( Ishii, Y; Suzuki, K; Takahashi, M; Yoshida, S, 2005) |
"In advanced gastric cancer, the frequency of relapses such as metastasis to the peritoneum is high." | 1.33 | [Prediction and treatment of peritoneal dissemination in gastric cancer]. ( Aratake, K; Itabashi, M; Kameoka, S; Mitsuhashi, M; Ogawa, S; Seshimo, A; Shirotani, N, 2005) |
"We reported 2 cases with advanced gastric cancer, successfully treated with TS-1 and CDDP." | 1.33 | [Two cases of advanced gastric cancer, successfully treated with TS-1/CDDP combination chemotherapy--case report]. ( Ando, K; Ishihara, C; Ishiwa, N; Morinaga, S; Noguchi, Y; Ogoshi, T; Shotsu, M; Takeda, A; Yamamoto, Y; Yoshida, S; Yoshikawa, T, 2005) |
"We report herein a case with stage IV gastric cancer previously treated with TS-1 completely responding to second-line chemotherapy with weekly paclitaxel therapy." | 1.33 | [A case of stage IV gastric cancer previously treated with TS-1 completely responding to second-line chemotherapy with weekly paclitaxel therapy]. ( Jingu, K; Kagaya, A; Ochiai, T; Sasagawa, K, 2005) |
" Because salvage therapy with S-1 alone showed good antitumor efficacy and beneficial tolerability when the standard dosage was maintained, it was considered that this home therapy was effective for advanced/recurrent breast cancer that was resistant to anthracycline and taxane antitumor drugs." | 1.33 | [Effective salvage chemotherapy with S-1 alone in a patient with lung metastasis of breast cancer]. ( Itoh, K; Minami, H, 2005) |
"Three cases with unresectable advanced gastric cancer with liver metastases were successfully treated by the combination therapy of TS-1 and cisplatin( CDDP)." | 1.33 | [Three advanced gastric cancer cases with liver metastases successfully treated by TS-1/CDDP combination therapy]. ( Goto, H; Ina, K; Inagaki, J; Ito, A; Ito, N; Kataoka, T; Matsui, W; Nagao, S, 2006) |
"This chemotherapy made it possible to treat liver and lymph node metastasis in an ambulatory setting." | 1.33 | [A case of recurrent esophageal cancer responding to second-line chemotherapy of TS-1/docetaxel combination]. ( Hashimoto, Y; Hayashidani, Y; Morifuji, M; Murakami, Y; Sudo, A; Sueda, T; Sugiyama, Y; Uemura, K, 2006) |
"The patient diagnosed as recurrent pancreatic cancer was treated with UFT combined gemcitabine (GEM) chemotherapy." | 1.33 | [A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease]. ( Kagaya, T; Kaneko, S; Kato, Y; Sunagozaka, H; Yamashita, T, 2006) |
" We carried out 4-week administration of 80-120 mg/day of TS-1 according to body surface area, followed by a 2-week discontinuation, then repeated administration which adjusting the dosage according to the incidence of side effects, and discussed the antitumor effects and adverse events." | 1.33 | [Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer]. ( Hatori, S; Imada, T; Kunisaki, C; Makino, T; Ohshima, T; Rino, Y; Suda, T; Takanashi, Y; Yamada, R; Yamazaki, Y, 2006) |
"At laparotomy to improve anemia and pyloric stenosis in September 2001, lymphnode metastases invaded the stomach and the pancreatic body." | 1.33 | [A case of advanced gastric cancer treated by TS-1 for 3 years and 7 months]. ( Ishizuka, D; Kobayashi, K; Tada, T; Ueki, K; Wakakuwa, R, 2006) |
" Thus, TS-1 and CPT-11 combination therapy has been effective for 17 months, suggesting that it is promising for long-term administration and survival to continue it perseveringly." | 1.33 | [A case of non-curatively resected gastric cancer successfully treated over 17 months with TS-1 and irinotecan combination therapy]. ( Kawamura, S; Okumura, S; Shimada, E; Sumi, Y; Tei, M; Yamagishi, D, 2006) |
"We report a case of N 3 gastric cancer successfully treated by TS-1 followed by curative resection." | 1.33 | [A case of N3 gastric cancer successfully treated by TS-1 followed by curative resection]. ( Hara, S; Hashizume, S; Ishikawa, H; Iwasaki, K; Kamohara, R; Kondou, M; Minami, H; Sumida, Y; Tokunaga, T; Yoshida, K, 2006) |
"In two patients with advanced pancreatic cancer with cervical lymph node or liver metastasis and no indication of pancreatic resection and radiotherapy, oral treatment with S-1 (an anti-cancer agent of fluoropyrimidine derivative) exerted high anti-tumor activity on the metastatic lesions." | 1.33 | [Two cases of advanced pancreatic cancer with cervical lymph node or liver metastasis responding well to S-1 monotherapy]. ( Funakoshi, A; Senju, T; Sumii, T, 2006) |
"We have experienced three gastric cancer cases successfully treated by the combination therapy of CDDP and TS-1." | 1.33 | [Three cases of successfully resectable advanced gastric cancer responding to TS-1 plus CDDP]. ( Hatakeyama, G; Hosoi, Y; Koeda, K; Obuchi, T; Sugimura, Y, 2006) |
"Further examination showed an advanced gastric cancer with peritoneal dissemination." | 1.33 | [A case of advanced gastric cancer with peritoneal dissemination responding remarkably to TS-1/CDDP combination chemotherapy]. ( Asagoe, K; Azechi, H; Inoue, F; Ishii, K; Katsurada, A; Kondo, M; Nishikawa, K; Nishiura, H; Nonami, M; Otani, Y; Saiga, T; Shigemori, M; Suwa, H; Tojo, M, 2006) |
"We report a recent case of squamous cell carcinoma originating in the right tonsil, with metastasis to the right superior cervical lymph nodes (T3N2bM0: stage IVA)." | 1.32 | [A case of advanced lateral wall oropharyngeal carcinoma showing complete response to chemotherapy with TS-1]. ( Hashimoto, K; Iguchi, H; Nakamura, A; Sunami, K; Takayama, M; Yamane, H, 2003) |
"Paclitaxel 90 mg was infused once a week, and TS-1 100 mg was administered daily." | 1.32 | [A case of advanced gastric cancer treated with paclitaxel and TS-1]. ( Kokai, H; Nikkuni, K; Saito, M; Tsukahara, A, 2003) |
"Paclitaxel was administered to 4 patients at a weekly dose of 80 mg/m2/day for three weeks followed by a one week interval." | 1.32 | [Treatment outcomes with paclitaxel for advanced gastric cancer patients previously treated with TS-1]. ( Chida, N; Imai, G; Ishibashi, J; Iwabuchi, M; Matsuda, Y; Mochida, A; Shiina, M; Suzuki, S; Suzuki, T; Tadokoro, K; Takahashi, H; Yamada, K; Yokoyama, H, 2003) |
"We report a case of advanced gastric cancer resected after successful treatment with the novel oral anticancer drug TS-1." | 1.32 | [A case of advanced gastric cancer resected after successful treatment with the novel oral anticancer drug TS-1]. ( Chiba, M; Hayashi, K; Inaba, Y; Kamio, Y; Koyama, M; Tamura, M; Tsuge, T; Watabe, S, 2003) |
"S-1 appears to be safe and highly active, with favorable longterm survival in patients with metastatic gastric cancer, particularly in those with diffuse-type histology and peritoneal metastasis." | 1.32 | Efficacy and safety profile of S-1 in patients with metastatic gastric cancer in clinical practice: results from a post-marketing survey. ( Boku, N; Doi, T; Hamamoto, Y; Kawai, H; Mera, K; Muto, M; Nagashima, F; Ohtsu, A; Sano, Y; Yano, T; Yoshida, S, 2003) |
"was started for the residual cancer lesions, with CDDP i." | 1.32 | [Sustained NC status for a long period after combined chemotherapy of TS-1 and CDDP for residual lesions following gastrectomy for gastric cancer]. ( Hasegawa, S; Imazu, H; Matsubara, T; Nakamura, Y; Nozoe, Y; Ochiai, M; Sakai, W; Sakurai, Y; Tonomura, S; Yoshida, I, 2003) |
"Preoperative diagnosis was stage IV gastric cancer (T3 (SE) H0 P0 N3), and we considered a curative operation impossible." | 1.32 | [A case of advanced gastric cancer with abdominal paraaortic lymph node swelling successfully resected following neoadjuvant chemotherapy of TS-1 and low-dose cisplatin]. ( Kanehiro, T; Morifuji, M; Murakami, Y; Sasaki, M; Sueda, T; Uemura, K; Yokoyama, T; Yokoyama, Y, 2003) |
"Biliary stenosis was remarkably improved." | 1.32 | [A case of advanced gallbladder cancer with biliary tract stenosis which responded to TS-1 chemotherapy]. ( Kuramochi, H; Ohashi, M; Tenma, N, 2003) |
"A 62-year-old advanced gastric cancer patient with bulky N2 lymph node metastases was treated by neoadjuvant chemotherapy with TS-1 and CDDP." | 1.32 | [A case of advanced gastric cancer responding to neoadjuvant TS-1/CDDP therapy]. ( Kameyama, H; Nashimoto, A; Ohta, T; Takii, Y; Tanaka, O; Tsuchiya, Y; Yabusaki, H, 2003) |
"The upper endoscopy revealed advanced gastric cancer." | 1.32 | [A case of advanced gastric cancer with multiple liver metastases responding to TS-1 and CDDP]. ( Akaiwa, J; Kondo, Y; Makuuchi, H; Morita, M; Nabeshima, K; Nakamura, K; Nishi, T; Ogoshi, K; Okamoto, Y; Soeda, J; Tajima, T, 2003) |
"A patient with advanced recurrent laryngeal cancer complicated with cervical lymph node metastasis was successfully treated with chemoradiotherapy with an oral anticancer drug, TS-1." | 1.32 | [A case of lymph node metastasis after total laryngectomy successfully treated with chemoradiotherapy with TS-1]. ( Suzuki, S; Yoshihara, T, 2003) |
"This was diagnosed as inoperable gastric cancer, and gastro-jejunostomy was performed." | 1.32 | [A case of effective response to TS-1 of inoperable gastric cancer, in the course of chemotherapy for malignant lymphoma]. ( Fujita, T; Fukuda, K; Komatsubara, S; Mano, M; Nishi, H; Ohmura, Y; Takao, T; Yano, T, 2003) |
"At this time, no gastric cancer cells were detected in the resected specimen, including the primary lesion and lymph nodes, confirming a pathological complete response (CR grade 3)." | 1.32 | Histological complete response in a case of advanced gastric cancer treated by chemotherapy with S-1 plus low-dose cisplatin and radiation. ( Akiba, Y; Hibi, T; Kitajima, M; Kubota, T; Kumai, K; Otani, Y; Saikawa, Y; Shigematsu, N; Takahashi, T; Yoshida, M, 2003) |
"A 51-year-old male patient with esophageal cancer and cervical, thoracic and celiac artery lymph node metastases was treated by combination chemotherapy of TS-1 and cisplatin." | 1.32 | [A case of metastatic esophageal cancer responding remarkably to combination chemotherapy of TS-1 and cisplatin]. ( Doi, R; Iwase, H; Kaida, S; Nakarai, K; Okeya, M; Shimada, M; Tsuzuki, T, 2004) |
"We report a case of advanced gastric cancer with bulky N2 lymph node metastases resected after successful treatment with novel oral anticancer drug TS-1 as a neoadjuvant chemotherapy (NAC)." | 1.32 | [A case of advanced gastric cancer with bulky N2 lymph node metastases resected after successful treatment with TS-1]. ( Hirata, K; Inoue, D; Kashiwagi, K; Maeda, H; Sasaki, K; Shibuya, H; Takashima, T, 2004) |
"The prognosis of gastric cancer with liver metastasis is very poor." | 1.32 | [Gastric cancer with liver metastasis effectively treated by intra-hepatic arterial infusion]. ( Aoyagi, K; Imaizumi, T; Koufuji, K; Miyagi, M; Shirouzu, K; Takeda, J; Yano, S, 2004) |
"Since gastric cancer was detected, he was referred to our department." | 1.32 | [A case of gastric cancer with paraaortic lymph node metastasis responding to TS-1/CDDP combination therapy]. ( Aiba, M; Hamaguchi, K; Katsube, T; Konno, S; Murayama, M; Naritaka, Y; Obu, M; Ogawa, K; Shimakawa, T; Yagawa, Y, 2004) |
"A Case of Advanced Gastric Cancer with Multiple Liver Metastases Successfully Treated with TS-1 and CDDP: Akihiro Tsukahara, Kazuhiro Kaneko and Syuji Tanaka (Dept." | 1.32 | [A case of advanced gastric cancer with multiple liver metastases successfully treated with TS-1 and CDDP]. ( Kaneko, K; Tanaka, S; Tsukahara, A, 2004) |
"Computed tomography (CT) showed gastric cancer with extensive paraaortic lymph node metastasis." | 1.31 | [A case of gastric cancer with paraaortic lymph node metastasis responding to TS-1/CDDP as neoadjuvant chemotherapy]. ( Furukawa, J; Katsumoto, Y; Maruyama, K; Maruyama, N; Nakaguchi, K; Nakamura, M; Sue, F; Tanaka, J; Yokouchi, H; Yoshihara, W, 2002) |
"Five patients with inoperable advanced gastric cancer were treated with combination chemotherapy of TS-1 and cisplatin (CDDP)." | 1.31 | [TS-1/CDDP therapy for advanced gastric cancer as neoadjuvant chemotherapy]. ( Furukawa, J; Katsumoto, Y; Maruyama, K; Maruyama, N; Nakaguchi, K; Nakamura, M; Sue, F; Tanaka, J; Yokouchi, H; Yoshihara, W, 2002) |
"A patient with recurrent gastric cancer which infiltrated the pelvic muscle after the treatment of paraaortic lymph node and ovarian metastases was successfully managed by a novel oral anticancer drug, TS-1." | 1.31 | [A case of recurrent gastric cancer successfully treated with TS-1]. ( Higaki, K; Ikeda, T; Kobayashi, N; Ninomiya, M; Ohno, S; Okamura, S; Onoda, T; Shiozaki, S; Takakura, N, 2001) |
"A 67-year-old male patient with gastric cancer of Borrmann type 2 and liver and intra-abdominal lymph node metastases was treated by combined chemotherapy of TS-1 and CDDP TS-1 (100 mg/day) was administered for 14 days followed by 14 days rest as one course." | 1.31 | [Complete response in a case of advanced gastric cancer with liver and intra-abdominal lymph node metastases treated by combined chemotherapy of TS-1 and CDDP]. ( Hiraiwa, A; Indo, T; Iwase, H; Iyo, T; Kaida, S; Mizuno, T; Nakamura, M; Nakarai, K, 2001) |
"Computed tomography showed advanced gastric cancer with huge lymph node metastases." | 1.31 | [A case of postoperative gastric cancer responding to adjuvant chemotherapy with TS-1--a novel oral formation of 5-fluorouracil]. ( Harada, T; Kinoshita, S; Kitagawa, S; Morishita, M; Morita, K; Nakagawa, M; Nakamura, M; Yagi, S; Yamada, T; Yokoi, K; Yoshida, K, 2001) |
"A patient with advanced gastric cancer complicated with liver and lymph node metastases was successfully treated with a novel oral anticancer drug, TS-1, TS-1 was administered at a dose of 100 mg/day." | 1.31 | [A case of advanced gastric cancer successfully treated with TS-1]. ( Funakoshi, A; Iguchi, H; Matsuo, S; Miyagi, Y; Ouchi, J; Sumii, T; Uchimura, K; Yokota, M, 2002) |
"We report three patients with recurrent gastric cancer responding to TS-1 therapy after combination chemotherapy with 5-fluorouracil, mitomycin C and cisplatin." | 1.31 | [Three cases of recurrent gastric cancer responding to TS-1 therapy following combination therapy with 5-fluorouracil, mitomycin C and cisplatin]. ( Hayashi, K; Iijima, S; Koyama, Y; Miyazawa, K; Morikawa, A; Murakami, M; Okabe, R; Ozaki, K; Sugiyama, A; Suzuki, A, 2002) |
"We report one case of advanced gastric cancer with lung and lymph node metastases that completely responded to TS-1." | 1.31 | [A case report of advanced gastric cancer responding to TS-1, a novel oral fluorouracil derivative]. ( Isomoto, H; Kohno, S; Mizuta, Y; Morikawa, S; Murase, K; Murata, I; Nakamura, T; Ohnita, K; Taura, K; Yamasaki, K, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (0.25) | 18.2507 |
2000's | 178 (44.06) | 29.6817 |
2010's | 213 (52.72) | 24.3611 |
2020's | 12 (2.97) | 2.80 |
Authors | Studies |
---|---|
Demura, K | 1 |
Murakami, K | 2 |
Yoshida, M | 4 |
Yoneda, K | 1 |
Ohashi, T | 2 |
Osawa, H | 1 |
Ide, Y | 1 |
Morimoto, O | 2 |
Hatanaka, N | 1 |
Nishida, T | 3 |
Shin, K | 1 |
Park, SJ | 1 |
Lee, J | 3 |
Park, CH | 1 |
Song, KY | 1 |
Lee, HH | 1 |
Seo, HS | 1 |
Jung, YJ | 1 |
Park, JM | 1 |
Lee, SH | 1 |
Roh, SY | 1 |
Kim, IH | 1 |
Sato, Y | 5 |
Kurokawa, Y | 2 |
Doki, Y | 2 |
Mizusawa, J | 5 |
Tanaka, K | 5 |
Katayama, H | 4 |
Boku, N | 9 |
Yoshikawa, T | 10 |
Terashima, M | 7 |
Hariu, T | 1 |
Furutani, A | 1 |
Yamasaki, S | 1 |
Kitade, T | 1 |
Wakasa, M | 1 |
Sonoyama, T | 1 |
Urahigashi, A | 1 |
Fukunaga, H | 2 |
Sawami, H | 1 |
Hiraki, M | 2 |
Sawada, G | 1 |
Murakami, M | 2 |
Chihara, Y | 1 |
Yamamoto, M | 3 |
Kimura, H | 1 |
Morita, S | 7 |
Sato, T | 6 |
Nakamura, N | 2 |
Arai, S | 1 |
Tomi, Y | 1 |
Sanada, T | 2 |
Kuwabara, H | 4 |
Yoshida, T | 9 |
Goseki, N | 2 |
Koike, M | 1 |
Seita, K | 1 |
Ebata, T | 3 |
Mizuno, T | 3 |
Maeda, A | 3 |
Yamaguchi, R | 3 |
Kurumiya, Y | 1 |
Sakamoto, E | 3 |
Hiramatsu, K | 4 |
Ando, M | 2 |
Nagino, M | 5 |
Kinoshita, S | 4 |
Higashida, M | 1 |
Kubota, H | 2 |
Kitagawa, S | 2 |
Iwamoto, R | 1 |
Ueno, M | 3 |
Mineta, S | 1 |
Okamoto, Y | 2 |
Watanabe, Y | 4 |
Okada, T | 2 |
Tsuruta, A | 1 |
Akiyama, T | 1 |
Fujiwara, Y | 5 |
Ueno, T | 1 |
Wada, R | 2 |
Akamaru, Y | 1 |
Wada, N | 1 |
Hokkoku, D | 1 |
Ikeshima, R | 1 |
Munakata, K | 1 |
Takiuchi, D | 2 |
Ota, H | 2 |
Shibata, K | 1 |
Kobayashi, T | 4 |
Mizuno, S | 2 |
Matsuba, H | 1 |
Kanamori, M | 1 |
Maruyama, S | 1 |
Tamauchi, T | 1 |
Tohyama, T | 1 |
Sakamoto, K | 3 |
Tamura, K | 1 |
Nakamura, T | 6 |
Watanabe, J | 1 |
Wakisaka, H | 1 |
Takada, Y | 1 |
Yamamoto, A | 1 |
Suda, T | 3 |
Yamauchi, Y | 1 |
Kondo, S | 1 |
Okazaki, N | 1 |
Takahashi, K | 6 |
Watanabe, T | 4 |
Makuuchi, Y | 2 |
Ota, Y | 1 |
Nagakawa, Y | 1 |
Seshimo, A | 2 |
Katsumata, K | 2 |
Itoi, T | 1 |
Tsuchida, A | 3 |
Yamakoshi, Y | 1 |
Ohtani, H | 3 |
Nagamori, M | 1 |
Nomura, S | 4 |
Nakagawa, H | 1 |
Yoshii, M | 1 |
Tamura, T | 2 |
Toyokawa, T | 1 |
Tanaka, H | 2 |
Muguruma, K | 1 |
Ohira, M | 2 |
Mochizuki, S | 1 |
Matsui, T | 3 |
Nakamichi, N | 1 |
Hiramoto, H | 1 |
Ishimoto, T | 1 |
Kosuga, T | 2 |
Tsujiura, M | 1 |
Nakashima, S | 1 |
Masuyama, M | 1 |
Hirono, S | 1 |
Kawai, M | 4 |
Okada, KI | 1 |
Miyazawa, M | 1 |
Kitahata, Y | 1 |
Kobayashi, R | 1 |
Hayami, S | 1 |
Yamaue, H | 1 |
Wada, T | 2 |
Sekine, S | 1 |
Kamiya, A | 1 |
Hayashi, T | 6 |
Otsuki, S | 1 |
Yamagata, Y | 1 |
Katai, H | 3 |
Saito, H | 4 |
Fushida, S | 5 |
Miyashita, T | 1 |
Oyama, K | 4 |
Yamaguchi, T | 5 |
Tsukada, T | 1 |
Kinoshita, J | 3 |
Tajima, H | 2 |
Ninomiya, I | 2 |
Ohta, T | 4 |
Kano, K | 1 |
Aoyama, T | 6 |
Maezawa, Y | 2 |
Nakajima, T | 1 |
Ikeda, K | 2 |
Yamada, T | 11 |
Oshima, T | 3 |
Rino, Y | 6 |
Masuda, M | 5 |
Ogata, T | 6 |
Cho, H | 8 |
Yoshizawa, J | 1 |
Ishizone, S | 2 |
Ikeyama, M | 1 |
Nakayama, J | 2 |
Hosokawa, A | 1 |
Ando, T | 2 |
Ogawa, K | 3 |
Ueda, A | 1 |
Yoshita, H | 1 |
Mihara, H | 1 |
Fujinami, H | 1 |
Kajiura, S | 1 |
Yabushita, K | 1 |
Horikawa, N | 1 |
Kobayashi, Y | 1 |
Yoshioka, A | 2 |
Origasa, H | 1 |
Sugiyama, T | 1 |
Hayashi, K | 4 |
Nagasaki, E | 1 |
Nakada, K | 1 |
Tamura, M | 2 |
Arakawa, Y | 1 |
Uwagawa, T | 1 |
Yano, S | 2 |
Wang, X | 2 |
Zhao, DB | 1 |
Yang, L | 1 |
Chi, Y | 1 |
Tang, Y | 1 |
Li, N | 1 |
Wang, SL | 1 |
Song, YW | 1 |
Liu, YP | 1 |
Liu, WY | 1 |
Ren, H | 1 |
Zhang, T | 1 |
Wang, JY | 1 |
Chen, XS | 1 |
Fang, H | 1 |
Wang, WH | 1 |
Li, YX | 1 |
Jin, J | 1 |
Kamei, K | 1 |
Matsumoto, I | 3 |
Makutani, Y | 1 |
Kawaguchi, K | 3 |
Matsumoto, M | 2 |
Murase, T | 1 |
Satoi, S | 2 |
Nakai, T | 1 |
Kamata, K | 2 |
Imai, H | 1 |
Chikugo, T | 1 |
Takeyama, Y | 1 |
Shimaoka, H | 1 |
Shibata, R | 2 |
Hosoda, Y | 3 |
Hirano, Y | 2 |
Munechika, T | 2 |
Yonemitsu, K | 2 |
Ishii, Y | 2 |
Okamoto, T | 2 |
Maeno, H | 2 |
Noritomi, T | 1 |
Sueishi, K | 2 |
Shinkai, M | 2 |
Imano, M | 3 |
Hiraki, Y | 2 |
Kato, H | 3 |
Iwama, M | 2 |
Shiraishi, O | 1 |
Yasuda, A | 3 |
Kimura, Y | 7 |
Imamoto, H | 2 |
Furukawa, H | 4 |
Yasuda, T | 2 |
Kubota, T | 4 |
Choda, Y | 3 |
Morito, T | 1 |
Miyake, S | 2 |
Ishida, M | 3 |
Sato, D | 1 |
Sumitani, D | 1 |
Nakano, K | 1 |
Harano, M | 2 |
Matsukawa, H | 3 |
Ojima, Y | 3 |
Idani, H | 2 |
Shiozaki, S | 4 |
Okajima, M | 3 |
Mugitani, T | 1 |
Hatakeyama, T | 1 |
Sakai, T | 2 |
Matsumura, A | 1 |
Ogino, S | 1 |
Akami, T | 1 |
Okano, S | 1 |
Terashima, T | 1 |
Kawamoto, S | 4 |
Maekawa, K | 1 |
Kuroki, N | 1 |
Toyota, K | 1 |
Murakami, Y | 8 |
Kondo, N | 5 |
Uemura, K | 7 |
Nakagawa, N | 4 |
Takahashi, S | 4 |
Sueda, T | 7 |
Kim, SM | 1 |
An, JY | 1 |
Sohn, TS | 2 |
Kim, S | 2 |
Chiba, Y | 1 |
Shiraisi, O | 1 |
Tsubaki, M | 1 |
Nishida, S | 1 |
Morita, J | 1 |
Amano, S | 2 |
Sawazaki, S | 1 |
Numata, M | 1 |
Ozawa, Y | 1 |
Yukawa, N | 2 |
Tsuchiya, T | 2 |
Matsumoto, K | 3 |
Miyazaki, T | 1 |
Yamaguchi, H | 3 |
Yamazaki, T | 1 |
Sano, I | 1 |
Fukuoka, J | 1 |
Nakamura, Y | 5 |
Yamasaki, N | 1 |
Nagayasu, T | 1 |
Misumi, T | 1 |
Suzuki, T | 4 |
Tazawa, H | 1 |
Kojima, M | 2 |
Akabane, S | 1 |
Hadano, N | 1 |
Shimizu, W | 2 |
Ishiyama, K | 1 |
Onoe, T | 2 |
Sudo, T | 6 |
Shimizu, Y | 2 |
Hinoi, T | 1 |
Tashiro, H | 1 |
Okamoto, K | 3 |
Shoda, K | 1 |
Konishi, H | 1 |
Shiozaki, A | 2 |
Fujiwara, H | 4 |
Arita, T | 1 |
Morimura, R | 1 |
Murayama, Y | 2 |
Kuriu, Y | 2 |
Ikoma, H | 2 |
Nakanishi, M | 3 |
Otsuji, E | 2 |
Ono, K | 1 |
Takehana, T | 1 |
Yamamoto, K | 6 |
Kawai, S | 1 |
Nagase, M | 1 |
Watanabe, M | 5 |
Miyake, T | 1 |
Mikane, Y | 1 |
Syoji, R | 1 |
Kajiwara, Y | 1 |
Aoyama, K | 1 |
Nogami, T | 1 |
Nishikawa, H | 1 |
Shinoura, S | 1 |
Shigemitsu, K | 1 |
Nonaka, Y | 1 |
Hayashi, D | 1 |
Akiyama, N | 2 |
Karayama, M | 1 |
Inui, N | 1 |
Yasui, H | 6 |
Hozumi, H | 1 |
Suzuki, Y | 5 |
Furuhashi, K | 1 |
Fujisawa, T | 1 |
Enomoto, N | 1 |
Inami, N | 1 |
Matsuura, S | 1 |
Kaida, Y | 1 |
Uto, T | 1 |
Asada, K | 1 |
Matsuda, H | 1 |
Fujii, M | 4 |
Toyoshima, M | 1 |
Takahashi, R | 1 |
Ohashi, M | 5 |
Kano, Y | 2 |
Ida, S | 1 |
Kumagai, K | 1 |
Nunobe, S | 1 |
Chin, K | 3 |
Yamaguchi, K | 3 |
Sano, T | 5 |
Hiki, N | 1 |
Morita, Y | 1 |
Sakaguchi, T | 1 |
Kitajima, R | 1 |
Furuhashi, S | 1 |
Kiuchi, R | 1 |
Takeda, M | 1 |
Hiraide, T | 1 |
Shibasaki, Y | 1 |
Kikuchi, H | 2 |
Konno, H | 1 |
Takeuchi, H | 2 |
Kamiyama, K | 1 |
Sawada, S | 1 |
Fukuda, T | 2 |
Kato, N | 1 |
Kojima, A | 1 |
Hino, K | 1 |
Yamashita, I | 1 |
Ogura, G | 1 |
Uotani, H | 1 |
Tsuburaya, A | 14 |
Nakamura, K | 7 |
Imamura, H | 7 |
Nashimoto, A | 6 |
Fukushima, N | 3 |
Sasako, M | 5 |
Hanaka, J | 1 |
Kobayashi, A | 2 |
Goya, T | 1 |
Tanizawa, Y | 1 |
Bando, E | 2 |
Kawamura, T | 2 |
Tokunaga, M | 2 |
Sasaki, K | 3 |
Migita, K | 2 |
Takayama, T | 4 |
Saeki, K | 1 |
Matsumoto, S | 1 |
Wakatsuki, K | 1 |
Enomoto, K | 1 |
Tanaka, T | 2 |
Ito, M | 1 |
Kurumatani, N | 1 |
Nakajima, Y | 1 |
Kunisaki, C | 5 |
Hasegawa, S | 3 |
Takagawa, R | 3 |
Momiyama, M | 2 |
Kosaka, T | 2 |
Makino, H | 4 |
Ono, HA | 2 |
Akiyama, H | 3 |
Endo, I | 3 |
Takahari, D | 2 |
Hamaguchi, T | 2 |
Yoshimura, K | 3 |
Ito, S | 4 |
Fuse, N | 2 |
Konishi, M | 3 |
Goto, M | 2 |
Tanigawa, N | 2 |
Shirao, K | 1 |
Hashimoto, Y | 7 |
Muto, T | 1 |
Sasaki, H | 2 |
Urabe, K | 1 |
Ema, A | 1 |
Yamashita, K | 1 |
Sakuramoto, S | 1 |
Wang, G | 1 |
Mieno, H | 1 |
Nemoto, M | 1 |
Shibata, T | 1 |
Katada, N | 1 |
Kikuchi, S | 2 |
Hirata, A | 1 |
Itatsu, K | 1 |
Fukaya, M | 1 |
Yokoyama, Y | 2 |
Tsunoda, N | 1 |
Igami, T | 1 |
Sugawara, G | 1 |
Uehara, K | 3 |
Yoshioka, Y | 1 |
Usui, H | 1 |
Eshita, Y | 1 |
Ogawa, F | 1 |
Sasaki, T | 4 |
Shioyama, Y | 1 |
Atsumi, K | 1 |
Nonoshita, T | 1 |
Ooga, S | 1 |
Yoshitake, T | 1 |
Uehara, S | 1 |
Hirata, H | 1 |
Honda, H | 1 |
Kitayama, J | 3 |
Ishigami, H | 3 |
Yamashita, H | 3 |
Emoto, S | 1 |
Kaisaki, S | 2 |
Takahara, N | 1 |
Isayama, H | 1 |
Nakai, Y | 1 |
Hamada, T | 1 |
Uchino, R | 1 |
Miyabayashi, K | 1 |
Kogure, H | 1 |
Yamamoto, N | 2 |
Sasahira, N | 1 |
Hirano, K | 1 |
Ijichi, H | 1 |
Tateishi, K | 1 |
Tada, M | 1 |
Koike, K | 1 |
Kanagawa, T | 1 |
Ookawa, T | 1 |
Nogami, H | 1 |
Kobatake, T | 1 |
Saji, O | 1 |
Ishii, M | 1 |
Kobayashi, H | 1 |
Sumiyoshi, K | 1 |
Asano, T | 1 |
Iwata, K | 1 |
Okamura, R | 1 |
Kobayashi, S | 3 |
Koizumi, S | 1 |
Otsubo, T | 1 |
Fukai, Y | 1 |
Ojima, H | 2 |
Sano, A | 1 |
Akao, T | 1 |
Sohda, M | 1 |
Tanabe, A | 1 |
Shinmura, K | 2 |
Kaiho, T | 1 |
Yanagisawa, S | 1 |
Okamoto, R | 1 |
Nishimura, M | 1 |
Okaniwa, A | 1 |
Tsuchiya, S | 1 |
Shirai, J | 1 |
Fujikawa, H | 1 |
Iwasaki, K | 2 |
Sujishi, K | 1 |
Osaragi, T | 2 |
Yoneyama, K | 2 |
Kasahara, A | 1 |
Yamamoto, Y | 4 |
Nishikawa, K | 6 |
Iwase, K | 2 |
Aono, T | 1 |
Yoshida, H | 4 |
Nomura, M | 4 |
Tamagawa, H | 1 |
Matsuda, C | 1 |
Deguchi, T | 2 |
Kawada, J | 3 |
Higashi, S | 1 |
Deguchi, K | 1 |
Noguchi, Y | 2 |
Okumura, Y | 1 |
Fushimi, H | 2 |
Takagi, M | 2 |
Fukui, A | 2 |
Fujitani, K | 3 |
Endo, S | 3 |
Tanaka, Y | 2 |
Kondo, J | 1 |
Nisimura, T | 1 |
Nagashima, Y | 1 |
Nakamura, M | 6 |
Setoguchi, M | 1 |
Yoshino, S | 1 |
Sakata, K | 1 |
Hashimoto, T | 1 |
Takeno, A | 2 |
Taniguchi, H | 3 |
Morimoto, Y | 1 |
Kusama, H | 1 |
Matsushita, K | 1 |
Kawashima, H | 1 |
Kimura, K | 1 |
Mukai, Y | 1 |
Katsura, Y | 2 |
Kagawa, Y | 2 |
Okishiro, M | 1 |
Sakisaka, H | 1 |
Nakahira, S | 1 |
Egawa, C | 2 |
Takeda, Y | 2 |
Kato, T | 6 |
Tamura, S | 4 |
Yasui, T | 1 |
Mukubo, H | 1 |
Sato, N | 1 |
Kita, I | 1 |
Hyuga, N | 1 |
Kobayashi, K | 4 |
Watanabe, R | 2 |
Chono, A | 1 |
Matsumoto, T | 3 |
Takemoto, H | 2 |
Takachi, K | 2 |
Nishioka, K | 2 |
Aoki, T | 5 |
Uemura, Y | 3 |
Yoshida, K | 4 |
Matsuoka, T | 1 |
Hosaka, S | 1 |
Inada, K | 1 |
Tsukao, Y | 1 |
Moon, JH | 1 |
Hyuga, S | 1 |
Chono, T | 1 |
Matsuda, S | 1 |
Takahashi, T | 4 |
Fukada, J | 1 |
Fukuda, K | 3 |
Kawakubo, H | 1 |
Saikawa, Y | 3 |
Kawaguchi, O | 1 |
Shigematsu, N | 2 |
Kitagawa, Y | 1 |
Okabe, Y | 1 |
Yajima, K | 2 |
Ishikawa, T | 3 |
Kosugi, S | 2 |
Kanda, T | 2 |
Wakai, T | 3 |
Nagano, I | 1 |
Yamada, I | 1 |
Niwa, M | 1 |
Kanazawa, H | 1 |
Matsumoto, N | 1 |
Yoshinaka, H | 1 |
Adikrisna, R | 1 |
Irie, T | 1 |
Matsumura, S | 1 |
Tanaka, S | 4 |
Arii, S | 1 |
Kochi, M | 2 |
Kanamori, N | 2 |
Mihara, Y | 1 |
Funada, T | 1 |
Tamegai, H | 1 |
Takayama, Y | 1 |
Suda, H | 3 |
Harada, N | 2 |
Shirabe, K | 1 |
Yoshizumi, T | 1 |
Ikegami, T | 1 |
Uchiyama, H | 1 |
Soejima, Y | 1 |
Yamashita, Y | 2 |
Saeki, H | 2 |
Oki, E | 1 |
Kawanaka, H | 1 |
Morita, M | 4 |
Ikeda, T | 3 |
Matsuura, H | 1 |
Okadome, K | 1 |
Maehara, Y | 2 |
Tanabe, K | 2 |
Ito, Y | 9 |
Miyashita, Y | 2 |
Sakamoto, J | 5 |
Dong, L | 1 |
Li, J | 1 |
Lou, XP | 1 |
Miao, JH | 1 |
Lu, P | 1 |
Chang, ZW | 1 |
Han, ZF | 1 |
Hori, Y | 1 |
Itagaki, R | 1 |
Iwata, H | 1 |
Maekawa, S | 2 |
Ueki, K | 2 |
Tada, T | 2 |
Ishizuka, D | 2 |
Murase, H | 1 |
Oono, R | 1 |
Ueda, Y | 1 |
Enjoji, M | 1 |
Ishimaru, S | 1 |
Obara, M | 1 |
Ishida, T | 2 |
Zhang, ZD | 1 |
Kong, Y | 1 |
Yang, W | 1 |
Zhang, B | 1 |
Zhang, YL | 1 |
Ma, EM | 1 |
Liu, HX | 1 |
Chen, XB | 1 |
Hua, YW | 1 |
Toyoda, M | 1 |
Kaira, K | 1 |
Ohshima, Y | 1 |
Ishioka, NS | 1 |
Shino, M | 1 |
Sakakura, K | 1 |
Takayasu, Y | 1 |
Tominaga, H | 1 |
Oriuchi, N | 1 |
Nagamori, S | 1 |
Kanai, Y | 1 |
Oyama, T | 3 |
Chikamatsu, K | 1 |
Kurimoto, K | 1 |
Ishigure, K | 1 |
Mochizuki, Y | 2 |
Ishiyama, A | 1 |
Nakayama, H | 1 |
Tanaka, N | 4 |
Kobayashi, D | 2 |
Nakao, A | 2 |
Kodera, Y | 4 |
Ohue, M | 2 |
Sakai, D | 1 |
Noura, S | 2 |
Kinugasa, Y | 1 |
Fujita, S | 4 |
Shimada, Y | 1 |
Saito, N | 1 |
Moriya, Y | 1 |
Nakano, A | 1 |
Endo, M | 2 |
Hirayama, N | 1 |
Akai, T | 2 |
Matsubara, H | 1 |
Funakoshi, T | 1 |
Fukutomi, A | 2 |
Yamazaki, K | 3 |
Machida, N | 3 |
Todaka, A | 2 |
Tsushima, T | 2 |
Yokota, T | 3 |
Onozawa, Y | 2 |
Kenmotsu, H | 1 |
Okabayashi, T | 1 |
Shima, Y | 1 |
Iwata, J | 1 |
Sumiyoshi, T | 2 |
Kozuki, A | 1 |
Tokumaru, T | 1 |
Iiyama, T | 1 |
Kosaki, T | 1 |
Kobayashi, M | 5 |
Hanazaki, K | 1 |
Yamamura, A | 1 |
Ono, F | 1 |
Hiraga, M | 1 |
Omura, N | 1 |
Takano, N | 1 |
Sato, H | 2 |
Toyama, S | 1 |
Onochi, S | 1 |
Murakami, S | 2 |
Umeda, S | 1 |
Sozaki, M | 1 |
Miyoshi, K | 1 |
Ishikawa, M | 1 |
Uchiyama, A | 1 |
Ohuchi, K | 1 |
Nakano, R | 1 |
Omori, K | 3 |
Wakabayashi, K | 6 |
Ishibashi, Y | 3 |
Fukuda, N | 1 |
Niki, M | 1 |
Sano, M | 1 |
Ogura, R | 1 |
Wada, J | 1 |
Tanaka, C | 3 |
Fujiwara, M | 1 |
Lee, SJ | 1 |
Park, SH | 1 |
Park, JO | 1 |
Lim, DH | 1 |
Park, YS | 1 |
Lim, HY | 1 |
Choi, MG | 1 |
Lee, JH | 1 |
Bae, JM | 1 |
Kang, WK | 3 |
Itoyama, R | 1 |
Hashimoto, D | 1 |
Chikamoto, A | 1 |
Hayashi, H | 2 |
Beppu, T | 1 |
Baba, H | 4 |
Saito, M | 4 |
Kiyozaki, H | 2 |
Takata, O | 2 |
Suzuki, K | 3 |
Rikiyama, T | 1 |
Kimura, J | 2 |
Kanazawa, A | 2 |
Ota, M | 1 |
Kitayama, K | 1 |
Kanehara, I | 2 |
Teraoka, H | 1 |
Nishimura, J | 1 |
Noda, E | 1 |
Nishino, H | 3 |
Hirakawa, K | 4 |
Maeda, H | 2 |
Usui, T | 1 |
Kawamura, A | 1 |
Takeshita, A | 1 |
Konishi, K | 2 |
Okuyama, M | 2 |
Hiraoka, K | 2 |
Nakagawa, T | 1 |
Kim, C | 4 |
Nishijima, J | 1 |
Kimura, S | 2 |
Ohnuma, S | 2 |
Karasawa, H | 2 |
Kudoh, K | 1 |
Watanabe, K | 4 |
Nagao, M | 2 |
Abe, T | 3 |
Musha, H | 2 |
Morikawa, T | 2 |
Motoi, F | 2 |
Katayose, Y | 2 |
Naitoh, T | 1 |
Unno, M | 2 |
Kono, E | 1 |
Kudo, K | 1 |
Miyachi, T | 1 |
Kajiwara, T | 1 |
Nakagawa, K | 4 |
Naito, T | 1 |
Hokonohara, K | 1 |
Takata, A | 1 |
Hirota, M | 2 |
Oshima, K | 2 |
Tanida, T | 1 |
Hatano, H | 1 |
Noda, T | 1 |
Komori, T | 1 |
Iwazawa, T | 1 |
Akagi, K | 1 |
Adachi, S | 1 |
Dono, K | 1 |
Hirao, M | 2 |
Harada, Y | 1 |
Fukuda, Y | 1 |
Haraguchi, N | 1 |
Miyake, M | 1 |
Asaoka, T | 1 |
Miyamoto, A | 2 |
Miyazaki, M | 4 |
Ikeda, M | 3 |
Nakamori, S | 3 |
Sekimoto, M | 2 |
Nishiuchi, A | 1 |
Kato, S | 1 |
Kadokawa, Y | 1 |
Machimoto, T | 1 |
Asao, Y | 1 |
Furuyama, H | 1 |
Yoshimura, T | 2 |
Okada, K | 2 |
Ebisui, C | 1 |
Nushijima, Y | 1 |
Yanagisawa, T | 1 |
Okamura, S | 3 |
Fukuchi, N | 1 |
Murata, K | 1 |
Yokouchi, H | 3 |
Kinuta, M | 1 |
Mihara, K | 2 |
Yamashiro, N | 1 |
Nishiya, S | 1 |
Kemmochi, T | 1 |
Egawa, T | 3 |
Nagashima, A | 3 |
Ogasawara, T | 1 |
Ootsuka, Y | 1 |
Nakano, S | 1 |
Shida, T | 1 |
Kin, M | 1 |
Takahashi, M | 7 |
Komatsu, T | 1 |
Zhou, J | 1 |
Zhao, R | 1 |
Wen, F | 1 |
Zhang, P | 1 |
Tang, R | 1 |
Du, Z | 1 |
He, X | 1 |
Zhang, J | 1 |
Li, Q | 1 |
Takeuchi, E | 2 |
Goto, H | 4 |
Tojima, Y | 2 |
Yatsuya, H | 1 |
Shigematsu, T | 2 |
Murai, K | 1 |
Furuta, M | 1 |
Matsumoto, H | 5 |
Katayama, M | 2 |
Okajima, T | 2 |
Tanaka, M | 4 |
Baba, M | 1 |
Ryu, MH | 2 |
Baba, E | 1 |
Lee, KH | 2 |
Park, YI | 1 |
Hyodo, I | 2 |
Nam, BH | 1 |
Esaki, T | 1 |
Yoo, C | 1 |
Ryoo, BY | 2 |
Song, EK | 1 |
Cho, SH | 1 |
Yang, SH | 1 |
Zang, DY | 2 |
Shin, DB | 2 |
Park, SR | 2 |
Shinozaki, K | 1 |
Takano, T | 1 |
Kang, YK | 2 |
Ogata, D | 1 |
Hokama, Y | 1 |
Tsuchida, T | 1 |
Kataoka, K | 1 |
Shitara, K | 6 |
Tomita, T | 1 |
Bando, H | 1 |
Yamada, Y | 5 |
Tanabe, S | 2 |
Gotoh, M | 3 |
Sugimoto, N | 1 |
Nishina, T | 3 |
Amagai, K | 1 |
Niwa, Y | 1 |
Tsuji, A | 2 |
Tsuda, M | 1 |
Fujii, H | 1 |
Hironaka, S | 2 |
Shimada, K | 1 |
Miwa, H | 2 |
Hamada, C | 1 |
Cao, C | 1 |
Kuang, M | 1 |
Xu, W | 1 |
Zhang, X | 1 |
Chen, J | 1 |
Tang, C | 1 |
Okabe, H | 2 |
Hata, H | 1 |
Ueda, S | 3 |
Zaima, M | 1 |
Tokuka, A | 1 |
Ota, S | 1 |
Kinjo, Y | 1 |
Sakai, Y | 2 |
Mazaki, J | 1 |
Suematsu, Y | 3 |
Hiratsuka, M | 2 |
Makari, Y | 3 |
Mikami, J | 1 |
Kawase, T | 2 |
Hamakawa, T | 1 |
Hoshino, H | 1 |
Nakata, K | 2 |
Yamamoto, T | 2 |
Yamamura, J | 1 |
Kamigaki, S | 2 |
Ikeda, N | 1 |
Tsujie, M | 2 |
Munakata, S | 1 |
Ohzato, H | 3 |
Kim, Y | 2 |
Nishino, M | 2 |
Okano, M | 2 |
Yamasaki, M | 2 |
Nagai, K | 2 |
Yasui, M | 2 |
Tsujinaka, T | 2 |
Nomi, M | 2 |
Mase, T | 2 |
Nagao, S | 4 |
Nakada, S | 1 |
Kawamoto, J | 1 |
Yoichi, T | 1 |
Shinoda, K | 1 |
Ishigami, E | 1 |
Teranaka, R | 1 |
Nakazawa, K | 1 |
Tanaka, R | 1 |
Kametani, N | 1 |
Hirakawa, T | 1 |
Kato, Y | 4 |
Komoto, M | 2 |
Yamagata, S | 1 |
Ako, E | 1 |
Yamada, N | 1 |
Nishimura, S | 1 |
Taenaka, N | 1 |
Sasaguri, T | 1 |
Ohshima, T | 2 |
Yazawa, K | 1 |
Minami, Y | 1 |
Morita, A | 2 |
Eto, R | 1 |
Nakatsu, H | 1 |
Ozasa, H | 1 |
Shimizu, R | 1 |
Kemmochi, A | 1 |
Inagawa, S | 1 |
Akashi, Y | 1 |
Inagaki, Y | 1 |
Satomi, K | 1 |
Ohkohchi, N | 1 |
Torigoe, H | 1 |
Toyooka, S | 1 |
Katsui, K | 1 |
Soh, J | 1 |
Maki, Y | 1 |
Kiura, K | 1 |
Miyoshi, S | 1 |
Kim, SG | 1 |
Hwang, SH | 1 |
Kusama, T | 1 |
Yamagami, K | 1 |
Hasegawa, M | 1 |
Sone, N | 1 |
Kokado, Y | 1 |
Koshiba, T | 1 |
Ichikawa, K | 1 |
Sanefuji, K | 1 |
Kabashima, A | 1 |
Uesaka, K | 1 |
Okamura, Y | 1 |
Kaneoka, Y | 1 |
Sakamoto, H | 1 |
Morinaga, S | 3 |
Kainuma, O | 1 |
Imai, K | 1 |
Sata, N | 1 |
Hishinuma, S | 1 |
Hirano, S | 1 |
Ohashi, Y | 2 |
Iida, Y | 2 |
Ogawa, H | 3 |
Kamijo, T | 1 |
Hamauchi, S | 1 |
Nakagawa, M | 3 |
Yurikusa, T | 1 |
Tanuma, A | 1 |
Yamashita, A | 1 |
Nishimura, T | 1 |
Onitsuka, T | 1 |
Kuga, Y | 2 |
Moriya, T | 4 |
Fukuda, S | 1 |
Kiyota, S | 1 |
Matsuda, Y | 2 |
Hanada, S | 1 |
Kinoshita, M | 1 |
Nishizawa, S | 1 |
Kanazawa, G | 1 |
Nishiguchi, R | 1 |
Kim, DH | 1 |
Honda, M | 2 |
Sakamoto, T | 2 |
Asakage, M | 1 |
Kuwahara, R | 1 |
Akiyama, Y | 1 |
Inatome, J | 1 |
Naito, A | 1 |
Ohmura, Y | 2 |
Ogawa, T | 2 |
Ninomiya, M | 3 |
Nagai, Y | 1 |
Mimura, N | 1 |
Osakabe, H | 1 |
Katayanagi, S | 1 |
Shigoka, M | 1 |
Sumi, T | 1 |
Kawachi, S | 1 |
Kojima, T | 3 |
Higashi, Y | 1 |
Shoji, T | 1 |
Yamazaki, M | 1 |
Taniguchi, M | 2 |
Nishiyama, R | 1 |
Maruo, H | 1 |
Yamagishi, S | 1 |
Nakayama, M | 1 |
Fukabori, M | 1 |
Itoh, Y | 1 |
Mori, K | 1 |
Kishi, K | 2 |
Masuzawa, T | 1 |
Tsukada, R | 1 |
Tanemura, M | 1 |
Tei, M | 2 |
Otsuka, M | 1 |
Furukawa, K | 1 |
Akamatsu, H | 3 |
Ichikawa, H | 1 |
Hanyu, T | 1 |
Usui, K | 1 |
Muneoka, Y | 1 |
Otani, T | 1 |
Hishiki, M | 1 |
Nagahashi, M | 1 |
Sakata, J | 1 |
Kameyama, H | 2 |
Hama, N | 2 |
Maeda, S | 1 |
Uemura, M | 1 |
Miyake, K | 1 |
Matsusaki, K | 1 |
Hirose, N | 1 |
Okamoto, F | 1 |
Kawano, T | 1 |
Miura, O | 1 |
Okazaki, Y | 1 |
Toda, T | 1 |
Minamisono, Y | 1 |
Nagasaki, S | 1 |
Ina, K | 4 |
Kataoka, T | 2 |
Takeuchi, Y | 1 |
Fukuoka, T | 1 |
Miwa, T | 1 |
Nishio, T | 1 |
Furuta, R | 1 |
Masaki, A | 1 |
Mori, F | 1 |
Kayukawa, S | 1 |
Lee, JL | 1 |
Kang, HJ | 1 |
Kim, JG | 1 |
Chang, HM | 1 |
Kim, TW | 1 |
Baek, JH | 1 |
Min, YJ | 1 |
Otsuki, K | 1 |
Saigo, K | 1 |
Kenmochi, T | 2 |
Maruyama, M | 2 |
Akutsu, N | 1 |
Iwashita, C | 1 |
Sugano, N | 1 |
Wada, H | 1 |
Shiozawa, M | 1 |
Akaike, M | 1 |
Sugimasa, Y | 1 |
Arimoto, Y | 1 |
Nishio, K | 2 |
Adachi, K | 1 |
Ohba, H | 1 |
Shintani, M | 1 |
Yui, S | 1 |
Matono, S | 1 |
Horiuchi, H | 1 |
Kishimoto, Y | 1 |
Sasahara, H | 1 |
Ureshino, M | 1 |
Kashihara, M | 1 |
Sueyoshi, S | 1 |
Shirouzu, K | 2 |
Kishimoto, K | 1 |
Yoshida, S | 4 |
Ono, T | 1 |
Yoshihama, Y | 1 |
Nishiyama, A | 1 |
Sasaki, A | 1 |
Ishiguro, H | 1 |
Kuwabara, Y | 1 |
Kimura, M | 1 |
Mitsui, A | 1 |
Ogawa, R | 1 |
Fujii, Y | 1 |
Iguchi, H | 3 |
Uyama, T | 1 |
Amatsu, H | 1 |
Yamane, H | 2 |
Kusuki, M | 1 |
Nakamura, A | 2 |
Suzuki, S | 5 |
Hanata, K | 1 |
Nanjo, H | 1 |
Ishikawa, K | 1 |
Otani, K | 1 |
Kamei, T | 1 |
Soma, D | 1 |
Miyato, H | 1 |
Hidemura, A | 1 |
Nagawa, H | 1 |
Kitajima, Y | 1 |
Yakabe, T | 1 |
Ohtsuka, T | 1 |
Sato, S | 1 |
Nakafusa, Y | 1 |
Miyazaki, K | 1 |
Sugawara, H | 1 |
Ichiki, M | 1 |
Sai, K | 1 |
Ansai, M | 1 |
Nakano, Y | 2 |
Kawamura, M | 1 |
Ichinose, A | 1 |
Miyazaki, S | 2 |
Fujimura, T | 3 |
Yagi, Y | 1 |
Niwa, T | 1 |
Ohkawa, S | 1 |
Amano, A | 1 |
Masaki, T | 1 |
Miyakawa, K | 1 |
Fujita, M | 1 |
Hatori, M | 1 |
Ando, Y | 1 |
Kurihara, Y | 1 |
Takayama, S | 1 |
Shirota, T | 1 |
Tachikawa, T | 1 |
Shintani, S | 2 |
Naito, M | 1 |
Shinohara, T | 1 |
Ishii, F | 1 |
Maki, K | 2 |
Hoshino, S | 1 |
Kang, SM | 1 |
Murata, A | 1 |
Tendou, M | 1 |
Tezuka, K | 2 |
Nishino, Y | 1 |
Obama, K | 2 |
Hosogi, H | 1 |
Koizumi, W | 3 |
Takiuchi, H | 2 |
Muro, K | 2 |
Komatsu, Y | 1 |
Oya, H | 1 |
Honda, I | 1 |
Hirabayashi, S | 1 |
Onishi, E | 1 |
Nakanishi, K | 1 |
Fukumoto, R | 1 |
Nishi, T | 2 |
Morioka, Y | 1 |
Hashimoto, M | 1 |
Nagata, J | 1 |
Egi, H | 1 |
Takakura, Y | 1 |
Nakahara, H | 1 |
Matsugu, Y | 1 |
Kohashi, T | 1 |
Kadoya, T | 1 |
Ohmori, I | 1 |
Urushihara, T | 1 |
Itamoto, T | 1 |
Arita, M | 1 |
Usui, Y | 1 |
Okanobu, H | 1 |
Numata, Y | 1 |
Miwata, T | 1 |
Yoshimi, S | 1 |
Murakami, E | 1 |
Ohya, T | 1 |
Yabusaki, H | 3 |
Nakagawa, S | 1 |
Takii, Y | 2 |
Tsuchiya, Y | 2 |
Otsuo, T | 1 |
Noda, K | 1 |
Umekita, N | 2 |
Nasu, K | 1 |
Inoue, S | 2 |
Matsumura, H | 1 |
Iwasaki, Y | 3 |
Iwanaga, T | 3 |
Nakano, D | 3 |
Ami, K | 2 |
Nagahama, T | 2 |
Ohara, T | 1 |
Ganno, H | 2 |
Hataji, K | 2 |
Kurokawa, T | 2 |
Fukuda, A | 2 |
Andou, M | 1 |
Tei, S | 1 |
Arai, K | 2 |
Kubo, H | 2 |
Kijima, T | 1 |
Kitahara, M | 1 |
Tada, K | 2 |
Miyahara, M | 1 |
Hasegawa, H | 1 |
Kitano, Y | 1 |
Hatabe, S | 1 |
Inoue, K | 2 |
Funai, S | 1 |
Tanaka, A | 1 |
Kawaguchi, M | 1 |
Asada, Y | 1 |
Terada, T | 1 |
Takehara, A | 1 |
Munemoto, Y | 1 |
Fujisawa, K | 1 |
Mitsui, T | 1 |
Miura, S | 1 |
Sudo, Y | 1 |
Hirai, K | 2 |
Takeyoshi, I | 2 |
Kawate, S | 2 |
Sunose, Y | 2 |
Yoshinari, D | 2 |
Totsuka, O | 2 |
Nakanishi, H | 2 |
Yamamura, Y | 1 |
Kinoshita, K | 2 |
Kondo, K | 1 |
Kakisaka, T | 1 |
Aiki, F | 1 |
Matsuhisa, T | 1 |
Hattori, A | 1 |
Kazui, K | 1 |
Iijimal, S | 1 |
Handa, R | 2 |
Ooshima, S | 1 |
Miyake, Y | 2 |
Hoshi, M | 2 |
Doi, T | 5 |
Kurokawa, E | 2 |
Kikkawa, N | 2 |
Terakura, M | 2 |
Ikebe, T | 1 |
Nishioka, T | 1 |
Horiike, M | 1 |
Kaneko, M | 1 |
Aoki, Y | 1 |
Kameda, A | 2 |
Miyahara, E | 2 |
Funakoshi, M | 1 |
Hirai, T | 1 |
Shinto, O | 1 |
Yashiro, M | 1 |
Kawajiri, H | 1 |
Shimizu, K | 2 |
Shimizu, T | 2 |
Miwa, A | 1 |
Hijioka, S | 1 |
Seto, Y | 1 |
Hatake, K | 1 |
Kunieda, K | 2 |
Nagao, N | 2 |
Matsuhashi, N | 2 |
Sasaki, Y | 2 |
Yamada, A | 4 |
Kanematsu, M | 2 |
Imai, T | 3 |
Sakuratani, T | 2 |
Tajima, JY | 2 |
Nakagawa, Y | 1 |
Yanagawa, K | 1 |
Matsunaga, N | 1 |
Noda, S | 1 |
Taku, K | 1 |
Matsushita, S | 2 |
Kawai, K | 2 |
Mera, K | 3 |
Ibusuki, A | 1 |
Yoshii, N | 1 |
Kanekura, T | 2 |
Arai, T | 1 |
Fukunaga, M | 2 |
Ohsato, H | 1 |
Sohta, Y | 1 |
Kaze, C | 1 |
Akazawa, N | 1 |
Taguchi, K | 1 |
Imai, A | 1 |
Minato, M | 1 |
Iwaki, H | 1 |
Sugishita, H | 1 |
Ishida, N | 1 |
Sato, K | 2 |
Horiuchi, A | 1 |
Tanishima, H | 1 |
Horiuchi, T | 1 |
Tamagawa, K | 1 |
Tsujimoto, T | 1 |
Miyagawa, Y | 1 |
Ishida, K | 1 |
Uemura, R | 1 |
Hama, T | 1 |
Sakaguchi, S | 1 |
Shono, Y | 1 |
Tsubakihara, H | 1 |
Tabuse, K | 1 |
Akaza, H | 1 |
Ikemoto, I | 1 |
Namiki, M | 1 |
Usami, M | 1 |
Fujimoto, H | 2 |
Tsukamoto, T | 1 |
Naito, S | 1 |
Ayata, S | 1 |
Maruyama, Y | 1 |
Tsukada, Y | 1 |
Ishii, S | 1 |
Ueda, T | 1 |
Higuchi, M | 1 |
Mima, T | 1 |
Yakushiji, N | 1 |
Nishikawa, A | 1 |
Ohnishi, M | 1 |
Tanahashi, S | 1 |
Murai, M | 1 |
Yamamoto, D | 1 |
Kanematsu, S | 1 |
Ah, K | 1 |
Furuichi, N | 2 |
Yanagawa, S | 1 |
Takakura, N | 2 |
Aoki, H | 2 |
Ohno, S | 2 |
Nishizaki, M | 1 |
Endo, W | 1 |
Fujie, Y | 1 |
Toyoda, Y | 1 |
Yoshioka, S | 2 |
Hojou, S | 1 |
Maeura, Y | 1 |
Irino, T | 1 |
Okamura, A | 1 |
Inaba, Y | 2 |
Hayashi, S | 3 |
Danno, K | 2 |
Kagara, N | 1 |
Kanoh, T | 2 |
Ohnishi, T | 2 |
Tohno, T | 1 |
Kagawa, K | 3 |
Monden, T | 2 |
Imaoka, S | 2 |
Watayo, Y | 1 |
Amagasa, H | 1 |
Kawasaki, N | 1 |
Ohhinata, R | 1 |
Maeda, Y | 1 |
Sasaki, E | 1 |
Shingai, T | 1 |
Kano, S | 1 |
Gotoh, K | 1 |
Motoori, M | 1 |
Takahashi, H | 4 |
Miyashiro, I | 1 |
Ohigashi, H | 1 |
Yano, M | 1 |
Ishikawa, O | 1 |
Okubo, K | 1 |
Asukai, K | 1 |
Hata, T | 1 |
Maekawa, T | 1 |
Kashiwazaki, M | 1 |
Yano, K | 1 |
Fujimoto, T | 1 |
Kusumoto, M | 1 |
Toyoda, S | 1 |
Ishikawa, N | 2 |
Kusumoto, C | 1 |
Doi, F | 1 |
Hara, F | 1 |
Kiyoto, S | 1 |
Takabatake, D | 1 |
Takashima, S | 2 |
Aogi, K | 1 |
Ohsumi, S | 1 |
Shimane, T | 1 |
Akiyama, R | 1 |
Uzuki, A | 1 |
Sugimoto, A | 1 |
Ikenoya, Y | 1 |
Egawa, S | 1 |
Sanbe, T | 1 |
Suzaki, H | 1 |
Iwase, H | 4 |
Shimada, M | 3 |
Tsuzuki, T | 2 |
Sugihara, M | 1 |
Haruta, J | 1 |
Shinoda, M | 1 |
Kumada, T | 1 |
Chiba, F | 1 |
Shuto, C | 1 |
Yamada, S | 1 |
Konishi, F | 1 |
Yasumura, S | 1 |
Shojaku, H | 1 |
Takakura, H | 1 |
Fujisaka, M | 1 |
Tsubota, M | 1 |
Naruse, A | 1 |
Tachino, H | 1 |
Takita, M | 1 |
Iwasaki, E | 1 |
Hatogai, K | 1 |
Kishino, R | 1 |
Seki, E | 1 |
Izumiya, M | 1 |
Maeda, N | 1 |
Nakazawa, A | 1 |
Mizuki, A | 1 |
Handa, K | 2 |
Shimoyama, Y | 2 |
Mukai, K | 2 |
Higuchi, H | 1 |
Takaishi, H | 1 |
Hibi, T | 2 |
Tsukada, N | 1 |
Yamada, H | 1 |
Horie, A | 1 |
Nomura, T | 1 |
Iketani, S | 1 |
Kanai, I | 1 |
Nakatani, Y | 1 |
Hamada, Y | 1 |
Toriumi, F | 2 |
Ei, S | 1 |
Okada, R | 1 |
Masai, K | 1 |
Mito, M | 1 |
Ishimaru, N | 1 |
Mizuno, K | 1 |
Yamanashi, T | 1 |
Koshida, Y | 2 |
Motegi, K | 2 |
Tajima, T | 2 |
Takase, Y | 1 |
Takahashi, N | 1 |
Toya, H | 1 |
Hirano, T | 1 |
Goto, T | 1 |
Nemoto, H | 1 |
Yokomizo, K | 1 |
Kitamura, Y | 1 |
Sakuraba, K | 1 |
Soda, H | 1 |
Matsubara, T | 2 |
Ishibashi, K | 1 |
Kigawa, G | 1 |
Hibi, K | 1 |
Dan, N | 1 |
Tendo, M | 1 |
Hori, T | 1 |
Takiguchi, S | 1 |
Nakajima, K | 2 |
Miyata, H | 1 |
Mori, M | 1 |
Yonekura, K | 1 |
Miyaki, A | 1 |
Katsube, T | 2 |
Kuhara, K | 1 |
Usuda, A | 1 |
Isohata, N | 1 |
Asaka, S | 1 |
Murayama, M | 2 |
Naritaka, Y | 2 |
Makino, I | 1 |
Nakagawara, H | 1 |
Fujita, H | 1 |
Takamura, H | 1 |
Kitagawa, H | 1 |
Tani, T | 1 |
Nakashima, A | 2 |
Nitori, N | 1 |
Kato, A | 1 |
Okada, A | 1 |
Kuroda, J | 1 |
Kadomura, T | 1 |
Kubota, K | 1 |
Origuchi, N | 1 |
Fujisaki, M | 1 |
Kitajima, M | 3 |
Mikayama, Y | 2 |
Toyokawa, H | 1 |
Yanagimoto, H | 1 |
Kamata, M | 1 |
Ohe, C | 1 |
Sakaida, N | 1 |
Kitade, H | 1 |
Matsui, Y | 1 |
Kwon, AH | 1 |
Kawachi, Y | 1 |
Kuwabara, S | 1 |
Musha, N | 1 |
Wakabayashi, M | 1 |
Nakamura, H | 1 |
Katsuta, E | 1 |
Kaneko, J | 1 |
Iwata, N | 1 |
Aoyagi, H | 1 |
Takahata, T | 2 |
Hasegawa, K | 1 |
Maejima, S | 1 |
Yoneda, M | 1 |
Komatsu, S | 1 |
Ichikawa, D | 1 |
Ochiai, T | 3 |
Kokuba, Y | 1 |
Kametaka, H | 1 |
Koyama, T | 1 |
Seike, K | 1 |
Mitomo, S | 1 |
Koeda, K | 2 |
Chiba, T | 1 |
Uesugi, N | 1 |
Sugai, T | 1 |
Wakabayashi, G | 1 |
Minamoto, K | 1 |
Yuasa, I | 1 |
Inoue, T | 2 |
Yachida, S | 2 |
Usuki, H | 2 |
Kimura, T | 2 |
Hagiike, M | 2 |
Okano, K | 2 |
Mori, Y | 2 |
Tamamori, Y | 1 |
Azuma, T | 1 |
Kawakami, Y | 1 |
Honda, Y | 1 |
Nakahara, T | 1 |
Naeshiro, N | 1 |
Miyaki, D | 1 |
Nagaoki, Y | 1 |
Kawaoka, T | 1 |
Takaki, S | 1 |
Hiramatsu, A | 1 |
Waki, K | 1 |
Hyogo, H | 1 |
Aikata, H | 1 |
Arihiro, K | 1 |
Sanetou, H | 1 |
Chayama, K | 1 |
Ukon, K | 1 |
Itagaki, T | 1 |
Teramoto, S | 1 |
Okamura, K | 1 |
Hirata, Y | 1 |
Sakaguchi, K | 2 |
Takahashi, Y | 3 |
Suito, T | 1 |
Kameyama, Y | 1 |
Nakayama, S | 1 |
Hirayama, M | 1 |
Kuroiwa, G | 1 |
Kawano, Y | 1 |
Takada, K | 1 |
Miyanishi, K | 1 |
Takimoto, R | 1 |
Kobune, M | 1 |
Kato, J | 1 |
Tono, T | 1 |
Kawabata, R | 1 |
Fujii, C | 1 |
Izeki, C | 1 |
Oohinata, R | 1 |
Oohashi, M | 1 |
Wang, ML | 1 |
Zhou, LY | 1 |
Lu, XY | 1 |
Yang, JF | 1 |
Yu, HG | 1 |
Maruyama, K | 2 |
Furukawa, J | 2 |
Maruyama, N | 2 |
Tanaka, J | 2 |
Katsumoto, Y | 2 |
Nakaguchi, K | 2 |
Sue, F | 2 |
Yoshihara, W | 2 |
Hara, A | 3 |
Harada, T | 3 |
Tsunematu, I | 1 |
Izumi, N | 2 |
Iwamoto, S | 2 |
Satake, K | 2 |
Miyazaki, H | 1 |
Shiomi, T | 2 |
Hashimoto, K | 3 |
Yano, T | 3 |
Ono, H | 1 |
Sato, M | 1 |
Ohchi, T | 1 |
Kudo, S | 1 |
Ogata, K | 1 |
Koga, Y | 1 |
Ishiodori, H | 1 |
Ishihara, A | 1 |
Iyo, T | 2 |
Nakarai, K | 3 |
Kaida, S | 3 |
Indo, T | 2 |
Okeya, M | 2 |
Kusugami, K | 1 |
Uchida, Y | 1 |
Denno, R | 1 |
Kanai, M | 1 |
Takabayashi, A | 1 |
Itoh, H | 1 |
Ii, T | 1 |
Takegawa, S | 1 |
Kiriyama, M | 1 |
Dohba, S | 1 |
Kojima, Y | 2 |
Sunami, K | 1 |
Takayama, M | 1 |
Niki, T | 1 |
Nishisaki, H | 1 |
Inoue, H | 1 |
Hamano, K | 1 |
Maeda, T | 1 |
Okutani, T | 1 |
Hirohata, S | 1 |
Nakashima, T | 1 |
Yasutake, K | 1 |
Sashikata, T | 1 |
Tsukahara, A | 2 |
Nikkuni, K | 1 |
Kokai, H | 1 |
Iwabuchi, M | 1 |
Imai, G | 1 |
Yokoyama, H | 1 |
Mochida, A | 1 |
Shiina, M | 1 |
Yamada, K | 1 |
Ishibashi, J | 1 |
Chida, N | 1 |
Tadokoro, K | 1 |
Inaba, S | 1 |
Nakata, M | 1 |
Matsushita, Y | 1 |
Araki, Y | 1 |
Koyama, H | 1 |
Ogino, A | 1 |
Yamada, E | 1 |
Matsuyama, T | 1 |
Koyama, M | 1 |
Watabe, S | 1 |
Tsuge, T | 1 |
Kamio, Y | 1 |
Chiba, M | 1 |
Takahashi, I | 1 |
Kakeji, Y | 1 |
Emi, Y | 1 |
Sakurai, M | 1 |
Yonemura, Y | 1 |
Endo, K | 1 |
Ikeda, Y | 1 |
Toh, Y | 1 |
Kohnoe, S | 1 |
Okamura, T | 1 |
Kawai, H | 1 |
Ohtsu, A | 1 |
Hamamoto, Y | 1 |
Nagashima, F | 1 |
Muto, M | 1 |
Sano, Y | 1 |
Kobayashi, O | 2 |
Sairenji, M | 2 |
Motohashi, H | 1 |
Imada, T | 2 |
Ishimura, K | 1 |
Izuishi, K | 1 |
Karasawa, Y | 1 |
Goda, F | 1 |
Maeta, H | 1 |
Tsujitani, S | 1 |
Kaibara, N | 1 |
Takagane, A | 2 |
Abe, K | 1 |
Irinoda, T | 3 |
Nakaya, T | 1 |
Yonezawa, H | 1 |
Saito, K | 1 |
Kanzaki, N | 1 |
Ohtani, S | 1 |
Nemoto, T | 1 |
Hoshino, Y | 2 |
Kogure, M | 2 |
Miyagawa, K | 1 |
Mitachi, Y | 2 |
Masuda, T | 2 |
Oogoshi, T | 1 |
Sakai, W | 1 |
Imazu, H | 1 |
Yoshida, I | 1 |
Tonomura, S | 1 |
Nozoe, Y | 1 |
Sakurai, Y | 1 |
Ochiai, M | 1 |
Morifuji, M | 2 |
Yokoyama, T | 2 |
Kanehiro, T | 1 |
Sasaki, M | 2 |
Meguro, E | 2 |
Kaizuka, H | 1 |
Inaba, T | 1 |
Hayakawa, Y | 2 |
Okada, S | 1 |
Yamaguchi, S | 1 |
Wakabayashi, J | 1 |
Kuramochi, H | 2 |
Tenma, N | 1 |
Kawami, H | 1 |
Shigematsu, H | 1 |
Fujimoto, Y | 1 |
Masuda, H | 1 |
Karube, H | 1 |
Ookame, H | 1 |
Sakamoto, N | 1 |
Koizumi, Y | 1 |
Tomita, M | 1 |
Obata, H | 1 |
Nakajo, S | 1 |
Tanaka, O | 2 |
Nabeshima, K | 1 |
Soeda, J | 1 |
Kondo, Y | 1 |
Ogoshi, K | 1 |
Makuuchi, H | 1 |
Akaiwa, J | 1 |
Nakao, K | 2 |
Koishi, K | 1 |
Nishizaki, K | 1 |
Ooiwa, N | 1 |
Yamamura, T | 1 |
Esumi, K | 1 |
Masuda, N | 1 |
Shimizu, J | 2 |
Ishida, H | 2 |
Masutani, S | 1 |
Tatsuta, M | 1 |
Kawasaki, T | 1 |
Yoshihara, T | 1 |
Fujita, T | 2 |
Nishi, H | 1 |
Takao, T | 1 |
Mano, M | 1 |
Komatsubara, S | 1 |
Akiba, Y | 1 |
Otani, Y | 3 |
Kumai, K | 2 |
Akagi, Y | 1 |
Ito, K | 1 |
Hino, S | 1 |
Nonaka, T | 1 |
Hara, S | 2 |
Hamakawa, H | 1 |
Kajikawa, H | 1 |
Nario, K | 1 |
Miyahara, H | 1 |
Doi, R | 1 |
Tokuhara, T | 1 |
Michigami, S | 1 |
Yada, K | 1 |
Hibuse, Y | 1 |
Ogawa, Y | 1 |
Takashima, T | 3 |
Kashiwagi, K | 1 |
Inoue, D | 1 |
Shibuya, H | 1 |
Hirata, K | 2 |
Hoshimoto, S | 1 |
Hagiuda, J | 1 |
Igarashi, N | 1 |
Matsui, H | 1 |
Koyama, Y | 2 |
Miyakita, M | 1 |
Takanosu, S | 1 |
Tatsuzawa, Y | 2 |
Kawaura, Y | 2 |
Yasutomo, N | 1 |
Kawabata, M | 1 |
Inoue, Y | 3 |
Katsura, H | 1 |
Sakao, J | 2 |
Yokotani, H | 1 |
Souda, S | 2 |
Yajima, H | 1 |
Kusuyama, A | 1 |
Nagayama, A | 1 |
Anazawa, S | 1 |
Yanaga, K | 1 |
Aoyagi, K | 1 |
Koufuji, K | 1 |
Miyagi, M | 1 |
Imaizumi, T | 1 |
Takeda, J | 1 |
Konno, S | 1 |
Obu, M | 1 |
Hamaguchi, K | 1 |
Shimakawa, T | 1 |
Yagawa, Y | 1 |
Aiba, M | 1 |
Kaneko, K | 1 |
Watanabe, A | 3 |
Ishikawa, H | 4 |
Ohyama, T | 2 |
Niimi, Y | 1 |
Yunotani, S | 1 |
Noguchi, R | 1 |
Shinozaki, Y | 1 |
Tani, H | 1 |
Sakai, M | 2 |
Ishimitsu, T | 1 |
Tabuchi, M | 1 |
Hihara, J | 1 |
Ohta, K | 1 |
Hamai, Y | 1 |
Taomoto, J | 1 |
Toge, T | 1 |
Deguchi, Y | 1 |
Shioya, M | 1 |
Takenaka, K | 1 |
Doi, H | 1 |
Komai, Y | 1 |
Higuchi, A | 1 |
Abe, N | 1 |
Sugiyama, M | 1 |
Atomi, Y | 1 |
Ogino, H | 1 |
Misawa, T | 1 |
Nasu, T | 1 |
Ihara, Y | 1 |
Kubo, S | 1 |
Sadamoto, Y | 1 |
Mizuno, I | 1 |
Mohri, N | 1 |
Fukaya, S | 1 |
Shinagawa, N | 1 |
Manabe, T | 1 |
Nakata, B | 2 |
Sawada, T | 1 |
Mizukami, Y | 1 |
Suzuki, M | 1 |
Niimi, K | 1 |
Nagashima, T | 1 |
Shibata, N | 1 |
Eto, TA | 1 |
Hotokezaka, M | 1 |
Iwamura, T | 1 |
Chijiiwa, K | 1 |
Seo, S | 1 |
Miki, A | 1 |
Kitai, T | 1 |
Ino, K | 1 |
Higashiyama, H | 1 |
Ukikusa, M | 1 |
Waseda, R | 1 |
Ohtake, Y | 1 |
Nakamura, R | 1 |
Akatsu, Y | 1 |
Shioiri, T | 1 |
Kusano, T | 1 |
Kitamura, M | 1 |
Warabi, M | 1 |
Kawahara, Y | 1 |
Mitsuhashi, M | 1 |
Aratake, K | 1 |
Ogawa, S | 1 |
Itabashi, M | 1 |
Shirotani, N | 1 |
Kameoka, S | 1 |
Ishihara, C | 1 |
Ando, K | 1 |
Shotsu, M | 1 |
Ishiwa, N | 1 |
Takeda, A | 1 |
Ogoshi, T | 1 |
Ishiguro, A | 3 |
Munakata, M | 4 |
Sakata, Y | 4 |
Mizuno, Y | 1 |
Kotake, M | 1 |
Murakami, N | 1 |
Bandou, H | 1 |
Morita, K | 2 |
Koizumi, H | 1 |
Yoshino, H | 1 |
Tawaraya, K | 1 |
Ishiguro, K | 1 |
Tanemura, H | 1 |
Oshita, H | 1 |
Kanno, A | 1 |
Kusakabe, M | 1 |
Hatoh, T | 1 |
Yamada, M | 1 |
Adachi, T | 1 |
Saito, S | 1 |
Tomita, E | 1 |
Sugiyama, A | 3 |
Ishigami, S | 2 |
Aridome, K | 2 |
Nakajo, A | 1 |
Okumura, H | 1 |
Hokita, S | 2 |
Natsugoe, S | 2 |
Aikou, T | 2 |
Ikawa, S | 1 |
Kubota, D | 1 |
Katsuragi, K | 1 |
Ohba, K | 1 |
I, S | 1 |
Matsuyama, M | 1 |
Jingu, K | 1 |
Sasagawa, K | 1 |
Kagaya, A | 1 |
Itoh, K | 1 |
Minami, H | 2 |
Ito, A | 1 |
Ito, N | 1 |
Matsui, W | 1 |
Inagaki, J | 1 |
Miki, H | 1 |
Kittaka, N | 1 |
Aihara, T | 1 |
Sugimoto, K | 1 |
Tomita, N | 1 |
Takatsuka, Y | 1 |
Nakanome, A | 1 |
Shiga, K | 1 |
Sagai, S | 1 |
Kameyama, S | 1 |
Murayama, R | 1 |
Miyazato, K | 1 |
Kurashita, K | 1 |
Ishimine, T | 1 |
Nagamine, Y | 1 |
Kohakura, F | 1 |
Shinzato, S | 1 |
Tomimori, K | 1 |
Kugai, Y | 1 |
Uchima, H | 1 |
Ohnuma, M | 1 |
Uchiyama, T | 1 |
Kamiyama, Y | 1 |
Ise, H | 1 |
Tsunezuka, Y | 1 |
Oda, M | 1 |
Moriyama, H | 1 |
Nagata, N | 1 |
Oba, K | 1 |
Sugiyama, Y | 1 |
Hayashidani, Y | 1 |
Sudo, A | 1 |
Shirakawa, T | 1 |
Yokoi, K | 2 |
Seya, T | 1 |
Horiba, K | 1 |
Kanazawa, Y | 1 |
Okawa, K | 1 |
Yoshioka, M | 1 |
Oaki, Y | 1 |
Tokunaga, A | 1 |
Tajiri, T | 3 |
Ishizuka, T | 1 |
Yoshiyasu, M | 1 |
Yanagi, K | 1 |
Bando, K | 1 |
Sunagozaka, H | 1 |
Yamashita, T | 1 |
Kagaya, T | 1 |
Kaneko, S | 2 |
Anegawa, G | 1 |
Ohta, R | 1 |
Kai, T | 1 |
Anai, H | 1 |
Yokoyama, S | 1 |
Tsunoda, A | 1 |
Kamiyama, G | 1 |
Narita, K | 1 |
Suzuki, N | 1 |
Oonaka, T | 1 |
Kusano, M | 1 |
Okusaka, T | 1 |
Ueno, H | 1 |
Morizane, C | 1 |
Kamisawa, H | 1 |
Sasaki, S | 1 |
Hayashi, Y | 1 |
Kohri, K | 1 |
Yamada, R | 1 |
Hatori, S | 1 |
Makino, T | 1 |
Yamazaki, Y | 1 |
Takanashi, Y | 1 |
Kawasaki, K | 1 |
Kamigaki, T | 1 |
Takase, S | 1 |
Shirasaka, D | 1 |
Shinoda, H | 1 |
Kuroda, D | 1 |
Kuroda, Y | 1 |
Wakakuwa, R | 1 |
Nakajima, H | 1 |
Mizuta, N | 1 |
Mizuta, M | 1 |
Nakatsukasa, K | 1 |
Hachimine, Y | 1 |
Fujiwara, I | 1 |
Sawai, K | 1 |
Kawamura, S | 1 |
Yamagishi, D | 1 |
Sumi, Y | 1 |
Shimada, E | 1 |
Okumura, S | 1 |
Sumida, Y | 1 |
Kondou, M | 1 |
Hashizume, S | 1 |
Tokunaga, T | 1 |
Kamohara, R | 1 |
Matsutani, T | 1 |
Egami, K | 1 |
Sasajima, K | 1 |
Maruyama, H | 1 |
Miyamoto, M | 1 |
Maruta, F | 1 |
Koide, N | 1 |
Miyagawa, S | 1 |
Kasai, M | 1 |
Funakoshi, A | 2 |
Senju, T | 1 |
Sumii, T | 2 |
Jeung, HC | 1 |
Rha, SY | 1 |
Cho, BC | 1 |
Yoo, NC | 1 |
Roh, JK | 1 |
Roh, WJ | 1 |
Chung, HC | 1 |
Ahn, JB | 1 |
Obuchi, T | 1 |
Sugimura, Y | 1 |
Hatakeyama, G | 1 |
Hosoi, Y | 1 |
Nishiura, H | 1 |
Ishii, K | 1 |
Nonami, M | 1 |
Shigemori, M | 1 |
Katsurada, A | 1 |
Azechi, H | 1 |
Kondo, M | 1 |
Tojo, M | 1 |
Asagoe, K | 1 |
Inoue, F | 1 |
Suwa, H | 1 |
Saiga, T | 1 |
Tambo, Y | 1 |
Kasahara, K | 1 |
Fujimura, M | 1 |
Tamori, S | 1 |
Araya, T | 1 |
Sone, T | 1 |
Nakao, S | 1 |
Noda, Y | 1 |
Matsumoto, Y | 1 |
Hioki, J | 1 |
Chinen, T | 1 |
Nakachi, N | 1 |
Nakamoto, M | 2 |
Uchima, N | 1 |
Hirata, T | 1 |
Hokama, A | 1 |
Kinjo, N | 1 |
Kinjo, F | 1 |
Fujita, J | 1 |
Nakatani, K | 1 |
Nishimura, K | 1 |
Shimoda, T | 1 |
Azuma, M | 1 |
Katada, C | 1 |
Higuchi, K | 1 |
Saigenji, K | 1 |
Uchida, K | 1 |
Nakajima, G | 1 |
Harada, K | 1 |
Kawashima, Y | 1 |
Uchida, D | 1 |
Koga, M | 1 |
Kamitani, T | 1 |
Futami, K | 1 |
Arima, S | 1 |
Sakamoto, C | 1 |
Karimata, H | 1 |
Nagahama, M | 1 |
Akamatsu, M | 1 |
Teruya, J | 1 |
Takaesu, H | 1 |
Nishimaki, T | 1 |
Itoh, J | 2 |
Aoki, M | 1 |
Munakata, A | 1 |
Ito, T | 1 |
Murayama, T | 1 |
Toeda, H | 1 |
Imazu, Y | 1 |
Ooyama, R | 1 |
Mimatsu, K | 1 |
Kawasaki, A | 1 |
Oida, T | 1 |
Aramaki, O | 1 |
Kuboi, Y | 1 |
Kano, H | 1 |
Ogura, M | 1 |
Sou, K | 1 |
Saze, Z | 1 |
Otani, S | 1 |
Soeta, N | 1 |
Kashimura, S | 1 |
Osuka, F | 1 |
Odashima, Y | 1 |
Saito, T | 1 |
Tokita, H | 1 |
Kato, F | 1 |
Yamamoto, J | 1 |
Ohta, H | 1 |
Okuda, T | 1 |
Fujimi, A | 1 |
Kanisawa, Y | 1 |
Izumi, K | 1 |
Kitahara, T | 1 |
Matsuya, H | 1 |
Kawasaki, H | 1 |
Shibata, S | 1 |
Miyamoto, K | 1 |
Kijima, H | 1 |
Furuse, J | 1 |
Nakachi, K | 1 |
Suzuki, E | 1 |
Shimizu, S | 1 |
Ishii, H | 1 |
Yoshino, M | 1 |
Mizutani, S | 1 |
Uchikoshi, F | 1 |
Yoshidome, K | 1 |
Tori, M | 1 |
Ueshima, S | 1 |
Yamagami, Y | 1 |
Nakahara, M | 1 |
Teraishi, F | 1 |
Chikuba, A | 1 |
Nezu, M | 1 |
Shimamura, H | 1 |
Takiue, T | 1 |
Chikuba, H | 1 |
Tazawa, K | 1 |
Matsui, K | 1 |
Shinbo, M | 1 |
Yamagishi, F | 1 |
Tsukada, K | 1 |
Choi, YJ | 1 |
Chung, JS | 1 |
Shin, HJ | 1 |
Cho, GJ | 1 |
Wang, SG | 1 |
Lee, BJ | 1 |
Cho, BM | 1 |
Joo, YD | 1 |
Sohn, CH | 1 |
Sawaki, A | 1 |
Mizuno, N | 1 |
Hoki, N | 1 |
Takagi, T | 1 |
Yamao, K | 1 |
Shirasaka, T | 1 |
Saji, S | 1 |
Kitano, M | 1 |
Doi, M | 1 |
Sekine, K | 1 |
Shimizu, M | 1 |
Yoshii, H | 1 |
Iijima, S | 2 |
Oshima, S | 1 |
Narahara, H | 1 |
Shimokawa, T | 1 |
Tsuji, Y | 1 |
Abe, S | 1 |
Tamura, F | 1 |
Mizushima, T | 1 |
Nagashima, H | 1 |
Oura, K | 1 |
Kukitsu, T | 1 |
Yoshizaki, N | 1 |
Kondo, H | 1 |
Inuyama, Y | 2 |
Kida, A | 2 |
Tsukuda, M | 2 |
Kohno, N | 2 |
Satake, B | 2 |
Miyagawa, T | 1 |
Toyoda, H | 1 |
Uesato, K | 1 |
Asanuma, F | 1 |
Ohsaku, M | 1 |
Kaneo, K | 1 |
Tomita, H | 1 |
Yasuda, K | 1 |
Yamamori, T | 1 |
Misawa, K | 1 |
Ohashi, H | 1 |
Onoda, T | 1 |
Higaki, K | 1 |
Kobayashi, N | 1 |
Hiraiwa, A | 1 |
Morishita, M | 1 |
Yagi, S | 1 |
Yoriki, R | 1 |
Sado, S | 1 |
Kusumoto, Y | 1 |
Tamaki, H | 1 |
Hongo, S | 1 |
Yokota, M | 1 |
Ouchi, J | 1 |
Miyagi, Y | 1 |
Matsuo, S | 1 |
Uchimura, K | 1 |
Morikawa, A | 1 |
Okabe, R | 1 |
Miyazawa, K | 1 |
Ozaki, K | 1 |
Suzuki, A | 1 |
Yamasaki, K | 1 |
Morikawa, S | 1 |
Ohnita, K | 1 |
Taura, K | 1 |
Isomoto, H | 1 |
Mizuta, Y | 1 |
Murase, K | 1 |
Murata, I | 1 |
Kohno, S | 1 |
Takemura, M | 1 |
Ohta, Y | 1 |
Shuto, T | 1 |
Takemura, S | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Effect of Postoperative Supplemental Parenteral Nutrition (SPN) in Gastric Cancer Patients Who Underwent Gastrectomy: A Multicenter Prospective Randomized Controlled Trial[NCT04607057] | Phase 4 | 224 participants (Anticipated) | Interventional | 2020-12-22 | Recruiting | ||
Docetaxel, Oxaliplatin, Fluorouracil (FLOT Regimen) Combined With Teriprizumab (PD-1) in the First-line Treatment of Patients With Advanced Gastric Cancer and Peritoneal Metastasis: an Open, One-arm, Exploratory Study[NCT04886193] | 20 participants (Anticipated) | Interventional | 2021-04-16 | Recruiting | |||
The Exploratory Study of Conversion Surgery for Apatinib in Combination With Oxaliplatin/S-1(SOX) for Patients With Unresectable Gastric Cancer[NCT03007446] | Phase 2 | 20 participants (Anticipated) | Interventional | 2016-11-30 | Recruiting | ||
Apatinib Plus XELOX Regime as Neoadjuvant Therapy in Locally Advanced Gastric Cancer Patients With Lymph Node Metastasis[NCT03229096] | Phase 2 | 35 participants (Anticipated) | Interventional | 2017-02-01 | Recruiting | ||
Phase III Trial of 3-weekly vs. 5-weekly Schedule of S-1 Plus Cisplatin Combination Chemotherapy for First Line Treatment of Advanced Gastric Cancer.[NCT00915382] | Phase 3 | 625 participants (Actual) | Interventional | 2009-01-31 | Completed | ||
A Multi-center, II Phase,Randomized Controlled Clinical Study of Capecitabine Metronomic Chemotherapy After Gemcitabine Plus Capecitabine Standard Adjuvant Therapy for Stage II/III Pancreatic Cancer[NCT03959150] | Phase 2/Phase 3 | 231 participants (Anticipated) | Interventional | 2020-01-05 | Recruiting | ||
Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study[NCT04737551] | 400 participants (Anticipated) | Observational [Patient Registry] | 2020-01-01 | Recruiting | |||
Comparison of Efficacy and Tolerance Between Combination Therapy and Monotherapy as a First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer; Multicenter Randomized Phase 3 Study[NCT02114359] | Phase 3 | 111 participants (Actual) | Interventional | 2014-02-28 | Completed | ||
Phase III Study of Adjuvant Capecitabine vs Observation Alone in Curatively Resected Stage IB (by AJCC 6th Edition) Gastric Cancer(KCSG ST14-05)[NCT01917552] | Phase 3 | 870 participants (Anticipated) | Interventional | 2013-08-19 | Recruiting | ||
Randomized Open-label Trial of Dose Dense, Fixed Dose Capecitabine Compared to Standard Dose Capecitabine in Metastatic Breast Cancer and Advanced/Metastatic Gastrointestinal Cancers.[NCT02595320] | Phase 2 | 200 participants (Actual) | Interventional | 2015-10-05 | Active, not recruiting | ||
Phase III Trial of S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for First Line Treatment of Advanced Gastric Cancer[NCT01671449] | Phase 3 | 338 participants (Actual) | Interventional | 2012-12-31 | Completed | ||
A Phase II Study of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Combined With Sintilimab in Gastric Cancer With Peritoneal Metastasis[NCT05648487] | Phase 2 | 46 participants (Anticipated) | Interventional | 2023-01-01 | Not yet recruiting | ||
A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer[NCT01291407] | Phase 1 | 27 participants (Actual) | Interventional | 2010-11-30 | Completed | ||
A Phase II Study Assessing Efficacy and Safety of TS-1 in Combination With Calcium Folinate in Patients With Heavily Pre-treated Metastatic Colorectal Cancer[NCT03517618] | Phase 2 | 41 participants (Actual) | Interventional | 2014-07-05 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
24 reviews available for oxonic acid and Lymph Node Metastasis
Article | Year |
---|---|
Pharyngeal metastasis following living-donor liver transplantation for hepatocellular carcinoma: a case report and literature review.
Topics: Allografts; Biopsy; Carcinoma, Hepatocellular; Catheter Ablation; Chemotherapy, Adjuvant; Drug Combi | 2020 |
Gastric hepatoid adenocarcinoma resulting in a spontaneous gastric perforation: a case report and review of the literature.
Topics: Adenocarcinoma; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Drug Combination | 2017 |
[A Case of Remnant Gastric Cancer That Completely Responded to Neoadjuvant S-1 and Cisplatin Therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hum | 2017 |
[A case of gastric cancer with virchow and para-aortic node metastasis treated successfully by neo-adjuvant chemotherapy with S-1/CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Drug Combinations; Female; Humans; | 2013 |
[Urgent gastrectomy in a patient who developed perforated gastric cancer during preoperative chemotherapy with S-1 plus cisplatin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Combin | 2014 |
[A case of advanced sigmoid colon cancer with metastases in the liver and the paraaortic lymph nodes successfully treated with 5-FU/l-LV and FOLFOX4 followed by S-1 leading to long-term complete response].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Fluorouracil; Human | 2014 |
[Curative resection of stage IV advanced gallbladder cancer following combined treatment with gemcitabine and CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta, Abdominal; Cholecystectomy; Combined Mo | 2014 |
[Gastrectomy for a patient with advanced gastric cancer with spleen metastases following induction chemotherapy with S-1 plus cisplatin].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female | 2014 |
Gastric adenocarcinoma with para-aortic lymph node metastasis: a borderline resectable cancer?
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Combined Modality | 2015 |
[A case of advanced gastric cancer responding to S-1/CDDP neoadjuvant chemotherapy, leading to a pathological complete response].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Humans; Lymphati | 2015 |
[Curative resection for Stage IV advanced gastric cancer that responded to combination chemotherapy with docetaxel, cisplatin, and S-1].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Docetaxel; Dru | 2014 |
Gemcitabine plus S-1: a hopeful frontline treatment for Asian patients with unresectable advanced pancreatic cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Asian | 2015 |
[A Case of HER2-Positive Advanced Gastric Cancer with a Pathological Complete Response to Neoadjuvant Chemotherapy with S-1/CDDP/Trastuzumab].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastre | 2015 |
[A Case of Advanced Gastric Cancer with a Complete Response to S-1 Neoadjuvant Chemotherapy in an Elderly Patient].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Female; Gastrectomy; Humans; | 2016 |
[An Elderly Patient with Local Recurrence of Gastric Cancer Responding Completely to S-1 Monotherapy].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Gastrectomy; Humans; Lymphati | 2016 |
[A Case of Gastric Cancer Responding to Neoadjuvant Chemotherapy Leading to Histological Change to Grade 3].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hum | 2016 |
[A Case of Simultaneous Multiple Gastric Cancers Showing Differences of Response after Neoadjuvant Chemotherapy with Docetaxel, CDDP, and S-1].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Humans; Lym | 2016 |
Aggressive recurrence of gastric cancer as a granulocyte-colony-stimulating factor-producing tumor.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biopsy; Chemotherapy, Adjuvant; Drug Combinations; | 2010 |
[Pathological complete response in advanced gastric carcinoma by S-1/CDDP combination chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Combinati | 2011 |
[Advanced gastric cancer successfully treated by TS-1--case report].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Aorta, Abdominal; Combined Modality Therapy; | 2004 |
[Recurrence of esophageal cancer treated by combination TS-1/CDDP therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Admini | 2005 |
[Recent important insights into treatment of pancreatic cancer].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined | 2005 |
[A patient with esophageal cancer recurrence responding to S-1 combined with cisplatin (CDDP)].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2007 |
[A complete response persisting for twelve months with the use of TS-1 in a patient with paraaortic lymph node metastasis of gastric cancer].
Topics: Aged; Antimetabolites, Antineoplastic; Aorta; Drug Combinations; Female; Gastrectomy; Humans; Lymph | 2001 |
48 trials available for oxonic acid and Lymph Node Metastasis
Article | Year |
---|---|
A Phase II study of preoperative chemotherapy with docetaxel, oxaliplatin and S-1 in gastric cancer with extensive lymph node metastasis (JCOG1704).
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Clinical Protocols; Docetaxe | 2020 |
Phase 2 Trial of Adjuvant Chemotherapy With S - 1 for Node-Positive Biliary Tract Cancer (N-SOG 09).
Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Chemotherapy, Adjuvant; Cho | 2020 |
The survival and prognosticators of peritoneal cytology-positive gastric cancer patients who received upfront gastrectomy and subsequent S-1 chemotherapy.
Topics: Aged; Disease-Free Survival; Drug Combinations; Female; Gastrectomy; Humans; Lymphatic Metastasis; M | 2017 |
Phase I/II Study of S-1 Plus Cisplatin Alternating With S-1 Plus Docetaxel in Patients With Advanced Gastric Cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Com | 2018 |
S-1 chemotherapy and intensity-modulated radiotherapy after D1/D2 lymph node dissection in patients with node-positive gastric cancer: a phase I/II study.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Chemoradiotherapy, Adjuvant; Disease-Free Survival; Dr | 2018 |
Concurrent chemoradiotherapy using cisplatin and S-1, followed by surgery for stage II/IIIA non-small cell lung cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemora | 2019 |
Switch maintenance therapy with S-1 after induction therapy with carboplatin and nanoparticle albumin-bound paclitaxel in advanced lung squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Antineoplastic Combined Chemotherapy Protocols; Bone Neopl | 2019 |
An integrated analysis of two phase II trials (JCOG0001 and JCOG0405) of preoperative chemotherapy followed by D3 gastrectomy for gastric cancer with extensive lymph node metastasis.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy | 2019 |
Lymph node ratio is a critical prognostic predictor in gastric cancer treated with S-1 chemotherapy.
Topics: Adenocarcinoma; Aged; Chemotherapy, Adjuvant; Drug Combinations; Female; Humans; Japan; Lymph Node E | 2014 |
Phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis: -KOGC04-.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; | 2014 |
Phase II Study of Neoadjuvant Chemotherapy With S-1 and CDDP in Patients With Lymph Node Metastatic Stage II or III Gastric Cancer.
Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Drug Combinations; Female; Humans; Lymphatic Metastas | 2017 |
Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adj | 2014 |
Low creatinine clearance is a risk factor for D2 gastrectomy after neoadjuvant chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Mod | 2014 |
Comparison of short-term efficacy and safety of TIROX and DCF regimens for advanced gastric cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cisplatin; Docet | 2014 |
A phase I trial of preoperative S-1 in combination with oxaliplatin and pelvic radiation for lower rectal cancer with T4 and lateral pelvic lymph node metastasis.
Topics: Adenocarcinoma; Adult; Aged; Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; A | 2015 |
Cost-effectiveness analysis of gemcitabine, S-1 and gemcitabine plus S-1 for treatment of advanced pancreatic cancer based on GEST study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cost-Benefit Analysi | 2015 |
Phase II multicenter study of adjuvant S-1 for colorectal liver metastasis: survival analysis of N-SOG 01 trial.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colorectal Neoplasms; Disease- | 2015 |
Comparison of two different S-1 plus cisplatin dosing schedules as first-line chemotherapy for metastatic and/or recurrent gastric cancer: a multicenter, randomized phase III trial (SOS).
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched | 2015 |
A randomized Phase II trial of systemic chemotherapy with and without trastuzumab followed by surgery in HER2-positive advanced gastric or esophagogastric junction adenocarcinoma with extensive lymph node metastasis: Japan Clinical Oncology Group study JC
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; | 2015 |
Efficacy and safety of S-1 and oxaliplatin combination therapy in elderly patients with advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; F | 2016 |
A phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for stage III gastric cancer: KUGC03.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Dise | 2016 |
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Ductal; Chemotherapy, Adjuvant; Combined Modality | 2016 |
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Ductal; Chemotherapy, Adjuvant; Combined Modality | 2016 |
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Ductal; Chemotherapy, Adjuvant; Combined Modality | 2016 |
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Ductal; Chemotherapy, Adjuvant; Combined Modality | 2016 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
A randomised multicentre phase II trial of capecitabine vs S-1 as first-line treatment in elderly patients with metastatic or recurrent unresectable gastric cancer.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Bone Neoplasms; Capecitabi | 2008 |
Phase I pharmacokinetic study of weekly intravenous and intraperitoneal paclitaxel combined with S-1 for advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Fema | 2009 |
Feasibility and efficacy of preoperative chemotherapy with docetaxel, cisplatin and S-1 in gastric cancer patients with para-aortic lymph node metastases.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cisplatin; Docetaxel; Drug Combination | 2009 |
Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Follow-Up St | 2010 |
Phase II clinical trial of postoperative S-1 monotherapy for gastric cancer patients with free intraperitoneal cancer cells detected by real-time RT-PCR.
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Carcinoembryonic Antigen; Chemotherapy, Adjuvant; D | 2010 |
Phase I study of docetaxel, cisplatin and S-1 in patients with advanced gastric cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Femal | 2010 |
Efficacy of S-1 in patients with castration-resistant prostate cancer: a phase II study.
Topics: Adult; Aged; Alanine Transaminase; Androgen Antagonists; Anorexia; Antimetabolites, Antineoplastic; | 2010 |
Efficacy and safety of S-1 in patients with metastatic breast cancer: retrospective review in a single institution.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Bone Neoplasms; Breast Neoplasms; Drug Combinations; F | 2010 |
A phase II multi-center study of triple therapy with paclitaxel, S-1 and cisplatin in patients with advanced gastric cancer.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Surviva | 2011 |
Phase II trial of preoperative chemotherapy with docetaxel, cisplatin and S-1 for T4 locally advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy P | 2012 |
Long-term results of adjuvant gemcitabine plus S-1 chemotherapy after surgical resection for pancreatic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antimetabolites, Antineoplasti | 2012 |
A Phase II study of systemic chemotherapy with docetaxel, cisplatin, and S-1 (DCS) followed by surgery in gastric cancer patients with extensive lymph node metastasis: Japan Clinical Oncology Group study JCOG1002.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Chemotherapy, Adjuvant; Cisplati | 2012 |
Phase II trial of adjuvant chemotherapy with S-1 for colorectal liver metastasis.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, | 2013 |
Randomized phase II study comparing paclitaxel with S-1 vs. S-1 as first-line treatment in patients with advanced gastric cancer.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combin | 2013 |
Clinical efficacy of S-1 combined with cisplatin for advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy P | 2003 |
Combination chemotherapy of S-1 and low-dose cisplatin for advanced gastric cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cispla | 2003 |
Prediction of sensitivity to fluoropyrimidines by metabolic and target enzyme activities in gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Ch | 2003 |
[Evaluation of TS-1 combined with cisplatin for neoadjuvant chemotherapy in patients with advanced gastric cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule | 2003 |
[Combination chemotherapy with S-1 plus CPT-11 for patients with advanced or recurrent colorectal cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal | 2006 |
[S-1 monotherapy for pancreatic cancer].
Topics: Administration, Oral; Aged; Anorexia; Antimetabolites, Antineoplastic; Drug Administration Schedule; | 2006 |
A phase II trial of S-1 monotherapy in metastatic colorectal cancer after failure of irinotecan- and oxaliplatin-containing regimens.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colorectal Neoplasms; Dru | 2006 |
[Unresectable gallbladder cancer with lymph node and liver metastases completely responding to S-1 monotherapy - a case report].
Topics: Antimetabolites, Antineoplastic; Drug Combinations; Gallbladder Neoplasms; Humans; Liver Neoplasms; | 2007 |
A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment method.
Topics: Administration, Oral; Adult; Aged; Algorithms; Antimetabolites, Antineoplastic; Antineoplastic Combi | 2007 |
Multi-center phase II study for combination therapy with paclitaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistance to S-1 (OGSG 0302).
Topics: Adenocarcinoma; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Disease-Free | 2008 |
[Early phase II study of S-1 in patients with advanced head and neck cancer. S-1 Cooperative Study Group (Head and Neck Working Group)].
Topics: Administration, Oral; Adult; Aged; Anorexia; Antimetabolites, Antineoplastic; Carcinoma, Squamous Ce | 1998 |
[Late phase II study of S-1 in patients with advanced head and neck cancer].
Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug A | 2001 |
332 other studies available for oxonic acid and Lymph Node Metastasis
Article | Year |
---|---|
[A Case of Advanced Gastric Cancer with Distant Lymph Nodes Metastasis Showing a Complete Response to Six-Courses Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Gastrect | 2021 |
Efficacy of capecitabine and oxaliplatin versus S-1 as adjuvant chemotherapy in gastric cancer after D2 lymph node dissection according to lymph node ratio and N stage.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Adjuvant; D | 2019 |
[A Case of Trousseau Syndrome Complication during Chemotherapy for Advanced Gastric Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cerebral Infarction; Cisplatin; Female; Humans | 2019 |
[A Case of Successful Surgical Treatment for Paraaortic Lymph Nodes Recurrence of Gallbladder Cancer].
Topics: Aged; Drug Combinations; Gallbladder Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic | 2019 |
[A Case of Advanced Gastric Cancer with Right Gastroepiploic Vein Tumor Thrombus Treated by Preoperative S-1 plus CDDP That Resulted in Pathological Complete Response].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hum | 2019 |
[A Case of Long-Term Survival with Far Advanced Gastric Cancer after Multidisciplinary Treatments, including Conversion Surgery].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Humans; Lymphatic Metastasis; Mal | 2020 |
[Case of Gastric Cancer with Para-Aortic Lymph Node Metastases Successfully Treated with S-1/Docetaxel Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Lymph No | 2020 |
[Long-Term Survival for a Patient with StageⅣ Gastric Cancer with Multiple Liver Metastases for Ten Years Who Was Treated with Only S-1Chemotherapy].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Female; Gastrectomy; Humans; | 2020 |
[A Case of Histological Response of Grade 3 Achieved by Preoperative Chemotherapy with S-1/Oxaliplatin(SOX)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Gastrectomy; Humans; Lympha | 2021 |
[A Case of Advanced Gastric Cancer with Extensive Lymph Node Metastasis That Showed pCR to Preoperative Chemotherapy Containing SP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Gastrect | 2020 |
[A Case of Gastric Cancer with Extensive Lymph Node Metastasis Causing Stenosis Symptoms in the Primary pCR after Preoperative Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Constriction, Pathologic; Drug Combinations; G | 2021 |
Complete circumferential lymphadenectomy around the superior mesenteric artery with preservation of nerve plexus reduces locoregional recurrence after pancreatoduodenectomy for resectable pancreatic ductal adenocarcinoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Pancreati | 2021 |
Pathological complete response at the para-aortic nodes as a possible surrogate endpoint in gastric cancer surgery with para-aortic node dissection after neoadjuvant chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Biomarkers; Cape | 2022 |
Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cisplati | 2017 |
Chemotherapy for alpha-fetoprotein producing gastric cancers expressing human epidermal growth factor receptor 2.
Topics: Aged; alpha-Fetoproteins; Antimetabolites, Antineoplastic; Antineoplastic Agents, Immunological; Ant | 2018 |
[A Case of Conversion Surgery for a Patient with Initially Unresectable Pancreatic Cancer with a Pathological Complete Response to S-1 Chemotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Combinations; Female; Humans; Lymphatic Metastasis; Neoa | 2017 |
[Combination Chemotherapy Including Intraperitoneal(IP)Administration of Paclitaxel(PTX)followed by PTX, CDDP and S-1Triplet Chemotherapy for CY1P0 Gastric Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Humans; | 2017 |
[A Case of Duodenal Invasive Advanced Gastric Cancer in Which the Primary Tumor Achieved pCR, but Viable Cancer Cells Remained in Lymph Node No.13 after Neoadjuvant Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Duodenum; Female; Gastrecto | 2017 |
[A Case of Stage IV Breast Cancer with Extensive Metastasis Successfully Treated with S-1 plus Anastrozole Therapy].
Topics: Aged; Anastrozole; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Drug Co | 2017 |
[A Successful Treatment for Stage III c Gastric Cancer with Low Cardiac Function Using S-1 plus Oxaliplatin(SOX)as a Neoadjuvant Chemotherapy].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Gastre | 2017 |
Cytoplasmic Hu-Antigen R (HuR) Expression is Associated with Poor Survival in Patients with Surgically Resected Cholangiocarcinoma Treated with Adjuvant Gemcitabine-Based Chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Biomarkers, Tumor; Cell N | 2018 |
Adjuvant Chemotherapy Versus Chemoradiotherapy Versus Surgery Alone for Early Gastric Cancer with One or Two Lymph Node Metastasis.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemoradiotherap | 2018 |
Intraperitoneal Administration of Paclitaxel Followed by Paclitaxel, Cisplatin, and S-1 Chemotherapy for Cytology-positive Gastric Cancer: A Feasibility Study.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Feasibility Stud | 2018 |
[A Case of Long-Term Survival in a Patient with Advanced Gastric Cancer with Para-Aortic Lymph Node Metastasis Who Responded to Combined Modality Therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Combined Modality Therapy; Drug Co | 2018 |
[A Case of Advanced Gastric Cancer with Para-Aortic Lymph Node Metastasis Treated with Conversion Surgery after S-1 plus Oxaliplatin Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Gastrectomy; Humans; Lymph Node Excision; Lymp | 2018 |
[A Case of cStage Ⅲ Esophagogastric Junction Adenocarcinoma That Showed pCR to Preoperative Chemotherapy Containing SOX].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Esophagogas | 2018 |
[Gastric Neuroendocrine Carcinoma(NEC)Treated with CDDP plus CPT-11 Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Neuroendocrine; Cisplatin; Drug Com | 2019 |
[A Case of Gastric Small Cell Carcinoma with Rapid Regrowth after Surgery].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Drug Combinations; | 2019 |
Timing and site-specific trends of recurrence in patients with pathological stage II or III gastric cancer after curative gastrectomy followed by adjuvant S-1 monotherapy.
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Female; Gastrectom | 2019 |
Body weight loss after surgery affects the continuity of adjuvant chemotherapy for pancreatic cancer.
Topics: Aged; Chemotherapy, Adjuvant; Deoxycytidine; Drug Combinations; Female; Gemcitabine; Humans; Logisti | 2019 |
[A Case of Long-Term Survival Following Two-Stage Surgery for Perforated Advanced Gastric Cancer Caused by Chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hum | 2019 |
[Long-Term Survival of a Patient with Inoperable Gastric Cancer with Distant Lymph Node Metastasis-A Case Report].
Topics: Aged; Drug Combinations; Female; Humans; Lymph Nodes; Lymphatic Metastasis; Oxonic Acid; Stomach Neo | 2019 |
Intramucosal gastric cancer with fifteen metastatic lymph nodes: report of a case.
Topics: Aged; Antimetabolites, Antineoplastic; Biopsy; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; | 2012 |
The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Ant | 2013 |
Factors predictive of recurrence after surgery for gastric cancer followed by adjuvant S-1 chemotherapy.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuv | 2013 |
Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Combinations | 2014 |
Perineural invasion in extrahepatic cholangiocarcinoma: prognostic impact and treatment strategies.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; | 2013 |
[A case of mediastinal lymph node gastric cancer recurrence during S-1 adjuvant therapy successfully treated with cisplatin + capecitabine as second-line chemotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2013 |
[A case of advanced gastric cancer with bulky lymph node metastases responding to S-1/CDDP neoadjuvant chemotherapy and leading to less invasive surgery and a pathologically complete response].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Humans; L | 2013 |
Treatment outcome of high-dose-rate interstitial radiation therapy for patients with stage I and II mobile tongue cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brachytherapy; Carboplatin; | 2013 |
Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Combined | 2014 |
Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Combined | 2014 |
Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Combined | 2014 |
Salvage gastrectomy after intravenous and intraperitoneal paclitaxel (PTX) administration with oral S-1 for peritoneal dissemination of advanced gastric cancer with malignant ascites.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Ascites; Combined | 2014 |
A retrospective study of S-1 and oxaliplatin combination chemotherapy in patients with refractory pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemo | 2013 |
[A case of recurrent pancreatic cancer effectively responding to S-1 combined irinotecan third-line chemotherapy with PSK].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Combinations; Female; Human | 2013 |
[A case of advanced gastric cancer with regional lymph node metastasis showing pathological complete response after preoperative chemotherapy with docetaxel, cisplatin, and S-1].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Humans; Lym | 2013 |
[A case of effective multidisciplinary treatment for advanced gallbladder carcinoma with distant lymph node metastases].
Topics: Antineoplastic Agents; Combined Modality Therapy; Deoxycytidine; Drug Combinations; Female; Gallblad | 2013 |
[A case of gastric cancer with intensive peritoneal dissemination treated with long-term chemotherapy and surgery].
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Combinati | 2013 |
[A case of advanced gastric cancer with para-aortic lymph node metastasis successfully treated with preoperative S-1/Lentinan chemotherapy followed by curative gastrectomy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Biopsy; Drug Combinations; Gastrectomy; | 2013 |
[A case of locally advanced residual gastric cancer treated with combined resection of multiple adjacent organs].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hepatecto | 2013 |
[Pathological complete response in advanced gastric carcinoma with lymph node metastasis treated with combination neoadjuvant chemotherapy comprising S-1 and cisplatin-a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Humans; L | 2013 |
[A case of advanced gastric cancer responding to combined systemic and intraperitoneal chemotherapy with docetaxel, cisplatin, and S-1].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Gastrectomy | 2013 |
[A case of SPT therapy( S-1+CDDP+trastuzumab) was successful for HER2-positive gastric cancer accompanied by distant lymph node metastasis].
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug C | 2013 |
[A case of delayed subcutaneous metastases of gastric carcinoma effectively treated with S-1 plus cisplatin chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Drug Combina | 2013 |
[Long-term survival after surgical resection of a cancer of unknown primary site-a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Combination | 2013 |
Surgical treatment and adjuvant chemotherapy for patients with biliary tract cancer: single institution experience of 100 patients.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Biliary Tract Neoplasms; Biliary Tr | 2013 |
[A case of complete response(CR)to S-1 and paclitaxel(PTX)combination therapy in a patient with unresectable gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Humans; Lymphatic M | 2014 |
[A case of advanced gastric cancer treated with curative resection after preoperative combined chemotherapy with docetaxel, cisplatin, and S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Femal | 2014 |
Clinical evaluation of cetuximab combined with an S-1 and oxaliplatin regimen for Chinese patients with advanced gastric cancer.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Cetu | 2014 |
Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer.
Topics: Adult; Aged; Aged, 80 and over; Amino Acid Transport System ASC; Amino Acid Transport System y+; Ant | 2014 |
A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for stage III/IV gastric cancer (CCOG 1106).
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; | 2015 |
[A case of advanced gastric cancer with para-aortic lymph node metastases responding to S-1/CDDP chemotherapy that leads to a pathological complete response].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Combined Modality Therapy; D | 2014 |
Clinicopathological features and outcomes of gastric cancer patients with pulmonary lymphangitis carcinomatosa.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; H | 2014 |
S-1 vs. gemcitabine as an adjuvant therapy after surgical resection for ductal adenocarcinoma of the pancreas.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Pancreatic Ductal; Chemo | 2014 |
[A case of a patient with gastric cancer and peritoneal dissemination who survived for more than 10 years after successful treatment with S-1].
Topics: Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Female; Gastrectomy; | 2014 |
[A case of squamous cell carcinoma of the nipple skin successfully treated with S-1 alone].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Carcinoma, Squamous Cell; | 2014 |
[A case of gastric cancer with N2 lymph node metastasis and pancreatic invasion effectively treated with docetax-el/S-1 as a neoadjuvant chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Lymphati | 2014 |
[A case of advanced gastric cancer with multiple liver, lung, and lymph node metastases treated with S-1, CDDP, and trastuzumab].
Topics: Adenocarcinoma; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; C | 2014 |
Is pancreatic fistula associated with worse overall survival in patients with pancreatic carcinoma?
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemother | 2015 |
Adjuvant chemoradiation with 5-fluorouracil/leucovorin versus S-1 in gastric cancer patients following D2 lymph node dissection surgery: a feasibility study.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carc | 2014 |
Hepatobiliary and pancreatic: sigmoidal mesenterial lymph node metastasis from pancreatic cancer.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Colon, | 2014 |
Treatment of stage IV gastric cancer with induction chemotherapy using S-1 and cisplatin followed by curative resection in selected patients.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Mod | 2014 |
Impact of S-1 plus Cisplatin Neoadjuvant Chemotherapy on Scirrhous Gastric Cancer.
Topics: Adenocarcinoma, Scirrhous; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy | 2015 |
[A case of recurrent gastric cancer successfully treated with S-1 oral administration].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Drug Combinations; Fatal Outcome; Femal | 2015 |
[A case of liver and para-aortic lymph node metastasis of colorectal cancer responding to S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Aorta; Colonic Neoplasms; Drug Combinations; Female; Humans; | 2015 |
[A case of pathological complete response to lt. Lateral lymph node metastasis from lower rectal cancer by S-1 combined neoadjuvant chemoradiotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Drug Combinations | 2014 |
[Two cases of advanced gastric cancer achieved pathological complete response by preoperative chemotherapy with S-1 plus weekly low-dose CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hum | 2014 |
[A case report of advanced gastric cancer with bulky lymph node metastases successfully treated with induction chemotherapy followed by curative resection].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Combinations; Female; Gastrectomy; Humans; Induction Che | 2014 |
[A case of advanced gastric cancer successfully treated with second-line chemotherapy followed by curative conversion gastrectomy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Combined Modality Therapy; Drug | 2014 |
[A case of successful treatment of peritoneal dissemination from gastric cancer with S-1/DOC chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Gastrectomy; Hum | 2014 |
[A case of gastric cancer showing response to first-line XP regimen after lymph node recurrence during the administration of S-1 as postoperative adjuvant chemotherapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Chemotherapy, Ad | 2014 |
[A case of recurrent gastric cancer successfully treated with TS-1+CDDP chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Gastrectomy; Humans | 2014 |
[Locally Advanced Gastric Cancer Treated with Curative Gastrectomy and Showing Pathological Complete Response after Chemotherapy with S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Combinations; Gastrectomy; Humans; Lymphatic Metastasis; | 2015 |
Successful treatment of bilateral multiple lymph node metastases in extramammary Paget's disease with surgery and sequential chemotherapy of S-1 and docetaxel.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Docetaxel; Drug Com | 2015 |
[A Study of Preoperative Chemotherapy with S-1 plus Cisplatin for Advanced Gastric Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Gastrect | 2015 |
[A Case of Bone Metastasis from Early Gastric Cancer after a Five-Year Disease-Free Interval Following Gastrectomy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Combinations; Female | 2015 |
[Hepatic Resection of Multiple Liver Metastases from Gastric Cancer after Molecular Targeted Chemotherapy(S-1 plus Cisplatin plus Trastuzumab)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastrectomy; Hepatecto | 2015 |
[Four Cases of Primary Small Intestinal Cancer].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Duodenal Neoplasms; Fem | 2015 |
[A Case Report--A Synchronous Liver Metastasis from Gastric Cancer Treated with Chemotherapy, Surgical Resection of the Gastric Cancer, and RFA of the Liver Metastasis].
Topics: Aged; Antimetabolites, Antineoplastic; Catheter Ablation; Combined Modality Therapy; Drug Combinatio | 2015 |
[Multidisciplinary Therapy for Advanced Gastric Cancer with Liver and Brain Metastases].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality | 2015 |
[A Case of Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Humans | 2015 |
[A Case of Resected Advanced Gastric Cancer Exhibiting Pathological Complete Response after Neoadjuvant Che-motherapy(DTX/CDDP/S-1:DCS)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Human | 2015 |
[A Case of Advanced Gastric Cancer Responding to Neoadjuvant Docetaxel/CDDP/S-1 Therapy with Metallic Stent Placement, Leading to Curative Surgery].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Gastrectomy | 2015 |
[A Case of Advanced Gastric Cancer with Long-Term Survival after Chemotherapy with Combined S-1 and CPT-11].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Drug Combinations; Humans; Irinotecan; | 2015 |
[A Case of Recurrent Gallbladder Cancer with a Complete Response to S-1 Alternate-Day Administration].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Female; Gallbladder Neoplasms | 2016 |
Induction S-1+Concurrent Radiotherapy Followed by Surgical Resection of Locally Advanced Non-small-cell Lung Cancer in an Elderly Patient.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Drug Combi | 2016 |
The association between the duration of fluoropyrimidine-based adjuvant chemotherapy and survival in stage II or III gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cape | 2016 |
[A Case of Virchow's Lymph Node Recurrence of Gastric Cancer Who Had Underwent Gastrectomy, and Treated with S-1 Monotherapy Leading to Complete Response (CR)].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Combinations; Gastrectomy; Humans; Lymphatic Metastasis; | 2016 |
Prognostic Factors and Multidisciplinary Postoperative Chemoradiotherapy for Clinical T4a Tongue Cancer.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Chemoradioth | 2016 |
[Resection of Advanced Intrahepatic Cholangiocarcinoma after an Effective Response to S-1 and Gemcitabine Combination Therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Cholangiocarcinoma; Deoxy | 2016 |
[A Case of Long-Term Survival after Combination Therapy for Gastric Cancer with Synchronous Multiple Liver Metastasis].
Topics: Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Gastrectomy; Hepatectomy | 2016 |
Squamous cell carcinoma of the extrahepatic bile duct with metachronous para-aortic lymph node metastasis successfully treated with S-1 plus cisplatin.
Topics: Aged; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Extrahepatic; Carcinoma, Squ | 2016 |
Surgery after intraperitoneal and systemic chemotherapy for gastric cancer with peritoneal metastasis or positive peritoneal cytology findings.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th | 2017 |
[A Case of Successful Multidisciplinary Therapy for Advanced Esophagogastric Junction Cancer with Multiple Lymph Node Metastase].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Esoph | 2016 |
[A Case of Advanced Gastric Cancer with Para-Aortic Lymph Node Dissection after Neoadjuvant Chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Drug Combinations; Female; Humans; | 2016 |
[Long-Term Complete Response by S-1 Chemotherapy for Gastric Cancer with Para-Aortic Lymph Node Metastases].
Topics: Aged; Antimetabolites, Antineoplastic; Aorta; Drug Combinations; Gastrectomy; Humans; Lymph Node Exc | 2016 |
[A Case of Advanced Gastric Cancer with a Pathological Complete Response after Neoadjuvant Chemotherapy(S-1/Oxaliplatin)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Gastrectomy; Humans; Lymphatic Me | 2016 |
[A Case of Pathological Complete Response after SOX Chemotherapy in Advanced Gastric Cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Female; Gastrectomy; Humans | 2016 |
[A Case of Lymph Node Metastasis of Intrahepatic Bile Duct Cancer Successfully Treated Using Multidisciplinary Therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; | 2016 |
[Case of gastric cancer with recurrence of carcinomatous lymphangiosis of the lung 7.6 years after surgery and successfully treated with S-1/low-dose CDDP/Lentinan combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Humans; | 2008 |
Pathological complete response induced by the combination therapy of S-1 and 24-h infusion of cisplatin in two cases initially diagnosed as inoperable advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone | 2008 |
[A case of complete response to combination therapy of S-1 and CDDP for Stage IV gastric cancer with Virchow's lymph node and para-aorta lymph node metastasis].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Biopsy; Carcinoembryonic Antigen; Cisplatin; | 2008 |
Long-term survival after multimodal therapy in a patient demonstrating intrahepatic cholangiocarcinoma with hilar invasion and intrahepatic metastases.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Bile Ducts, Intrahepatic | 2008 |
[A case of advanced gastric cancer with pulmonary carcinomatous lymphangitis and paraaortic lymph node metastases responding to combination chemotherapy of S-1 and irinotecan(CPT-11)].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Camptothecin; Drug Combinations; Female | 2008 |
[A case of advanced gastric cancer with giant lymph node metastasis responding to S-1/CDDP neoadjuvant chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Drug Combination | 2008 |
[Two cases of giant metastatic cervical lymphnode from oral cancer responding to concurrent chemoradiotherapy with S-1].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug C | 2008 |
[Marked response to combination chemotherapy using S-1, CPT-11 for lymph node metastasis of gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Drug Combinat | 2008 |
[A successful case of advanced nasal adenocarcinoma treated with tumor dormancy therapy with S -1 alone].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dis | 2008 |
Adenosquamous carcinoma of maxillary sinus: case showing complete response to S-1.
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ad | 2009 |
[Complete response obtained with first-line therapy as S-1, followed by second-line 5'-DFUR plus paclitaxel therapy in a patient with multiple liver and lymph node metastases from gastric cancer].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoembryonic Antigen; Drug Co | 2009 |
[Noticeable clinical response to S-1/CDDP combination therapy for Virchow node recurrence after surgery for advanced gastric carcinoma with marked involvement of the esophagus - report of a case].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cisplatin; Drug Combination | 2009 |
The usefulness of perfusion-weighted magnetic resonance imaging in advanced pancreatic cancer.
Topics: Aged; Antineoplastic Agents; Deoxycytidine; Drug Combinations; Female; Gemcitabine; Humans; Kaplan-M | 2009 |
[S-1/CDDP combined neoadjuvant chemotherapy and surgical resection for advanced gastric cancer. Analysis of 12 patients with lymph node metastasis in Saitama Red Cross Hospital].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2009 |
S-1 mediates the inhibition of lymph node metastasis in oral cancer cells.
Topics: Animals; Antimetabolites, Antineoplastic; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tu | 2009 |
[A case of gastric cancer with posterior mediastinal lymph node metastasis responding to combination therapy of Paclitaxel and S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Ch | 2009 |
[A case report of primary duodenal adenocarcinoma with marked lymph node metastases responding to chemotherapy with S-1 plus CDDP combination].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chem | 2009 |
Induction chemotherapy with S-1 plus cisplatin followed by surgery for treatment of gastric cancer with peritoneal dissemination.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Comb | 2009 |
[A case of advanced gastric cancer that a medical therapy effect was provided grade 3 by a histopathological diagnosis after long-term chemotherapy].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic C | 2009 |
[A case of advanced rectal cancer that responded to S-1 with an extended complete response].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Camptothecin; Drug Combina | 2009 |
[A case of effective chemoradiotherapy using S-1 and CDDP for left inguinal lymph node metastasis of anal canal carcinoma].
Topics: Administration, Oral; Aged; Anal Canal; Antimetabolites, Antineoplastic; Antineoplastic Agents; Anti | 2009 |
Preoperative chemotherapy with S-1 and cisplatin for highly advanced gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chem | 2009 |
[A case of advanced right colonic cancer successfully treated by surgery and post operative chemotherapy].
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites, | 2009 |
[A case of advanced gastric cancer with paraaortic lymph node recurrence reaching a long-term survival by S-1 chemotherapy].
Topics: Antimetabolites, Antineoplastic; Aorta, Abdominal; Chemotherapy, Adjuvant; Drug Combinations; Humans | 2009 |
[A case of recurrence gastric cancer patient who was post operated and multi drug chemotherapy was effective for administration of S-1 and docetaxel combination therapy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco | 2009 |
[Two cases of advanced gastric cancer with peritoneal dissemination, and Virchow's metastases successfully treated by combination therapy of S-1 and docetaxel].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy | 2010 |
[S-1 + CPT-11 combination therapy with continuing 30-month CR in a recurrent gastric cancer with para-aortic lymph node metastasis in adjuvant chemotherapy with S-1--a case report].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemothe | 2010 |
[A case of gastric cancer with Virchow and para-aortic node metastases treated successfully using S-1].
Topics: Antimetabolites, Antineoplastic; Drug Combinations; Female; Gastrectomy; Humans; Lymph Node Excision | 2010 |
[A case of advanced gastric cancer with distant lymph node metastases in cervical, supraclavicular and superior mediastinum successfully treated with S-1/Cisplatin (CDDP)/Lentinan combination chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Gastrosc | 2010 |
[A case of metachronous multiple lung metastases and intraabdominal lymph node metastases of rectal cancer responding to S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Humans; Lung Neoplasms; Lym | 2010 |
[A 14-month surviving patient on advanced esophageal cancer with big lymph node metastasis to cardia responding to S-1 plus cisplatin (CDDP) therapy at home].
Topics: Aged; Antineoplastic Agents; Cardia; Cisplatin; Drug Combinations; Esophageal Neoplasms; Esophagosco | 2008 |
[A case of advanced gastric cancer responding to neoadjuvant chemotherapy with S-1 and CDDP combination].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Gastrosc | 2010 |
[A patient with small intestinal cancer and extensive lymph node metastasis who responded to S-1].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Drug Combinations; Endosc | 2010 |
Characterization of a novel lymph node metastasis model from human colonic cancer and its preclinical use for comparison of anti-metastatic efficacy between oral S-1 and UFT/ LV.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Colonic Neoplasms; Drug C | 2010 |
Combination effect of a TGF-beta receptor kinase inhibitor with 5-FU analog S1 on lymph node metastasis of scirrhous gastric cancer in mice.
Topics: Activin Receptors, Type I; Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Combination | 2010 |
Eight-year survival after advanced gastric cancer treated with S-1 followed by surgery.
Topics: Aged; Antimetabolites, Antineoplastic; Disease-Free Survival; Drug Combinations; Humans; Lymphatic M | 2010 |
[Three cases of gastric cancer with para-aortic lymph node metastases succesfully treated by S-1/CDDP combination therapy followed by curative resection].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Combined Modality Therapy; D | 2010 |
[A case of gastric cancer with para-aortic lymph node metastasis successfully treated with S-1/paclitaxel/lentinan combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Biopsy; Combined Modality Therapy; Drug | 2010 |
Metastatic cutaneous squamous cell carcinoma treated successfully with surgery, radiotherapy and S-1/cisplatin chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cis | 2010 |
[A case of luminal B recurrent breast cancer with liver and lymph node metastases successfully treated with combination therapy of S-1 plus trastuzumab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Prot | 2010 |
[A case of advanced gastric cancer responding to S-1/paclitaxel/lentinan as neoadjuvant chemoimmunotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Gastrectomy; Humans; Lentin | 2010 |
[A case of cervical lymph node recurrence of advanced gastric cancer responding to combination therapy of S-1, CDDP and docetaxel].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Humans; Lym | 2010 |
A case of pathological complete response of advanced rectal cancer to preoperative chemoradiotherapy using S-1.
Topics: Adult; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Colostomy; Drug Combinations; Female | 2010 |
[Response in a case of inoperable bile duct cancer treated by combined chemotherapy of S-1 and gemcitabine].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bile Duct Neoplasms; Deoxycytidine; Drug Combination | 2010 |
[Combination chemotherapy of S-1, docetaxel and CDDP produces a remarkable response in a patient with metastases of supraclavicular lymph nodes and gingival carcinoma of the mandible].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clavicle; Docetaxel; Drug Combinations; F | 2010 |
[Complete histological response in advanced gastric cancer with Virchow's node metastasis after chemotherapy including S-1/CDDP--report of a case].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco | 2010 |
Efficacy and toxicity of concurrent chemoradiotherapy with nedaplatin and S-1 for head and neck cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Combined Modality Th | 2011 |
[A case of multi-drug resistant breast cancer with liver metastasis treated effectively by S-1 monotherapy].
Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Carcinoma, Ductal, Breast; Drug Combinations; Dru | 2010 |
[A case of advanced colon cancer with metastases to both supraclavicular and para-aortic lymph nodes effectively treated by radiation and S-1 therapy].
Topics: Administration, Oral; Colonic Neoplasms; Combined Modality Therapy; Drug Combinations; Female; Human | 2010 |
[A 6-year survival case of locally advanced unresectable pancreatic tail cancer treated with chemo-radiation therapy].
Topics: Combined Modality Therapy; Deoxycytidine; Drug Combinations; Fatal Outcome; Gemcitabine; Humans; Lym | 2010 |
[A clinical case of lymph node recurrence after resection of gastric cancer successfully treated by combination chemotherapy with irinotecan and cisplatin].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineopl | 2010 |
[Highly advanced gastric cancer that responded to neoadjuvant combination chemotherapy with docetaxel/CDDP/S-1 (DCS)].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco | 2010 |
[A case of advanced gastric cancer successfully treated with chemoradiotherapy targeting for recurrent lymph node metastasis].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2010 |
[Report of two cases successfully treated by chemo-radiation against lymph node metastasis after gastric cancer surgery].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2010 |
[A case of gastric endocrine cell carcinoma with liver metastases treated with S-1/CDDP].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Ant | 2010 |
[A long-term disease-free survival case of advanced rectal cancer with massive metastasis to the lateral pelvic and para-aortic lymph nodes].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined C | 2010 |
[A case report of primary adenocarcinoma of small intestine].
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; | 2010 |
[A case of multiple para-aortic lymph node metastases from squamous cell carcinoma of an unknown primary responding completely to chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Carcinoma, Squamous Cell; Cisplatin; Drug Com | 2011 |
Macroscopic tumor size as an independent prognostic factor for stage II/III gastric cancer patients who underwent D2 gastrectomy followed by adjuvant chemotherapy with S-1.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuv | 2011 |
[Efficacy of concurrent chemoradiotherapy in cases with cervical lymph node metastasis from oropharyngeal or hypopharyngeal cancer].
Topics: Adult; Aged; Aminohydrolases; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Ther | 2011 |
Early gastric cancer combined with multiple metachronous osteosclerotic bone and bone marrow metastases that responded to chemoradiotherapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Neoplasms; Bone Ne | 2011 |
[Effect of S-1 in a patient with metastatic eyelid sebaceous carcinoma].
Topics: Aged; Drug Combinations; Eyelid Neoplasms; Female; Humans; Lymphatic Metastasis; Oxonic Acid; Positr | 2011 |
A case of gastric cancer accompanied with massive splenic invasion by metastatic lymph nodes.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Endoscopy, Digestive S | 2011 |
[Advanced gallbladder cancer that showed complete response to gemcitabine plus S-1 chemotherapy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug | 2011 |
Stereotactic radiosurgery in combination with chemotherapy as primary treatment for head and neck cancer.
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Proto | 2012 |
[An elderly gastric cancer patient with multiple-node metastases treated successfully using S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Biopsy; Combined Modality Therapy; Drug Combinations; Humans; | 2011 |
[Complete response to S-1/CDDP combination in a patient with obstructive jaundice secondary to lymph node metastasis by gastric cancer - a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Female; Humans; Jaundi | 2011 |
[A case of breast cancer with postoperative metastasis to the supraclavicular lymph nodes-recurrence-free survival achieved by surgical excision following chemotherapy].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Biopsy, Needle; Breast Neoplasms; Clavicle; Combine | 2011 |
Intraperitoneal docetaxel combined with S-1 for advanced gastric cancer with peritoneal dissemination.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Ther | 2012 |
Successful treatment of metastatic extramammary Paget's disease with S-1 and docetaxel combination chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Docetaxel; Drug Combinations; | 2011 |
[Evaluation of pre-operative chemotherapy with S-1 plus CDDP against advanced gastric cancer with paraaortic lymph node metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Combined Modality Therapy; D | 2011 |
Efficacy of pre-operative chemotherapy with docetaxel, cisplatin, and S-1 (DCS therapy) and curative resection for gastric cancer with pathologically positive para-aortic lymph nodes.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Doce | 2012 |
Combined analysis of dihydropyrimidine dehydrogenase and human equilibrative nucleoside transporter 1 expression predicts survival of pancreatic carcinoma patients treated with adjuvant gemcitabine plus S-1 chemotherapy after surgical resection.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biom | 2012 |
Clinical experience with chemoradiotherapy comprising S-1 plus low-dose cisplatin in a patient with stage IV anal cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Chemoradiotherapy; Cisplatin; Drug C | 2011 |
Risk factors for peritoneal recurrence in stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomy.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Co | 2012 |
Neo-adjuvant chemoradiation therapy using S-1 followed by surgical resection in patients with pancreatic cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemoradiotherapy; | 2012 |
[A case report of chemoradiotherapy combined with S-1 responding to squamous cell carcinoma of the anal canal].
Topics: Aged; Antimetabolites, Antineoplastic; Anus Neoplasms; Carcinoma, Squamous Cell; Chemoradiotherapy; | 2011 |
[Prognosis and clinical course of gastric cancer with para-aortic lymph node metastasis after curative D2 gastrectomy and adjuvant chemotherapy with S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Aorta; Combined Modality Therapy; Drug Combinations; Female; | 2011 |
[A case of locally advanced gastric cancer responding to preoperative S-1/CDDP combination chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Combinati | 2011 |
[A case of residual metastatic lymph node lesion following definitive chemoradiotherapy for T4 esophageal cancer, successfully treated by outpatient clinic-based sequential chemotherapy with docetaxel followed by S-1].
Topics: Aged; Ambulatory Care Facilities; Antineoplastic Agents; Chemoradiotherapy; Docetaxel; Drug Combinat | 2011 |
[A case of long-term survival of a patient with intrahepatic bile duct cancer and early nodal recurrence who responded to S-1 therapy].
Topics: Aged; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Drug Combinati | 2011 |
[A case of advanced gastric cancer with multiple bone metastases and distant lymph node metastases successfully treated by S-1/CDDP combination chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Combinations; Humans | 2012 |
[A case of S-1-resistant resected advanced gastric cancer with para-aortic lymph node recurrence responding to bi-weekly CPT-11 and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta, Abdominal; Camptothecin; Cisplatin; Drug Comb | 2012 |
Pilot feasibility study of neoadjuvant chemoradiotherapy with S-1 in patients with locally advanced gastric cancer featuring adjacent tissue invasion or JGCA bulky N2 lymph node metastases.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Anorexia; Antimetabolites, Antineoplastic; Chemoradiotherap | 2012 |
[Two cases of stage IV gastric cancer undergoing adjuvant surgery after down staging by chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Humans; Liver Ne | 2012 |
[A case of advanced hepatocellular carcinoma with lung, brain and lymph node metastases recurred 8 years after hepatectomy successfully treated by operation, radiation and systemic chemotherapy using S-1/CDDP].
Topics: Adult; Antimetabolites, Antineoplastic; Brain Neoplasms; Carcinoma, Hepatocellular; Combined Modalit | 2012 |
[A case of advanced gastric cancer with recurrence-free long survival showing disappearance of distant lymph node metastases by S-1/docetaxel therapy followed by curative resection].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Combinations; Humans; Lymphati | 2012 |
[Two cases of long-term response treated by S-1 with concurrent radiotherapy followed by S-1 treatment for non-small cell lung cancer patients].
Topics: Adult; Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Drug Comb | 2012 |
Diagnostic validity of CT gastrography versus gastroscopy for primary lesions in gastric cancer: evaluating the response to chemotherapy, a retrospective analysis.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug | 2013 |
[A case of paraaortic lymph node metastasis of gastric cancer resistant to chemotherapy successfully treated with chemoradiation therapy].
Topics: Antimetabolites, Antineoplastic; Aorta; Chemoradiotherapy; Drug Combinations; Humans; Lymphatic Meta | 2012 |
[A case report of advanced gastric cancer with increased C-reactive protein(CRP) and decreased albumin levels: chemotherapy with nutritional supportive care using eicosapentaenoic acid (EPA)-enriched enteral nutrition agent].
Topics: Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein; Cisplatin; Drug Combinations; Ei | 2012 |
[A clinical case of lymph node recurrence after the resection of esophagogastric junction cancer treated by chemoradiation therapy].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Chemoradiotherapy; Drug Combinations; Esophagogastr | 2012 |
[A case of gastric cancer with paraaortic lymph node metastasis responding to TS-1/CDDP as neoadjuvant chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Drug Administratio | 2002 |
[A case of gastric carcinoma with metastasis in a paraaortic lymph node that responded to TS-1/CDDP combination therapy, in which the patient was able to undergo extirpation with grade B curability].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Drug Administration Schedule; Drug | 2002 |
[Complete response in a case of recurrent gastric cancer treated with TS-1].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antimetabolites, Antineoplastic; Drug Administration Sch | 2002 |
[A case of advanced gastric cancer with invasion of pancreas effectively treated by combined chemotherapy of TS-1 and paclitaxel (TXL)].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Administration Schedule | 2002 |
[Complete response in a case of advanced scirrhous type 3 gastric cancer of with bulky N2 para-aorta lymph node metastases treated by combined chemotherapy of TS-1 and CDDP].
Topics: Adenocarcinoma, Scirrhous; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Drug Ad | 2002 |
[TS-1/CDDP therapy for advanced gastric cancer as neoadjuvant chemotherapy].
Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedul | 2002 |
[A case of recurrent advanced gastric cancer suggesting the efficacy of TS-1 and CDDP combination chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Aorta; Bone Neoplasms; Chemotherapy, | 2002 |
[A case of stage IV gastric carcinoma with lymph nodes metastases of the paraaorta responding markedly to TS-1].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Aorta; Chemotherapy, Adjuvant; Cispl | 2002 |
[A case of advanced lateral wall oropharyngeal carcinoma showing complete response to chemotherapy with TS-1].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Combined Modality | 2003 |
[A case of advanced gastric adenocarcinoma with mild elevation of serum SCC that responded remarkably to adjuvant chemotherapy of ADM, CDDP, ETP and 5-FU (ACVF)].
Topics: Adenocarcinoma; Aged; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Chemothera | 2003 |
[A case of advanced gastric cancer treated with paclitaxel and TS-1].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Gas | 2003 |
[Treatment outcomes with paclitaxel for advanced gastric cancer patients previously treated with TS-1].
Topics: Adenocarcinoma; Adult; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Proto | 2003 |
[A case report--TS-1/CDDP combined chemotherapy found effective for metastatic recurrence after operation for colon cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colon, Sigmoid; Combined Modality T | 2003 |
[A case of advanced gastric cancer resected after successful treatment with the novel oral anticancer drug TS-1].
Topics: Adenocarcinoma; Administration, Oral; Antimetabolites, Antineoplastic; Drug Administration Schedule; | 2003 |
S-1 in the treatment of advanced and recurrent gastric cancer: current state and future prospects.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug | 2003 |
Efficacy and safety profile of S-1 in patients with metastatic gastric cancer in clinical practice: results from a post-marketing survey.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Drug Combinations; Drug Evaluation; Fe | 2003 |
Longterm control of advanced and recurrent gastric cancer (ARGC) by S-1.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Dose-Response Relationship, Drug; D | 2003 |
Dihydropyrimidine dehydrogenase (DPD) activity in gastric cancer tissue and effect of DPD inhibitory fluoropyrimidines.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Dihydrouracil Dehyd | 2003 |
[A case of gastric cancer with metastasis to cervical lymph nodes and pulmonary lymphangitis carcinomatosa responding to neoadjuvant chemotherapy with TS-1 and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Cisplatin; Drug Combinations; Gastrectomy | 2003 |
[Sustained NC status for a long period after combined chemotherapy of TS-1 and CDDP for residual lesions following gastrectomy for gastric cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administ | 2003 |
[A case of advanced gastric cancer with abdominal paraaortic lymph node swelling successfully resected following neoadjuvant chemotherapy of TS-1 and low-dose cisplatin].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Aorta, Abdominal; Cisplatin; Drug Ad | 2003 |
[A case of advanced gastric cancer which became operable after chemotherapy with combination of TS-1/CDDP and in which complete disappearance of liver metastasis was histopathologically confirmed].
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined | 2003 |
[A case of advanced gallbladder cancer with biliary tract stenosis which responded to TS-1 chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Diseases; Cisplatin; Constriction, Pat | 2003 |
[A case of advanced gastric carcinoma successfully treated with TS-1/CDDP as a neoadjuvant chemotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, Adjuvant; Cisplatin; | 2003 |
[Remarkable response of simultaneous advanced esophageal and gastric cancer to combined chemotherapy with weekday-on/Weekend-off TS-1 plus biweekly cisplatin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Carcinoma, Squamo | 2003 |
[A case of advanced gastric cancer attaining histological CR of paraaortic lymph node after TS-1/CDDP neoadjuvant chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta; Chemotherapy, Adjuvant; Cisplatin; Drug Admin | 2003 |
[A case of advanced gastric cancer responding to neoadjuvant TS-1/CDDP therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; D | 2003 |
[A case of advanced gastric cancer with multiple liver metastases responding to TS-1 and CDDP].
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Adminis | 2003 |
[A case of distant metastasis from advanced gastric cancer treated with TS-1, which maintained NC (no change) for 9 months].
Topics: Administration, Oral; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinatio | 2003 |
[A case of lymph node recurrence after curative operation of type 4 gastric cancer, successfully treated with TS-1].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinatio | 2003 |
[A case of lymph node metastasis after total laryngectomy successfully treated with chemoradiotherapy with TS-1].
Topics: Antimetabolites, Antineoplastic; Drug Combinations; Humans; Laryngeal Neoplasms; Laryngectomy; Lymph | 2003 |
[A case of effective response to TS-1 of inoperable gastric cancer, in the course of chemotherapy for malignant lymphoma].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinatio | 2003 |
Histological complete response in a case of advanced gastric cancer treated by chemotherapy with S-1 plus low-dose cisplatin and radiation.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Adm | 2003 |
[Concurrent chemoradiation experience of recurrent gastric cancers resistant to TS-1].
Topics: Aged; Antineoplastic Agents, Phytogenic; Camptothecin; Drug Administration Schedule; Drug Combinatio | 2003 |
[A case of advanced maxillary carcinoma with cervical lymph node metastases showing a complete response to the combination therapy of CDDP, TS-1 and radiation].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuva | 2004 |
[A case of neck metastasis from hypopharyngeal carcinoma successfully treated with TS-1].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Drug Administration Schedule; Drug Combin | 2004 |
[A case of metastatic esophageal cancer responding remarkably to combination chemotherapy of TS-1 and cisplatin].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Drug Administra | 2004 |
[A case of heterochronous liver metastasis of gastric cancer favorably responding to TS-1].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Adminis | 2004 |
[A case of advanced gastric cancer with bulky N2 lymph node metastases resected after successful treatment with TS-1].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Administration Sche | 2004 |
[A case of advanced gastric cancer with a tumor embolus in the portal vein successfully treated with TS-1 and CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug | 2004 |
[A case of paraaortic lymph nodes metastases responding to TS-1 following surgery for gastric cancer].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Aorta; Combined Modality Therapy; Drug Administrati | 2004 |
[A complete response using TS-1 in a patient with paramesenteric lymph node recurrence of gastric cancer].
Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Administratio | 2004 |
[A case of recurrent gastric cancer tolerant to TS-1 therapy successfully treated by TS-1 combined with docetaxel].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Docetaxel; Drug Administrati | 2004 |
[A case of gastric cancer with abdominal paraaortic lymph node metastases responding to TS-1 plus CDDP neoadjuvant chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Aorta, Abdominal; Cisplatin; Drug Ad | 2004 |
[Gastric cancer with liver metastasis effectively treated by intra-hepatic arterial infusion].
Topics: Administration, Oral; Adult; Aged; Agmatine; Antineoplastic Combined Chemotherapy Protocols; Cisplat | 2004 |
[A case of gastric cancer with paraaortic lymph node metastasis responding to TS-1/CDDP combination therapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Aorta; Cisplatin; Combined Modality | 2004 |
[A case of advanced gastric cancer with multiple liver metastases successfully treated with TS-1 and CDDP].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration | 2004 |
[Clinical efficacy of TS-1 combined with cisplatin for advanced cardiac gastric cancer with multiple liver metastases--two case reports].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cardia; Cisplatin; Drug Admini | 2004 |
[Three advanced gastric cancer patients successfully treated by combination therapy of docetaxel and TS-1].
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Adm | 2005 |
[A case of advanced gastric cancer with pulmonary carcinomatous lymphangiosis responding remarkably to combination chemotherapy of docetaxel (TXT) and TS-1].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Docetaxel; Drug Administration Sched | 2005 |
[A case of advanced gastric cancer effectively treated by TS-1 for 4 years].
Topics: Adenocarcinoma; Administration, Oral; Antimetabolites, Antineoplastic; Drug Administration Schedule; | 2005 |
[Successfully resected advanced gastric carcinoma after combined chemotherapy of TS-1 plus CDDP--a case report].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality T | 2005 |
[A case of gastric cancer with peritoneal recurrence which developed during adjuvant administration of TS-1 showing complete response by weekly docetaxel regimen].
Topics: Adenocarcinoma; Antineoplastic Agents, Phytogenic; Carcinoembryonic Antigen; Chemotherapy, Adjuvant; | 2005 |
[Stage IV gastric cancer patient who underwent palliative gastrectomy showing complete response to induction therapy with methotrexate plus 5-fluorouracil and secondary treatment with oral TS-1].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Pr | 2005 |
[An unresectable advanced gastric cancer with Virchow's metastasis, carcinomatous ascites and rectal stenosis, effectively managed with combined chemotherapy of biweekly paclitaxel and TS-1].
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined C | 2005 |
[A case of gastric cancer with abdominal para-aortic lymph node metastases responding to TS-1 + CDDP neoadjuvant chemotherapy].
Topics: Aorta, Abdominal; Cisplatin; Drug Combinations; Drug Therapy, Combination; Female; Humans; Lymphatic | 2005 |
[A case of transverse colon cancer with left supraclavicular lymph node metastasis and paraaortic lymph node metastases responding to TS-1].
Topics: Antimetabolites, Antineoplastic; Aorta; Biomarkers, Tumor; CA-19-9 Antigen; Clavicle; Colectomy; Col | 2005 |
[Preoperative combination chemotherapy with TS-1 is effective in a case gastric cancer with peritoneal dissemination].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Ascites; Cisplatin; Drug Administrat | 2005 |
[A case of advanced gastric cancer responding to neoadjuvant TS-1/CDDP chemotherapy].
Topics: Adenocarcinoma; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dru | 2005 |
[A case of advanced gastric cancer with paraaortic lymph node metastasis reaching long-term survival by TS-1 treatment].
Topics: Antimetabolites, Antineoplastic; Aorta; Colectomy; Combined Modality Therapy; Disease-Free Survival; | 2005 |
[Prediction and treatment of peritoneal dissemination in gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combination | 2005 |
[Two cases of advanced gastric cancer, successfully treated with TS-1/CDDP combination chemotherapy--case report].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched | 2005 |
[A case of advanced gastric cancer with obstructive jaundice that responded to TS-1/CPT-11 combination therapy after percutaneous transhepatic cholangio drainage].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract; Camptothecin; Combined Modality Thera | 2005 |
[A case of primary small intestinal cancer accompanied by virchow lymph node metastasis undergoing TS-1 treatment].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinatio | 2005 |
[Neoadjuvant chemotherapy using TS-1 and CDDP against large type 3/Type 4/Bulky N 2 advanced gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug | 2005 |
[Radiation therapy leading to complete response of residual lymph node metastasis in advanced gastric cancer].
Topics: Aged; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Gastrectomy; Hu | 2005 |
[A case of synchronous gastric and hepatocellular carcinoma successfully treated by TS-1 and hepatic arterial infusion chemotherapy (HAI) of low-dose CDDP].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellula | 2005 |
[A case of stage IV gastric cancer previously treated with TS-1 completely responding to second-line chemotherapy with weekly paclitaxel therapy].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Chemothera | 2005 |
[Effective salvage chemotherapy with S-1 alone in a patient with lung metastasis of breast cancer].
Topics: Administration, Oral; Anthracyclines; Antimetabolites, Antineoplastic; Breast Neoplasms; Bridged-Rin | 2005 |
[A case of gastric adenosquamous carcinoma with abdominal paraaortic lymph node metastases successfully treated by TS-1 plus CDDP neoadjuvant chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta, Abdominal; Carcinoma, Adenosquamous; Chemothe | 2006 |
[Three advanced gastric cancer cases with liver metastases successfully treated by TS-1/CDDP combination therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Adm | 2006 |
[Two cases of gastric cancer with peritoneal dissemination that responded to TS-1 without progression or recurrence for over 3 years].
Topics: Aged; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Administration Schedule; Drug | 2006 |
[A case report of cancer of the lip--complete response by a neo-adjuvant chemotherapy using a novel method of TS-1 administration].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Chemotherapy, Adjuvant; Drug Administrati | 2006 |
[A case of scirrhous gastric cancer responding to TS-1/CDDP neoadjuvant chemotherapy].
Topics: Adenocarcinoma, Scirrhous; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Adm | 2006 |
[A case of advanced colon cancer with metastases to both para-aortic lymph nodes and cervical vertebrae effectively treated by TS-1 therapy].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Aorta; Cecal Neoplasms; Cervical Vertebrae; C | 2006 |
[A case of a second cancer of metachronous multiple primary non-small cell lung cancer successfully treated with TS-1 and CDDP chemotherapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinom | 2006 |
A feasibility study of sequential paclitaxel and S-1 (PTX/S-1) chemotherapy as postoperative adjuvant chemotherapy for advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Drug Combinatio | 2006 |
[A case of recurrent esophageal cancer responding to second-line chemotherapy of TS-1/docetaxel combination].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Chemotherapy, Adjuva | 2006 |
[A case of advanced gastric cancer successfully treated by TS-1 and CDDP after jejunostomy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Drug Admini | 2006 |
[A patient with hepatic, pulmonary, and nodal metastases of colon cancer responding to CPT-11/TS-1 therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colectomy; Colonic Neoplasms; Co | 2006 |
[A case of recurrent pancreatic cancer responding to TS-1 combined gemcitabine chemotherapy after UFT combined gemcitabine chemotherapy resulting progressive disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administration Schedule; Drug Co | 2006 |
[A case of inoperable gastric small cell carcinoma effectively treated by chemotherapy and radiotherapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Carcinoma, Smal | 2006 |
Complete response of a recurrent advanced urachal carcinoma treated by S-1/cisplatin combination chemotherapy.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; | 2006 |
[Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer].
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Administration | 2006 |
[A case of unknown primary cancer responding to TS-1].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinatio | 2006 |
[A case of advanced gastric cancer treated by TS-1 for 3 years and 7 months].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Comb | 2006 |
[A case of multi-drug resistant recurrent breast cancer with multiple bone metastasis responding to TS-1 and trastuzumab].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Prot | 2006 |
[A case of non-curatively resected gastric cancer successfully treated over 17 months with TS-1 and irinotecan combination therapy].
Topics: Anorexia; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Combined Modality Therapy; D | 2006 |
[A case of N3 gastric cancer successfully treated by TS-1 followed by curative resection].
Topics: Adenocarcinoma; Administration, Oral; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Combi | 2006 |
[A case of non-curatively resected colon cancer with liver and lymph node metastases treated by TS-1/CPT-11 combination therapy].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carcinoembryonic | 2006 |
Efficacy of S-1 for patients with peritoneal metastasis of gastric cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Dihydrouracil Dehydrogenase (NADP); | 2006 |
[A case of advanced gastric cancer with long-term survival treated by chemotherapy and surgical cytoreduction].
Topics: Adenocarcinoma, Mucinous; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Combin | 2006 |
[Two cases of advanced pancreatic cancer with cervical lymph node or liver metastasis responding well to S-1 monotherapy].
Topics: Adenocarcinoma; Administration, Oral; Aged; Anemia; Antimetabolites, Antineoplastic; Drug Administra | 2006 |
[Three cases of successfully resectable advanced gastric cancer responding to TS-1 plus CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Drug Adm | 2006 |
[A case of advanced gastric cancer with peritoneal dissemination responding remarkably to TS-1/CDDP combination chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched | 2006 |
[A case of advanced large cell lung carcinoma for whom fourth-line chemotherapy of cisplatin and gemcitabine proved effective for the first time].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Cisplatin; Deoxy | 2007 |
[A case of advanced gastric cancer successfully treated with TS-1/CDDP combination chemotherapy, able to maintain CR for more than two years against multiple liver metastases].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched | 2007 |
[Recurrent esophageal cancer with complete response to TS-1 chemotherapy].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Ther | 2007 |
A case of suspected S-1 induced interstitial pneumonia.
Topics: Adult; Antimetabolites, Antineoplastic; Diagnosis, Differential; Drug Combinations; Dyspnea; Female; | 2007 |
Successful treatment of S-1 + CDDP followed by salvage EMR for a case with metastatic Barrett's esophageal cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Barrett Esophagus; Cisplatin; Drug C | 2007 |
Combination therapy of S-1 and CDDP for patients with colorectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisp | 2007 |
[A case of advanced oral squamous cell carcinoma responding to concurrent radiotherapy with S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Drug Adm | 2007 |
[A case of ascending colon cancer with enlarged metastatic lymph nodes around superior mesenteric arterial root that responded dramatically to S-1 and CPT-11 combination chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colectomy; Colon, Ascending; Colonic N | 2007 |
[A case of multiple bone metastases from gastric cancer treated with combination chemotherapy of S-1 and CDDP].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cisplatin; Drug Admi | 2007 |
[A case of advanced gastric cancer with lung metastasis effectively treated by combination chemotherapy using S-1 and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Drug Adminis | 2007 |
[A case of unresectable advanced pancreatic cancer treated by S-1 with concurrent radiotherapy].
Topics: Adenocarcinoma; Aged; Ambulatory Care; Antimetabolites, Antineoplastic; Camptothecin; Drug Administr | 2007 |
[A case of S-1-resistant recurrent gastric cancer successfully treated with weekly administration of paclitaxel].
Topics: Antineoplastic Agents, Phytogenic; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Combin | 2007 |
[A case of breast metastasis of gastric cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Signet Ring Cell; Cispl | 2007 |
[Evaluation of combination therapy of high-dose toremifene and oral chemotherapy].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Capecitabine | 2007 |
[A patient with pulmonary metastasis from breast cancer after surgery who responded to S-1].
Topics: Adenocarcinoma; Antigens, Tumor-Associated, Carbohydrate; Antimetabolites, Antineoplastic; Biomarker | 2007 |
[A case of curatively resected AFP producing gastric cancer with massive lymph node metastasis effectively treated by neoadjuvant-chemotherapy of S-1 and CDDP].
Topics: Adenocarcinoma; Aged; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Chemothera | 2007 |
[A case of advanced gastric cancer responding remarkably to neo-adjuvant combination chemotherapy using CPT-11 plus S-1].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Ch | 2007 |
[A case of recurrence after resection of stage IV advanced bile duct cancer responding well to S-1/cisplatin combination chemotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy P | 2007 |
[A case of unresectable advanced pancreatic cancer with peritoneal dissemination responding to continuous dose S-1 monotherapy after chemo-radiation therapy].
Topics: Antimetabolites, Antineoplastic; Combined Modality Therapy; Deoxycytidine; Drug Combinations; Female | 2007 |
[A case of gastric cancer with severe lymph node metastasis effectively treated with docetaxel / S-1 as neoadjuvant chemotherapy].
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Docetaxel; Drug Combinations; Humans; | 2007 |
[A case of advanced gastric cancer with peritoneal dissemination responding to S-1/CDDP neoadjuvant chemotherapy].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Sched | 2007 |
[Marked response to S-1 chemotherapy for para-aortic lymph node metastasis arising from gastric cancer].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Aorta; Drug Administration Schedule; Drug Com | 2007 |
[A case of unresectable gastric cancer presenting pylorus stenosis treated orally with S-1 therapy after gastrojejunostomy].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Constriction, Pathologic; Drug Administ | 2007 |
Induction chemotherapy with S-1 plus cisplatin in patients with locally advanced squamous cell carcinoma of the head and neck.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Co | 2008 |
[Effect of S-1 in a patient with post-operative recurrence of carcinoma of the ampulla of Vater].
Topics: Ampulla of Vater; Antimetabolites, Antineoplastic; Common Bile Duct Neoplasms; Drug Combinations; Fe | 2007 |
[An elderly patient with recurrent rectal cancer successfully responded to S-1 combined with CPT-11].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Colonoscopy; Drug C | 2007 |
[Three successful cases with CPT-11 + CDDP chemotherapy where S-1 failed to respond to recurrent gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Cisplatin; Dr | 2007 |
The successfully curative treatment of advanced gastric adenocarcinoma with multiple liver metastases and paraaortic lymph node metastases by salvage operation following the biweekly paclitaxel and S-1 combination chemotherapy: a case report.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Drug Combinations; Endo | 2007 |
[A case of metastatic gastric endocrine cell carcinoma which could be curably resected after chemotherapy with S-1/CDDP].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Ce | 2008 |
[A complete response persisting for seven months with the use of TS-1 in a patient with paraaortic lymph node metastasis of gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta; Drug Administration Schedule; Drug Comb | 2000 |
[A case report of TS-1 in a patient with advanced gastric cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combination | 2000 |
[A case of recurrent gastric cancer successfully treated with TS-1].
Topics: Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinations; Female; Huma | 2001 |
[Complete response in a case of advanced gastric cancer with liver and intra-abdominal lymph node metastases treated by combined chemotherapy of TS-1 and CDDP].
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Drug Combin | 2001 |
[A case of postoperative gastric cancer responding to adjuvant chemotherapy with TS-1--a novel oral formation of 5-fluorouracil].
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Co | 2001 |
[A case of advanced gastric cancer successfully treated with TS-1].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Drug Combinations; Humans; Lymph Nodes; Lymphatic M | 2002 |
[Three cases of recurrent gastric cancer responding to TS-1 therapy following combination therapy with 5-fluorouracil, mitomycin C and cisplatin].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administ | 2002 |
[A case report of advanced gastric cancer responding to TS-1, a novel oral fluorouracil derivative].
Topics: Adenocarcinoma, Papillary; Administration, Oral; Aged; Antineoplastic Agents; Carcinoembryonic Antig | 2002 |
[A case of unresectable gastric cancer complicated by a serious hepatic disorder and Virchow lymph node metastasis in which FP therapy and TS-1 administration were effective].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocol | 2002 |